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a-Lactalbumin: Lactose, the major source of carbohydrate in most 
mammalian milks, is synthesised from glucose and UDP-galactose in a 
reaction catalysed by the enzyme lactose synthase (LS). The biosynthesis 
of LS is catalysed by the reversible binding o f the regulatory subunit a - 
Lactalbumin (LA) to Galactosyltransferase (GT, catalytic subunit) 
promoting the glucose binding (1000-fold decrease in Km for glucose).
An important feature of LA is that its three dimensional structure 
is similar to that of c-type lysozyme (LZ) and the two proteins are 
homologous (about 40% sequence identity) with divergent functions.
2+
LA binds calcium strongly (also other metal ions such as Zn , 
Mn2+, Co2+, Tb3+, Na+, K+) and specifically whereas in the LZs there are 
two subgroups, representing paralogous gene lines, of which only one 
binds Ca ion. High affinity Ca binding to LA stabilises the native 
structure and is required for the efficient generation of native protein 
with correct disulphide bonds from the reduced denatured state. At 
ambient temperature and low ionic strength the apo-protein assumes a 
molten globule state. Calcium greatly accelerates folding by binding to 
rate limiting intermediates in the folding process. To investigate the role 
of calcium in the LA structure with the goal of obtaining high-resolution 
data relevant to its role in folding and stability, X-ray structures at 2.2 A 
resolution have been determined for crystals o f the apo- and holo-forms 
of bovine LA. Although Ca removal has little effect on protein 
structure in the metal binding site, a significant structural change was 
observed in the LA cleft region at the periphery o f the hydrophobic box 
in the region around Tyr-103 of the helical lobe and Gln-54 of the beta 
lobe. This change results in a more open cleft structure in the apo-protein 
and appears to reflect an effect of calcium binding on buried solvent 
molecules which in turn affects interactions between the lobes. This
provides high-resolution structural information on the mechanism
2+ . 
through which Ca binding can facilitate the formation of packing
interactions in the inter-lobe region at later stages of folding.
Bovine LA had been used as a model system for the design of a 
series o f LA variants at regions proposed to be directly involved in LA 
action in LS complex in order to follow a ‘structure-based’ approach. A 
detailed structural investigation was performed for three LA variants: 
Alai 09-Pro, Tyr 103-Pro and Trpl 18-His while crystallisation conditions 
for additional four mutants: Phe31-Tyr, His32-Tyr, L ysll4-A sn have 
been established.
Retinol binding protein: Retinol binding protein (RBP) is a 
specific carrier protein synthesised in the hepatocytes. Its physiological 
role is the delivery of retinol to the peripheral target tissues. In the 
plasma it also forms a complex with transthyretin (TTR). Being a carrier 
protein, RBP molecule appears to be a good model protein for protein 
engineering studies and for the design of molecules that will enable RBP 
to transport not only drugs but also other molecules.
Investigations into the relationship between sequence 
conservation, stability and folding with RBP had been performed and in 
the context of these studies the high-resolution structures of rRBP and a 
double variant W67L/W91H was determined at 1.7 and 2.0 A resolution 
respectively. The overall structures of the two proteins are very similar 
and the most ordered region of the molecule was formed by residues 
surrounding the p-barrel in both cases apart from the flexible 62-68 loop. 
Glycerol molecules (used during data collection as cryoprotectant) and 
water molecules were identified bound in the core of the p-barrel at the 
retinol binding site.
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Chapter 1.: Crystallisation o f proteins 1
1.1. CRYSTALLISATION OF PROTEINS
1.1.1. Factors affecting the crystallisation of proteins
Proteins subjected to crystallisation trials are obtained either by 
means of protein engineering or by isolation from a natural source and 
should be pure and homogeneous. Screening of various crystallisation 
conditions are carried out where parameters that affect the formation (or 
quality in the case of already established conditions) of the crystals are 
adjusted to achieve the optimum.
A crystal is an orderly three-dimensional array of molecules held 
together by non-covalent interactions. The crystallisation conditions that 
are used should fulfil two aims: (i) to reach a point of supersaturating at 
which crystals are formed and (ii) to enable the crystals to grow large 
enough for diffraction studies.
A protein is considered to be a large polyvalent ion and its 
solubility depends on interactions of the molecule with water. Ionic 
strength, pH, temperature and organic solvents are factors that affect the 
solubility of a protein in different ways.
Kam et al. (1978) have proposed three distinct phases that 
describe the production of usable crystals judging from their size and 
their population: (i) the nucleation; it is the process during which 
aggregates begin to grow when they reach a critical size (nucleus), (ii) 
the post-nucleation growth; it is defined by the rate o f transport o f 
protein molecules to the crystal and the probability of attachment o f a 
molecule which decreases when the diffusion of protein molecules is 
slow (the rate of deposition of protein mass at the crystal surface is
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given by Fick’s law), (iii) the cessation o f  growth; it must be due to a 
modified property of the crystal surface. The faster the crystals grow, 
the larger their number and the smaller their terminal size. Re-growth of 
the terminal sized crystals, cut into pieces to approximately the same 
terminal size has been observed for the exposed surface and the 
poisoning of favourable growth sites on the surface by impurities is 
been considered as a possible cause (Blundell and Johnson, 1976; Feher, 
1986; Kam et al., 1978).
1.1.2. Vapour diffusion as a crystallisation technique
In the most common methods of growing protein crystals, purified 
protein is dissolved in an aqueous buffer containing a precipitant such as 
ammonium sulphate or polyethylene glycol, at a concentration below 
that necessary to precipitate the protein (McPherson, 1982). Vapour 
diffusion is the most widely used method for crystallisation, in which 
the protein/precipitant solution is allowed to reach equilibrium in a 
closed container with a larger aqueous reservoir where the precipitant 
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this technique is the ‘hanging-drop method’ according to which equal 
volumes of the purified protein (usually dissolved in water) and the 
reservoir solution are mixed, and the new solution is suspended as a 
droplet underneath a cover slip, sealed onto the top of the reservoir with 
vacuum grease (Figure 1.1).
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1.2. PRINCIPLES OF X-RAY DIFFRACTION
X-rays are electromagnetic radiation of wavelengths in the range 
of 0.1-100A (lnm=10A; wavelength of visible light ^=400-700 nm) 
produced when high-energy electrons collide with and displace an 
electron from a low-lying orbital in a target metal atom. Consequently, 
an electron from higher orbital drops into the resulting vacancy, 
emitting its excess energy as an X-ray photon.
Most widely used X-ray sources are: X-ray tubes, rotating anode 
tubes, and particle accelerators that produce synchrotron radiation in the 
X-ray region. The first two are more common as laboratory or 
conventional sources and accelerate electrons to a high voltage of 40-50 
kV at a metal target (usually copper with characteristic wavelength 
X= 1.5418 A) filter and focus X-rays by means of a monochromator and 
curved mirrors. The monochromator is either a piece of nickel or single­
crystal that removes any radiation absorbed by the sample and does not 
contribute to the diffraction pattern. Mirrors deflect focused X-rays at 
low angle and as a result increase the brilliance and consequently allow 
resolution of very large unit cells with closely spaced diffraction spots. 
As brilliance of the beam is designated the fraction of flux over the 
angle through which radiation is emitted multiplied by the cross 
sectional area of the source, where flux is the number of photons emitted 
within a given wavelength range.
However, the use of synchrotron radiation is much more effective 
in protein crystallography. Synchrotron radiation is electromagnetic 
radiation produced when electrons or positrons moving at relativistic 
energies are constrained to follow a circular path defined by dipole
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magnets or magnetic insertion devices like undulators (periodic array of 
permanent magnets) or wiggler magnets (superconducting magnets that 
force the electron beam to effectively take a higher acceleration and 
emit radiation at short wavelength). At the Daresbury Synchrotron 
Radiation Source, electrons are injected into a booster synchrotron by a 
12 MeV linear accelerator and they are accelerated to an energy of 600 
MeV prior to their extraction from the synchrotron. Injection o f the 
electrons into the 2 GeV storage ring follows until a stored current up to 
300 mA has been achieved and finally the electrons obtain an energy of 
2000 MeV by increase of the field strengths in the magnets.
The highly monochromatic and tuneable nature of the beam and 
the great intensity (at least 1000 times that of a conventional source) 
combined with the small divergence, the high intensity over a 
continuous wavelength from 0.02 - 0.26 nm make the use of synchrotron 
radiation essential in protein crystallography. Moreover, the use o f short 
selected wavelengths lead to reduced radiation damage and absorption 
effects and is beneficiary for the determination of the phases for the 
reflection (Blundell and Johnson, 1976; McRee, 1993; Rhodes, 1993).
The interaction of the synchrotron light beam with an 
experimental sample must be recorded in some way so it can be 
analysed giving information about the innermost structure of the sample. 
X-ray generators are equipped with an area detector for this purpose. A 
more advanced detector that has been used lately is the image plate, 
which is exposed to X-rays as any other detector. The X-ray photon 
causes a chemical change in the plate coating and as a result it releases a 
fluorescence scanned with light of the proper wavelength. Most recently 
charged couple detectors (CCD) have been launched with improved
Chapter 1.: Principles o f X-ray diffraction
features compared to image plate such as the dynamic range of the 
recorded reflections, reduced read out and erase time as well as 
minimum phi rotation of the crystal along the spindle axis allowing the 
time that the crystal is in a diffracting position to be almost the same to 
the oscillation time and as a result reduce the noise.
X-rays can be 
diffracted even by the 
smallest molecules (the 
dimensions of the 
scattering objects are of 
the same order of 
magnitude of the 










produce a focused image of a molecule because there is no lens capable 
of focusing X-rays. A computer, which simulates an image- 
reconstructing lens by measuring the directions and the intensities of the 
diffracted X-rays gives the answer to this problem (Figure 1.2). 
However, a single molecule is a very weak diffractor of X-rays, so the 
analysis of crystal diffraction rather than individual molecules is 
essential since the scattering from any molecule is reinforced by the 
scattering of all the others.
The diffraction pattern obtained gives both the beam intensity and 
direction for each diffracted beam, parameters required from a computer 
program in order to reconstruct an image of molecules in the unit cell.
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A protein crystal is an orderly three-dimensional array of 
molecules held together by non-covalent interactions and its simplest 
volume element representative of the whole crystal is the unit cell. The 
array of points at the comers of the vertices o f the unit cell is called 
lattice. The unit cell can be subdivided into equivalent parts called
asymmetric units {Figure 1.3). The number of molecules that can be
observed per asymmetric unit is 
indicative of how compact the 
molecules are packed within the
crystal.
Bragg in 1913 was the first who 
succeeded in visualising the scattering 
o f X-rays by a crystal in terms of 
reflections from planes of atoms.
According to Bragg’s law a set of parallel planes with index hkl (Miller 
indices) and interplanar spacing dm  produces a diffracted beam {Figure 
1.4), when X-rays of wavelength X impinge on the planes at an angle 0 
and are reflected at the same angle, only if  0 meets the condition
2*/hkl-sin0 = n^, n integer
crystal





BC = AB sin6 = dhkl sin0
Figure 1.4
Schematic description o f Bragg’s law.
(The closer the separation ofplanes d^kh the larger the angle o f  diffraction)
Chapter 1.: Principles ofX-rav diffraction 8
Another approach of X-ray diffraction more general than that of 
Bragg’s was proposed by Ewald in 1921 by the use of geometrical
construction (Figure 1.5) 
according to which X-rays 
will be diffracted in the 
direction CB if the point B 
represents a reciprocal lattice 
point (the dimensions
Figure 1.5 are inversely proportional to
The Ewald’s geometric construction where s^
is the incident vector, s the diffracted vector those of the real lattice).
and SJs a reciprocal lattice vector
The spacing of the reflections in the lattice on the film is 
designated as reciprocal lattice while real lattice is the spacing of the 
unit cell in the crystalline lattice. The diffraction pattern that emerges is 
the product of the diffraction of the molecule (molecular transformation) 
with the diffraction of the reciprocal lattice.
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1.3. DATA COLLECTION
13.1. Crystal mounting and alignment
The crystals are usually mounted in thin-walled capillaries in 
order to minimise the absorption of the scattered X-rays and the 
background of the glass, provided that the data collection is taking place 
under room temperature. Nowadays, more and more crystallographic 
data collections on biological macromolecules are performed at 
cryogenic temperatures and these data are usually superior to those 
collected at room temperature in many respects.
The temperatures used in 
the crystal freezing technique are 
in the range of 80 to 100°K. The 
crystal is placed rapidly directly 
in the stream of cold nitrogen gas, 
and it is conveyed by a loop made 
of very fine fibre o f nylon or glass 
wool, held in a thin film of 
cryoprotectant {Figure 1.6). The crystal is held in the loop by surface 
tension and is frozen immediately. The presence of the cryoprotectant is 
of great importance but varies considerably because it has to be 
compatible with the crystal. Substances such as glycerol, polyethylene 
glycol (PEG), 2,4 dimethyl-pentanodiol (MPD) etc., that aim to form a 
thin film (amorphous glass) around the crystal which will prevent the 
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Data collection at cryogenic temperatures has tremendous 
benefits: (a) Reduced crystal radiation damage both primary and 
secondary that increases significantly the life o f the crystal. Primary 
damage is caused by ionisation effects due to incident photons and 
depends on the energy the crystal absorbs (dose). Secondary damage is 
observed only when the data collection takes place at room temperature. 
The production rate of free radicals increases either by direct hydrolysis 
o f water molecules (macromolecular crystals have usually high solvent 
content), or by reactions initiated by radiation. Diffusion of radicals to 
distant regions mediated by crystal water and heating of the sample by 
intense X-ray follows and damage becomes more severe proportionally 
to time. At cryogenic temperatures free radicals produced by the 
incident X-ray photons cannot diffuse away from the site o f their 
production to create damage over the entire crystal, (b) Reduced thermal 
vibrations that result in lower thermal parameters (B factors) and thus 
render reflections at higher resolution accessible to measurement, (c) 
Elimination of mechanical stress is of great importance especially for 
manipulating fragile crystals, (d) It enables studies of the intermediate 
states of a catalytic process in enzymatic reactions since the rate of the 
reactions slows down in cold. Molecules are trapped in a particular 
intermediate state of a catalytic process giving the opportunity to obtain 
a snapshot of the corresponding step of the chemical reaction (Garman 
and Schneider, 1997; Rodgers, 1994). (e) Increased signal to noise ratio 
is observed by avoiding background X-ray scatter from excess of 
mother liquor and glass/quartz capillary tube, (f) Improvement o f the 
data quality by collecting complete data sets from only one crystal.
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As every other technique apart from advantages it also has 
drawbacks: (i) Non-isomorphism, where changes in the unit cell or in 
thermal and structural parameters are observed (e.g. between native and 
derivative data sets), (ii) Alterations in the overall structure or in 
physical and chemical properties dependent on temperature, (iii) 
Variations in the atomic displacement parameters and multiple site 
disorders affected by temperature, (iv) Changes caused by the
cryoprotectant binding which might be competitive or synergistic in the 
case of a possible ligand or just cause conformational changes
preventing the aim of the experiment, (v) Ice formation due to not 
optimal cryoprotectant conditions and (vi) Mosaicity increase.
The crystal’s orientation, dimensions and symmetry are some of 
the factors that should be taken into consideration for the alignment of 
the crystal. The crystal is rotated around one axis, usually perpendicular 
to the beam and is aligned at 0-180-90-270°. The alignment o f the 
crystal should be towards the longest axis, since the cell dimension
along the spindle axis will 
never have an effect 
because it will never lie 
along the beam (Figure 
1.7) (Dauter, 1997). Only 
the axis perpendicular to 
the rotation angle is 
limiting.
The spot size or 







Schematic description o f  the 
construction usedfor data collection
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rotational direction and depends on the crystal quality and the X-ray 
optics available, as well as the desired resolution should be considered 
before deciding the rotation angle. The maximum rotation angle in the 
area o f the diffraction pattern perpendicular to the rotation axis and at 
maximum diffraction angle can be calculated using the following 
equation:
Arotationmax = t a n ' c e l l  edge) -  spotwidth
Another limitation during data collection is a region of reciprocal 
space near the rotation axis that cannot be collected because the Lorentz 
correction is too high. Lorentz correction is dependent on the geometry 
of the detector and accounts for the amount o f time a reflection spends 
in diffracting conditions while being rotated through the Ewald sphere.
1.3.2. Preliminary characterisation of the crystal.
Preliminary characterisation of the crystal involves the extraction 
of information that would describe best the features of the exposed 
crystal and would facilitate X-ray data collection. Visual inspection of 
the diffraction pattern o f a single computer reconstructed image 
provides a vast amount o f information. The quality o f the crystal can be 
assessed by the limit o f observable diffraction which is defined as the 
resolution where at least one third of the possible reflections are still 
visible above background and the mosaicity of the crystal, a measure of 
the order within a crystal that can be estimated by the broadness of lunes 
on the diffraction pattern and the sharpness of the spots. The reciprocal 
space symmetry can be identified by the lattice representation on the
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diffraction pattern, the spacegroup can be determined from the 
systematic absences and the unit cell dimensions as well as the number 
of molecules per asymmetric unit can be estimated. The appropriate 
crystal size can also be decided from the diffraction pattern. Crystals 
with large unit cells usually give weak diffraction patterns since the 
amount of photons they diffract is spread out over more reflections.
1.3.3. Data integration and Reduction
The collected data are processed by indexing the reflections. 
Several algorithms have been developed with the aim to automate the 
procedure of indexing and the most common for data integration and 
reduction are the HKL package (Otwinowski and Minor, 1997) and 
MARXDS (Kabsch, 1988). In particular the HKL package is very widely 
used and provides several levels of insight into the data at each stage of 
the measurement and data analysis process: (i) presents data visually, up 
to a single pixel level (XdisplayF), (ii) provides numerical analysis of 
one oscillation image (.DENZO) and (iii) provides statistics for the full 
data set (SCALEPACK). Use of the above package is a significant tool 
especially during data collection since it gives answers to very basic 
questions like whether to proceed with data collection. One or two 
images are enough to index, estimate the mosaicity and to work out the 
data collection parameters (avoiding overlap of reflections).
Autoindexing in DENZO involves the determination of a standard 
lattice. It searches for real-space vectors (3 linearly independent vectors- 
a basis) that would index all of the observed peaks and reduces the cell 
by conversion of the basis into a standard cell according the
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International Tables for Crystallography, which contain an index for 
standard space group and symmetry classification. The highest 
symmetry lattice that fits the data with minimal distortion is selected 
and the processing of rest of the data will be performed accordingly 
using the initial estimates as reference.
Once indexed it is necessary to scale the data. Scaling is the 
operation of setting the sum of one data set to the other. Systematic 
errors in the data due to absorption and decay mean that different parts 
of the data require different scale factors. Often scaling is performed in 
bins based on resolution. The program SCALEPACK from the HKL 
package (Otwinowski and Minor, 1997) reduces the bias towards 
reflections with an integrated intensity below the average. Percentage 
completeness is the number of unique reflections measured over the 
number of unique reflections possible and one of the major values 
obtained after data reduction. The important parameter is the merging R 
(Km), an internal measure of data precision given by the equation:
D  /  T \  _  ^  ~  ^  1 f \ f \
^ m C O _  V  V  r X
2 ^ 1  h h i
where 7h is the weighted mean measured intensity of the observations 7hi 
in which the intensities of the symmetry related reflections, which 
should be the same, are compared and Rm is the estimate o f the 
disagreement (7h, 7hi).
The data quality is also assessed by the ratio of intensity to sigma 
of intensity I/a(I). a  of a reflection intensity is both an estimate of the 
accuracy of an individual measurement as opposed to the accuracy of
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the data set as a whole and a combination of counting statistics, 
background height and variance as well as the number of times the 
reflection was measured.
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1.4. STRUCTURE DETERMINATION
1.4.1. From structure factor to electron density. The phase problem.
The atomic scattering factor is the integration of the individual 
contributions over the volume of the atom is given by the following 
expression:
F (S ) =  jp(r)exp(2mr ■ S)dv
vo l.o f
atom
where p  is the variation in electron density over the entire volume of the 
atom. The total wave scattered by all the atoms in a molecule or the so- 
called ‘molecular transform’ is given by the equation:
G (S ) = Y,f/  exp(2flir, • £ )
y=]
where f, r, are the atomic scattering factor and the distance of the atom j 
from the origin respectively, for a molecule comprised o f N atoms. The 
structure factor for a particular reflection from a crystal can be 
represented by its amplitude and phase according to the following 
equation:
N
F (h k l)  =  exp2m(hXj +  ky>j + lZj) =  F (h k l)e x p /o r(M /)
7=1
where F(hkl) is the amplitude and a(hkl) is the phase. Once the structure 
o f the crystal is known the diffraction pattern of a crystal can be 
calculated from the structure factor equation. Consequently, taking into 
consideration that the crystal structure is the Fourier transform of the 
diffraction pattern, if  the structure factors F(hkl), are known for all 
reflections, hkl, then the electron density may be calculated for each
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point xyz in the unit cell as described in the expression (Blundell and 
Johnson, 1976; Rhodes, 1993):
 ^ 00 00 00
p(xyz) =  77 X  2  F(hkl) e x p  -  2 m(hx + ky + lz)
h=—<x> k=—x> / = —oo
Both the amplitude F(hkl) and the phase a(hkl) o f the structure 
factor are necessary in order to calculate the electron density but the 
diffraction pattern can provide information only for the amplitude. 
Hence the ‘phase problem’. This can be solved by using one o f the 
following methods: (i) the ‘isomorphous replacement’ (IR) in which 
indirect experimental estimates of the protein phase angles are provided, 
after the introduction o f a heavy atom marker, by observing the 
interference effects o f the intensities on scattered beams (Greene et al., 
1954; Ke, 1997), (ii) the ‘molecular replacement’ (MR) is applicable 
only in the case of significant amino acid sequence identity between the 
starting model used to determine the orientation and the position of the 
crystal structure of a molecule and the molecule itself. Both phase angle 
estimations and amplitudes give an approximate Fourier synthesis o f the 
unknown structure (Rossmann, 1972) and (iii) anomalous scattering in 
which all the phase information emerges from the scattering information
of an atom whose natural absorption frequency is close to the
wavelength of the incident radiation. Resolved anomalous scattering 
requires intensity measurements at one wavelength, while the multiple 
wavelength anomalous dispersion method, most commonly used in 
large molecules requires intensity measurements at several wavelengths 
(the tuneable SRS is most appropriate for such cases) (Hendrickson, 
1991).
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1.4.2. Molecular replacement technique using AMoRe.
AMoRe is one of the most commonly used Automated Molecular 
Replacement program package to determine the positions of the 
molecules in the unit cell (Navaza, 1994). Homologous molecular 
models to the molecules included in the crystal are placed in tentative 
positions in the unit cell in such a configuration that give acceptable 
agreement between the calculated and the observed structure factors 
(Navaza and Saludjian, 1997).
Some of the factors affecting the success o f the method are (i) the 
quality and the completeness of the collected data, (ii) the percentage of 
homology between the search molecular models and the actual 
molecules to be determined, (iii) the relative size of the search model 
compared to the content of the crystal cell and (iv) the applied criteria 
used to assess the quality of agreement between the model and the 
experimental data.
The molecular models are treated in every case as a rigid body 
and their position in the crystal cell is identified by three rotational and 
three translational parameters calculated accordingly by the rotation 
(RF) and translation function (TF). The combined results of the rotation 
and translation functions using as criteria not only the peak height from 
the rotation function (program ROTING) but also the correlation 
coefficient from the translation function (program TRAING) to assess 
the selected positions, are finally submitted to rigid body refinement 
(program FITING).
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1.5. STRUCTURE REFINEMENT
1.5.1. General principles of crystallographic refinement.
The molecular models that emerge from molecular replacement 
need further manipulation since there are several variations to the actual 
molecules in the crystal in terms of amino acid sequence, side or even 
main chain conformational alterations, etc. A number of algorithms have 
been developed over the years with the aim to overcome model 
discrepancy by applying an automated refinement procedure.
Crystallographic refinement is a technique that optimises the 
agreement of an atomic model with both observed diffraction data and 
chemical restraints. The measure of the agreement is a ‘cost function’ 
e.g. a function of the observed and calculated values which reduces as 
the model improves. The target function for crystallographic refinement 
formulated in such a way to search for global minima is given by the 
following expression:
E  c^hem x^ray^ xray
where Echem is an empirical potential energy function of all atomic 
positions that contains information about chemical interactions, 
describing covalent and non-covalent interactions.
Echem = Z  kb(r ~ ro f  + X  kS (0-0„)2 + 2 X ( ® - <BJ 2 +
bonds angles dihedrals chiral,planar' v /
covalent int enactions
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Additional restraints and constraints can be used by fixing the 
position of various atoms, bond lengths, angles, dihedrals, in order to 
improve the ratio of the observations to the refined parameters to avoid 
overparameterisation of the modeL In the case of multiple copies of 
molecules in the asymmetric unit non-crystallographic symmetry or 
crystallographic symmetry can also be used as a means to increase the 
signal to noise ratio by using average of all molecules while treating 
them as equivalent entities.
Exray stands for the difference between observed and calculated 
diffraction data according the equation:
E = Sxrcty h Fobs<h>-  k Fcalc(h>
while is a weight chosen to balance the forces arising from each 
term. The standard crystallographic residual is enriched by a term of 
additional phase restraints based on the difference between experimental 
phases and those calculated from the model so is is described by
E = Z  xray Fobs(h>-  k Fcalc(h> +wp ? 4 w h> - w h)
where wp is the weight given to the phase restraint and/ is a square-well 
function with a width equal to the arccosine of the figure of merit [w(h)] 
for each reflection. Figure of merit is the fraction o f the correct structure 
factors (Adams et al., 1997; Briinger and Rice, 1997).
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Optimisation methods such as Conjugate Gradient (CG, belongs 
to the first derivative methods and identifies the nearest minimum in the 
target function by increasing the radius of convergence) or Least 
Squares (LSQ, the weighted sum of squares o f the deviations between 
the observed and the calculated quantities) are the most widely used 
methods but their major disadvantage is that convergence can be 
hindered by ‘trapping’ the initial models in multiple local minima. 
Hence, the need for maximum likelihood (ML) target functions became 
apparent to avoid various assumptions made during LSQ refinement. 
The method of LSQ implies that (i) the current phase is always the 
correct one, (ii) the atoms should move towards or away from a certain 
and not an unknown plane, (iii) the effects o f coordinate errors lead to a 
Gaussian error in |Fcalc| as an estimate of |Fobg|, (iv) the most probable 
value o f |Fobs| is not generally equal to |Fcalc| because of the effect of 
phase errors. In the ML method the probability o f a particular |Fobs| 
amplitude is obtained by integrating the probability o f true structure 
factors with that amplitude over all possible phases.
The above refinement technique’s aim is to overcome the local 
minima that the model might be ‘trapped’ during minimisation o f their 
target function and the procedure of simulated annealing provides the 
necessary potential energy to the system to cope with such barriers. 
Annealing is a physical process wherein a solid is heated until it is 
converted to a viscous liquid comprising a random arrangement o f all 
particles. The viscous liquid is then cooled slowly allowing particles to 
arrange in the lowest energy state. In the case o f simulated annealing as 
a molecular dynamics refinement method combined with the
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optimisation techniques, the simulation starts at a temperature of 300°K 
and the system is heated to a temperature of 5000°K before it starts 
cooling down. A control parameter that determines the likelihood of the 
target function to overcome barriers is designated as ‘temperature and 
has no physical aspect (Briinger and Rice, 1997).
The most widely used refinement programs for protein 
crystallography are X-PLOR (Briinger, 1992b), REFMAC from the 
CCP4 package (CCP4, 1994) and CNS by Briinger et al. (1998). All the 
programs use a combination of a minimisation technique along with 
simulated annealing and seem to cope well with the present needs.
CNS in particular has the unique feature o f using the combined 
simulated-annealing/maximum-likelihood model refinement (Adams et 
al., 1997; Briinger and Rice, 1997). Refinements with the maximum- 
likelihood target require computation of cross-validated g a values. The 
cross-validated oA error estimates and the weight between X-ray 
diffraction target function and the geometric energy function in the 
course of refinement are recalculated in the course o f refinement. 
Recalculation of the oA error estimates is extremely important since the 
maximum-likelihood target functions depend on these values, thus it has 
been incorporated after initial energy minimisation as well as after 
molecular dynamics simulated annealing (Briinger et al., 1998).
At this stage where the necessity to refine the position (x , y, z) and 
the thermal parameters (B factor) of atoms for the initial model against 
the X-ray observations has already been made clear, a new parameter to 
assess the quality of the structure at each stage of refinement is 
introduced and is described by the expression:
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°  = -------------------  i-----------
I | F j
In this expression each |Fobs| is derived from a measured reflection 
intensity and each |Fcalc| is the amplitude of the corresponding structure 
factor calculated from the current model. The values of R, the 
crystallographic reliability index, indicate the agreement of calculated 
and observed intensities. It is necessary to perform successive cycles of 
refinement followed by rebuilding of the protein until the value of R is 
between 0.15 and 0.20 for a well-refined structure. Another reliable and 
unbiased parameter used to evaluate the information content of a model 
produced by X-ray crystallography is a statistical quantity (i?free) that 
measures the agreement between observed and computed structure 
factor amplitudes for a ‘test’ set o f reflections that is omitted in the 
modelling and refinement process (Briinger, 1992a). The criteria for 
assessing the quality of a structure apart from the reliability factor is 
also the stereochemical identity measured by the root mean square 
deviation (r.m.s.) from covalent bond lengths, which should be in the 
range o f 0.01-0.02 A.
It is difficult to correct gross errors by any of the refinement 
procedures mentioned above as it is usually indicated by the reliability 
factors. Use of either the initial phase information or the current one 
depending on the stage of the refinement can be used to calculate a 
variety o f maps [usually (2|Fobs|-|FcaIC|) and (|Fobs|-|Fcalc|) maps] that 
would facilitate model building. Some useful protocols such as inclusion 
of bulk solvent correction that enhances the signal-to-noise ratio of 
electron density difference maps for missing parts of the model or
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simulated annealing omit maps calculated for regions in doubt to 
remove any model bias are also used.
Model building is performed using the program ‘O’ for molecular 
graphics (Jones et al., 1991). It supplies a set of tools to perform a 
variety of manipulations such as movement/rotation of small parts o f the 
structure manually, assignment of a side chain rotamer for a specific 
residue from a database, insertion/removal of residues from a region. 
The quality of the model can be improved by local real space refinement 
procedure during model building exercises.
An automated refinement procedure (ARP) can also be used based 
on the iterative use of unrestrained least squares minimisation coupled 
with constant updating o f the model. It is a comparable procedure to the 
iterative least-squares/Fourier synthesis approach for small molecules 
and it requires very high-resolution quality data or else it can be used to 
improve unrestrained parts o f the molecule (e.g. solvent or ligand 
molecules). The philosophy behind this procedure is that the quickest 
way to move an atom from its current position to another is to remove it 
and add a new one. The new set of atoms, which does not have to 
contain the same number o f atoms as before, is subjected to least 
squares optimisation of their parameters against the experimental data. 
A requirement of the procedure is that the density maps are calculated 
using model phases, the quality of which defines the convergence limit.
Density at the atomic centre and density shape (and not thermal 
parameters) are used in order to decide upon rejection of certain atoms. 
Addition of atoms is performed using grid points with the highest 
density that satisfy the distance constraints selected for the new atoms.
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Real space refinement can be used for the refinement of the atomic 
positions and for identifying a wrongly placed atom. Geometric 
restraints are also taken into consideration. The program ARP has been 
incorporated in the CCP4 package (Lamzin and Wilson, 1997).
1.5.2. Twinning.
Twinning is a crystal growth anomaly in which the specimen is 
composed of separate crystal domains whose orientations differ in a 
specific way. Multiple crystal growth disorders are common, but 
twinning refers to special cases where some or all of the lattice 
directions in the separate domains are parallel. This leads to either 
partial or complete coincidence between the lattices of the distinct 
domains (Redinbo and Yeates, 1993).
Twinning can be classified into three categories according to the 
extent the separate lattices coincide as (i) nonmerohedral or epitaxial: 
the overlap occurs in less than three dimensions, (ii) pseudomerohedral: 
the lattices overlap approximately (but not exactly) and (iii) merohedral 
twinning: the lattices of two or more distinct domains coincide exactly 
in three dimensions. Particularly in merohedral twinning, although the 
diffraction pattern appears normal each observed intensity is a weighted 
sum of intensities of two reflections that are related by twinning 
operation but not crystallographic symmetry.
4bs(hi) = (l-a)/(h,) + a/(h2)
70bs(h2) = a/(h1) + (l-a)/(h2)
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a , is the twinning fraction that represents the fractional volume of the 
crystal occupied by domains in the second orientation. In the case that a  
equals 0 then no twinning is detected but if the value of a  is less than 
1/2 then the crystal is considered to be partial twinned. Problems arise 
when a  becomes 1/2, perfect twinning, in which reflections related by 
the twin law contribute equally to each observed intensity (Yeates, 
1997).
1.6. STRUCTURE ANALYSIS
The final stage is the analysis of the structure in which the overall 
architecture of the molecule is studied. Ramachandran plot (<p and y/ 
angles of the polypeptide backbone are printed) that will assess the 
geometry of the structure, inter- and intramolecular contacts in the 
crystal as well as a record of polar and non-polar interactions need to be 
examined. More extensive analysis involves superposition with other 
known homologous structures from which useful information can be 
derived as well as attempts to extrapolate the current finding to other 
analogous systems.
The overall procedure showing the basic stages in the 
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2. a-LACTALBUMIN
2.1. INTRODUCTION
2.1.1. a-Lactalbumin as a modulator of Lactose Synthase complex
Lactose, the major source of carbohydrate in most mammalian 
milks, is synthesised from glucose and UDP-galactose in a reaction 
catalysed by the enzyme lactose synthase (LS, EC 2.4.1.22) (Acharya et 
al., 1989; Smith et al., 1987; Stuart et al., 1986). This enzyme is a 
complex composed of two distinct protein components: a-Lactalbumin 
(LA) and UDP-galactose p-iV-acetylglucosaminide p i-  
4,galactosyltransferase (EC 2.4.1.38, GT).
GT, is a 55KDa type II membrane glycoprotein of the trans-golgi 
membranes of the mammary gland and other tissues. In most cells, GT 
participates in the biosynthesis of oligosaccharide chains of secretory 
and membrane-bound glycoconjugates by catalysing the transfer of 
galactose from UDP-galactose to non-reducing terminal p-linked N- 
acetylglucosaminyl (GlcNAc) moieties o f the oligosaccharide chain 
according to the following reaction:
UDP-D-galactose + N-acetylglucosamine —> 
—» UDP + D-galactosyl-N-acetyl-D-glucosamine
However, GT is unable to catalyse the biosynthesis of lactose 
(transfer of galactose to glucose) at physiological concentrations of 
glucose because of its poor affinity for this acceptor substrate. During


















The reaction o f  the biosynthesis o f  lactose catalysed by GT in the presence o f  LA
pregnancy GT is present in the mammary gland, as in most tissues, but 
when lactation begins after parturition, the specificity of GT changes to 
D-glucose by transferring the D-galactosyl group at a very high rate, thus 
making lactose according to the reaction:
UDP-D-galactose + D-glucose —> UDP + D-lactose
in the presence of a milk protein a-lactalbumin (LA) the synthesis of 
which is regulated in the mammary gland by hormones promoting 
lactation. LA is produced in the rough endoplasmic reticulum of the 
lactating mammary gland together with other milk proteins as a pre­
protein with a hydrophobic leader sequence. In lactose synthase, 
reversible binding of the regulatory subunit a-lactalbumin (LA) to GT 
promotes glucose binding (reflected in a 1000-fold decrease in the Km for 
glucose) and facilitates the biosynthesis o f lactose (Wang et al., 1989) 
{Figure 2.1). LA comes into contact with GT in the golgi apparatus
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(where GT is located) only during milk secretion after translocation 
across the ER membrane and proteolytic removal o f the leader sequence. 
Lactose is then produced but its size does not allow it to pass through the 
golgi membrane to the cytosol and as a result it accumulates generating a 
flow of cellular water into the golgi to maintain osmotic equilibrium, a 
process that contributes significantly to the so-called ‘aqueous phase’ of 
milk. When the production of lactose is complete, LA is secreted along 
with lactose by exocytocis in secretory vesicles formed by the golgi 
membranes (Brew and Grobler, 1992; Linzell and Peaker, 1971).
The mecha­
nism under which 
the two proteins 
GT and LA come 
into contact to 
form the lactose 
synthase complex 
is still unknown. A 
plausible model 
has been proposed 
for the regulatory 
action of LA by 
Brew et al. (1979)
{Figure 2.2). According to this model LA molecule should possess 
proximal areas for interaction with monosaccharides when in complex 
with the enzyme. Measurements of LA activity that support the 
assumption concerning the above plausible mechanism have been 
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absence and presence of LA (Bell et al., 1976; Khatra et al., 1974; 
Morrison and Ebner, 1971a; Morrison and Ebner, 1971b; Powell and 
Brew, 1976). The properties also of the covalently cross-linked LS 
complex and the effect o f the presence/absence of various metal ions
I O i
such as Mn , Ca or substrates such as monosaccharides or UDP- 
derivatives have been studied. The emerging results seem to be in favour 
of the synergistic binding o f LA and monosaccharide (glucose) to GT 
while in the case of oligosaccharides competitive inhibition between LA 
and the sugar is detected (Bell et al., 1976; Brew et al., 1975).
2.1.2. Description of a-Lactalbumin molecule.
LA is a 14.2 kDa globular ‘specifier’ protein that consists of a 
single polypeptide chain of 123 amino acids. An important feature o f LA 
is that its three dimensional structure is similar to that of c-type 
lysozyme (LZ) {Figures 2.3-2.5) and the two proteins are homologous 
(about 40% sequence identity, Figure 2.6) with divergent functions 
(Acharya et al., 1989; Smith et al., 1987; Stuart et al., 1986).
The overall structure of LA molecule is divided into two domains 
by a deep cleft, which is the corresponding active site in LZs {Figure 
2.3). Domain a  is comprised of 3 major a-helices and 2 short 3io helices 
(residues 1-34, 84-123) while domain P consists of a small 3-stranded 
antiparallel P-pleated sheet and a short 3io helix (residues 35-85). Four 
disulphide bridges occur between residues 6 and 120, 28 and 111,61 and 
77, 73 and 91, and stabilise the overall polypeptide fold of LA molecule 
(Acharya et al., 1989).
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a-Lactalbumin
Glu62-Thr65
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Structure o f LA (Acharya et al., 1991). The boxed areas represent the functional 
regions o f the molecule. The figure was generated using the program BOBSCRIPT 
(Esnouf 1997)





Structure o f hen egg white LZ (Steinrauf 1998). The figure was generated using the 
program BOBSCRIPT (Esnouf 1997)





Superposition o f LA and LZ structure indicating the similarity o f their 3D structure
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2+
LA binds calcium strongly (also other metal ions such as Zn , 
Mn2+, Co2+, Tb3+, Na+, K+) and specifically whereas in the LZs there are 
two subgroups, representing paralogous gene lines, of which one binds
*y_i_
Ca ion and the other (the ’conventional’ LZ group) does not {Figure 
2 .6).
Figure 2.6 (overleaf).
Sequence comparison for LA and LZ. The alignment shows a selection o f  LA and LZ 
(Ca2+-binding and non Ca2+-binding) sequences. The shaded areas correspond to 
conservative residues. The sequence retrieval was performed using the program WU- 
Blust (version 2.0) and the alignment using the program Clustalx.
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2.1.3. Metal ion binding properties and functional regions of LA.
o  I
The Kapp for Ca binding to apo-LA under physiological 
conditions is of the order of 10’ M (Kronman et al., 1981; Permyakov et 
al., 1981; Schaer et al., 1985). It is known that bound Ca2+ in LA is not 
required for its activity and can be deduced to be not needed for 
enhanced stability against denaturation (Ewbank and Creighton, 1991; 
Rao and Brew, 1989) although it plays an essential structural role in the 
protein. This may reflect the need by LA for additional free energy to 
stabilise the native state because of features that are not present in LZ or 
a regulatory action of calcium. LA and LZ also differ significantly in 
their molecular stabilities (Greene et al., 1999; Rao and Brew, 1989) and 
metal ion binding properties. LA can bind a number of different metal 
ions in solution (Musci and Berliner, 1985a; Musci and Berliner, 1985b; 
Musci and Berliner, 1986; Permyakov et al., 1991; Permyakov et al., 
1988) and exhibits a variety of different conformational states depending 
on its ligation state (Kronman, 1989; Kronman et al., 1981). It undergoes 
a more global transconformation to a molten globule state (neither fully 
folded nor fully unfolded) in response to mildly disruptive treatments 
such as low pH and exposure to high concentrations of certain metal ions 
or intermediate concentrations of denaturants (Kronman, 1989; 
Kuwajima et al., 1989). Exposure of native LA (N state) to pHs below 
4.0 promotes formation of a conformer (A state) whose properties are 
markedly different from those of the native protein. The side chains have 
increased freedom of movement with no spatial correlation while the 
molecule is in an apparent folded state, although less compact compared 
to the N state. Such differences include a markedly increased propensity 
for self-association and characteristic changes in spectroscopic
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properties. The enthalpy of the molten globule state is very nearly the 
same as that o f the fully unfolded state and substantially different from 
that of the folded state, hence LA molecule is seen as folded although 
somewhat less compactly than that in the N state, and of more ‘fluid- 
like’ character than that o f the native protein. This enhanced molecular 
flexibility of LA, as compared with LZs, may have evolved to suit the 
functional demands of its role in lactose synthase (Greene et al., 1999).
Crystal structures of different species variants of LA in different 
crystal forms and metal complexes (Acharya et al., 1991; Acharya et al., 
1989; Calderone et al., 1996; Chandra et al., 1998; Harata and Muraki, 
1992; Pike et a l., 1996; Ren et al., 1993; Stuart et al., 1986) have shown 
that a high affinity Ca binding site is located at the junction of these 
sub domains and is composed of a continuous section of polypeptide 
chain (residues 79-88) that contains highly conserved Ca2+ liganding 
aspartates {Figure 2.3). Although the presence of this site in LA was 
originally thought to represent a new evolutionary development (Stuart
2 j t
et al., 1986) recently, several LZs with Ca binding sites have been 
identified and molecular structure analyses indicate that the site is an 
ancient feature of the superfamily (Acharya et al., 1994; Grobler et al., 
1994a).
2+ 9+Recently a secondary Ca binding site (different from Zn or 
S O 42’ site), 7.9A away from the primary binding site was reported
(Chandra et al., 1998) Figure 2.3. This site had common features with
2 _|_
the Mn binding site as described by Gerken (1984). Based on the
• 21proximity of the Mn and Ca binding region and the location of the 
functional site on one side o f the charged surface of LA molecule it was 
proposed that these binding sites might have a definitive role in the
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formation of the lactose synthase complex (Chandra et al., 1998). It is 
worth noting that all of the metal ions that activate GT also bind to LA 
[for a review see Kronman (1989)].
The functional site of LA encompasses a region corresponding to 
a subsite in LZ and parts of the two adjacent substructures (Malinovskii 
et al., 1996). The available structural information on LA has 
demonstrated that part of the interaction site for GT (involving residues 
105-110) adopts two distinct conformations and that it is probably 
highly fluctuating in solution. The environments of both residues in LA 
that have been implicated in stabilising glucose binding by lactose 
synthase (Phe-31 and His-32) are affected by the conformation of the 
‘flexible-loop’ region {Figure 2.3) and may be critical for LA’s 
modulatory properties. Certainly, the unusual degree of conformational 
adaptability exhibited by LA in solution, depending on its interaction 
with metal ions, and the general observation that the interaction site is 
localised in one of the most flexible parts of the molecule, suggests that 
LA’s ability to adjust its conformational state may be important in the 
regulatory mechanisms mediated by this unusual protein (Malinovskii et 
al., 1996; Pike et al., 1996).
2.1.4. Site-directed mutagenesis as a tool to understand the 
functional regions of LA molecule.
In the absence of a 3D structure for the LS complex, only tentative 
conclusions could be made about the role of specific residues from 
kinetic results from the variants designed using site directed 
mutagenesis. However, it is possible to obtain significant amount of 
knowledge on the altered functional property of a variant by following a
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structure-based approach in combination with ‘Protein engineering 
experiments’.
Bovine LA was used as a model system. A series of LA variants at 
regions proposed to be directly involved in LA action in LS complex 
were produced in our collaborator’s laboratory (Prof. Keith Brew, 
University of Miami School of Medicine, USA) according to the 
protocol described by Grobler et al. (1994b). The sequence changes that 
have been introduced to the recombinant bovine protein (mLA) are 
summarised in Table 2.1.
Briefly, a facile bacterial expression system for a variant o f bovine 
LA, which could yield fully active recombinant LA (mLA) was 
generated in high yields. This system succeeds an earlier system in 
which bovine LA was expressed as a fusion protein from which a native, 
active protein was generated by limited proteolysis after extraction and 
treatment to generate native folding and disulphide bond formation 
(Wang etal., 1989).
Single site substitutions targeted selectively to residues of the 
aromatic clusters I and II, the functional regions of the protein, lying 
adjacent to the cleft, critical for both LA activity and glucose binding in 
LA complex (Grobler et al., 1994b; Malinovskii et al., 1996; Pike et al., 
1996).
A detailed structural investigation was performed for three LA 
variants (Figure 2.7): A lai 09-Pro, Tyr 103-Pro and T rpll8-H is, which 
seem to possess unusual kinetic properties, while crystallisation 
conditions for additional three mutants: His32-Tyr, Phe31-Tyr, L ysll4 - 
Asn have been established.
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Table 2.1 Amino acid substitutions in the functional sites of LA molecule
Functional Regions Residues involved Sequence changes



















other mutants Cys 6 Cys6-Ser
lie 55 Ile55-Val
Lys 114 Lysll4-Asn
The functional role of aromatic clusters I and II (Figure 2.3) in the 
LA molecule has been studied by Grobler et al. (1994b). Aromatic 
cluster I comprises the side chains of the invariant amino acids Phe 31, 
His 32, Gin 117 and Trp 118 together with Tyr 36, while aromatic 
cluster II designated also as ‘hydrophobic box’ includes Trp 26, Phe 53,
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Trp 60, Tyr 103 and Trp 104 (Table 2.1).
The rationale for the sequence substitutions was based either on 
conservation criteria with other LA primary structures, direct comparison 
with LZ sequence, stereochemical properties of particular residues that 
give them certain freedom of movements or the extent of perturbations 
caused to the activity o f LA when particular residues were subjected to 
chemical modification. For example, His 32 was changed to an Asn and 
Tyr (as in several LZ), a Glu (to investigate the effect of introducing a 
charged group into the cluster) and an Ala (to remove the side chain 
contribution).
AROMA TIC CL USTER I .
Histidine 32 to Tyrosine or Alanine : Histidine 32 participates in 
the formation of the surface that lies adjacent to the cleft region in LA 
{Figure 2.7, see page 50). This region is partly conserved and may 
provide part of the binding site for the sugar acceptor substrates of the 
GT. It has to be noted that the specific changes in these residues, which 
are quite close together on the surface of the LA molecule, and lack of 
effects on other residues, indicates the involvement of a region of LA 
that includes a number of conserved residues, including His32, in the 
interaction with GT (Brew and Grobler, 1992). It has been shown that 
modification of the imidazole group o f histidine 32 in LA by 
ethoxyformylation leads to a major reduction in activity (Brew et al., 
1979; Schindler et al., 1976). His 32 of human and bovine LA may play 
an important role in the interaction of LA and GT that leads to formation 
of LS. It has been suggested that the N -l atom of the imidazole ring of 
His 32 cannot be substituted without inactivation of the LA while
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substitution of the N-3 atom does not lead to complete inactivation 
suggesting a high degree of specificity in the interaction between LA and 
GT (Preels et al., 1979).
Phenylalanine 31 to Tyrosine: As in the case of histidine 32, Phe 
31 also lies adjacent to the cleft region and its ability to promote glucose 
binding (reflected by a 7-fold increase in Km for glucose) affecting only 
slightly affinity for GT when compared to mLA (Grobler et al., 1994b) 
makes it rather interesting for further investigation at a structural level.
Tryptophan 118 to Histidine: Tryptophan 118 side chain, as well 
as the side chains of the conserved residues Phe 31, His 32 and Gin 17 
lie in a region adjacent to the cleft (Figure 2.3). These are flanked by 
lysines 5 and 114, whose reactivities have been shown in previous 
studies to be perturbed upon binding of LA to GT (Brew and Grobler, 
1992; Brew et al., 1979). Sulphenylation of Trp 118 causes probably not 
complete inactivation of LA (Brew et al., 1979; Hill and Brew, 1975). 
O f the four tryptophans o f bovine LA (26, 60, 104 and 118), residues 60 
and 118 are the most susceptible to modification and reaction at either 
site reduces its affinity for galactosyltransferase or causes complete 
inactivation depending on the nature of the modification (Brew and 
Grobler, 1992). According to measurements performed by Grobler et al. 
(1994b), 40% of the free energy of the LA-GT interaction is lost on 
replacing Trp 118 with either histidine or tyrosine.
AROMATIC CLUSTER II.
Tyrosine 103 to Proline: Comparison of LA with LZ structures
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suggests that the two molecules have evolved from a common ancestor. 
The striking difference between these two proteins is the loss of activity 
for LA. The cleft region in LA structure is the corresponding binding site 
in LZ. Although the residues that line the cleft and act in substrate 
binding in LZ are conserved in all known LAs, one particular 
substitution of a tyrosine at position 103 (LA) for alanine or proline in 
LZ {Figure 2.7), has the effect of blocking the upper region of the cleft 
containing the A and B monosaccharide binding sites in LZ (Brew and 
Grobler, 1992; Malinovskii et al., 1996). Tyrosine 103 does not have a 
direct functional role by analogy with its function in the LZs, the 
possibility that part of the cleft in LA may act to facilitate glucose 
binding in the LS complex is raised (Brew and Grobler, 1992; 
Malinovskii et al., 1996; Shewale et al., 1984). Tyrosines 103 and 18 of 
human LA are susceptible to nitration with tetranitromethane (Tyr 103 > 
Tyr 18) with essentially no effect on its activity (Brew and Grobler, 
1992).
FLEXIBLE LOOP LEU105 - LEU110.
Alanine 109 to Proline: The conformation that the flexible loop 
(residues 105-110) of LA molecule adopts is critical for its functional 
properties. X-ray crystal structure analysis has revealed that changes in 
the crystallisation conditions result in either a helical or a loop 
conformation of the residues comprising this highly mobile part of the 
protein (Harata and Muraki, 1992; Pike et al., 1996). The substitution of 
alanine 109 to proline {Figure 2.7) has been performed with the aim to 
restrict the flexibility of the polypeptide chain, although the impact on 
LA activity from this substitution is very little (Malinovskii et al., 1996;
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Pike et al., 1996).
Histidine 107 to Alanine: Histidine 107 is part of the flexible loop 
and is in close proximity to Lys 108 which as it has been suggested by 
Brew et al. (1975) it is the major site of cross linking in the LS complex. 
The adaptability to two different conformations o f this loop region as 
exhibited in the 3D structure o f LA depending on the crystallisation 
environment was considered. His 107 to Ala variant was designed to 
favour the helical conformation observed in human LA crystals at 
physiological conditions, in which the side chain of residue 107 is buried 
(Pike, 1995).
Leucine 110 to Arginine: As in the case of His 107 and Ala 109 
variants from the flexible region, leucine 110 was mutated to arginine 
based on sequence comparisons with human and chicken LZs, in order to 
investigate the effects o f various side chain types on the loop 
conformation. More variants o f leucine substituted by Glu or His were 
also designed (Pike, 1995).
OTHER VARIANTS.
Lysine 114 to Asparagine: Lysine 114 is located at the beginning 
of the C-terminal tail o f LA molecule, which is known to exist in a 
number of energetically degenerate conformations, and belongs to the 
group of residues, which are proximal to aromatic cluster, I, a 
substructure previously identified to be crucial to LA action (Grobler et 
al., 1994b). Substitution of Asn for Lys 114 appears to produce a more
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than 30-fold reduction in activity that implicates a decrease in affinity for 
GT and increased thermal stability indicating a possible effect on the 
structure and/or dynamics of the flexible C-terminus (Greene et al., 
1999; Malinovskii et al., 1996).
Cysteine 6 to Serine: Cysteine 6 is involved in disulphide bond 
formation with cysteine 120 located at the C-terminus of the molecule 
(Figure 2.7). Out o f four disulphide bridges that stabilise the overall 
structure of LA, chemical studies have shown that only Cys6-Cysl20 is 
the most solvent-exposed disulphide bond, it gets immediately reduced 
in the absence of denaturants and is not essential for the structure or 
activity of LA (Shechter et al., 1973). It is known that the C-terminus of 
LA molecule is highly mobile and to a certain extent this mobility is 
anchored by this ‘reactive’ disulphide bridge. It appears that residues 
beyond Cysl20 are not necessary for either the structure or activity of 
LAs since they are variable or even absent in certain LAs or LZs 
(Grobler et al., 1994a). The high mobility of these residues is reflected in 
to the electron density map of the most LA structures that have been 
determined so far, where they appear to be disordered after position 120 
of the molecule. Moreover, residues from the N-terminus are involved in 
interactions with residues lining the calcium-binding site (Chaudhuri et 
al., 1999). Thus, with the aim to investigate the involvement of the tail of 
LA molecule as well as the minimal requirements o f that region for LA 
activity Cys 120 was mutated to Ser to abolish the disulphide bond. 
Progressive truncation of the polypeptide chain at positions 119, 118 and 
116 showed that residues from Trp 118 to the C-terminus are not
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essential for LA activity (Malinovskii et a l 1996) and the structure 








Figure 2 .7 .
Sequence substitutions in the mLA molecule. The figure was generated using the 
program BOBSCRIPT (Esnouf 1997).
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Isoleucine 55 to Valine: Isoleucine 55 is buried (-2%  exposed to 
the solvent) and a component o f a region of sequence that is conserved in 
even the most distant relatives o f LA such as bacterial transglycosylases 
and goose LZ. The isoleucine to valine mutation is highly conservative 
but the LA variant appears to have a perturbed structure or at least a near 
UV CD spectrum with a similar shape but reduced intensity indicating a 
less fixed tertiary structure. The secondary structure content seems to be 
unchanged based on far UV CD but the activity is greatly reduced (Prof. 
K. Brew, personal communication).
2.1.5. The 3D structure of GT molecule.
Most recently the crystal structure of the catalytic domain of GT 
in complex with uridine diphosphogalactose (UDP-Gal) was determined 
by (Gastinel et al., 1999 ) at 2.4A resolution (Figure 2.8). The catalytic 
domain of GT comprises 20% (3-strands, 23% a-helices and 2% 3i0 
helices and involves residues Leu 131 to Ser 402.
The core of the structure consists of an eight stranded p-sheet surrounded 
by two a-helices on the one side and by four a-helices on the other. 
Although the structure o f GT is of considerable importance in 
understanding the functional aspects of glycosyltransferases, very little 
information can be extracted towards understanding the interaction of 
GT with LA without the complex structure. However, it is now possible 
to perform modelling studies taking into consideration previous results 
obtained by chemical modification and site-directed mutagenesis studies. 
It also stresses the need for further direct structural studies on LA-GT 
complex.





involved in binding 
to a-Lactalbumin.H365
Figure 2 .8
Structure o f galactosyltransferase.
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2.2. CRYSTAL STRUCTURES OF apo-LA and bLA 
(holo-LA)
2.2.1. MATERIALS AND METHODS
2.2.1.1. Preparation of proteins
Pure apo-bovine LA used for crystallographic studies (described 
in this chapter) was purified by our collaborator Prof. K. Brew using the 
method developed by Martin Kronman (Kronman et al., 1981) based on 
a modified protocol by Aschaffenburg and Drewry (1957) 
(Aschaffenburg and Drewry, 1957). Apo-LA was isolated by gel 
filtration of the protein at pH 2.0 (‘Suprapure’ HC1), with subsequent 
removal of the acid by lyophilisation and reconstitution in very dilute 
pH 5 to 6 metal-free Tris buffer. Solutions of apo-LA are stored in the 
frozen state at concentrations of 3 to 5mM. All chemicals used were 
certified to contain < 2.0 ppm of Ca2+ or Mg2+ ions and solutions had 
been passed through a column of Chelex 100. Water used for dilutions 
and other purposes was deionised and then passed through columns of 
Chelex 100. All glassware and optical cells were treated with 
concentrated H N 03; concentrated H2S 0 4 while all plastic vials were 
soaked in EDTA and then rinsed with metal free water. Native bovine 
LA (bLA) was obtained from Sigma chemical company and used 
without further purification.
2*2.1«2.Crystallisation
Apo-LA: Crystals were grown with the method of vapour 
diffusion. Equal volumes (2.0 pi) of protein (~20mg/ml) and reservoir
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solution (2.0 M ammonium sulphate, Tris/HCl 0.1 M pH 6.0) were 
mixed on siliconised coverslips and left to equilibrate at 16°C against 
the reservoir solution. Crystals appeared in ~20 days as tetrahedra 
{Figure 2.9). Care was taken to avoid contamination by adventitious 
metal ions during crystallisation experiments. All glassware was acid 
washed using nitric acid and rinsed with chelex treated water according 
to the protocol of Veillon and Vallee (1978).
Figure 2 .9
Crystals o f apo-LA
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bLA: Native bovine LA was crystallised by the vapour diffusion 
method at 16°C against a reservoir solution containing 15% PEG 8K and 
0.05 M potassium dihydrogen orthophosphate. The protein 
concentration was 20.0 mg/ml prior to crystallisation. Equal volumes 
(2.0 jliI )  of the protein and reservoir solution were used. Parallelepiped 
crystals appeared overnight and continued to grow for about five days 
(Figure 2.10).
Figure 2 .1 0
Crystals o f bLA
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2*2.13* Diffraction data collection
Apo-LA: Data were collected from one crystal at the Synchrotron 
Radiation Source, Daresbury on station PX9.5 (oscillation range 1.0°, 
exposure time ~150 sec/image, ^=0.90 A) at room temperature using a 
30cm MAR Research image plate. Absence of (0 0 1) reflections 
hindered the immediate spacegroup determination for apo-LA. The data 
set was processed in tetragonal lattice which indicated the possibility of 
6 or 8 molecules in the asymmetric unit with a solvent content o f -60  % 
(Matthews coefficient o f -3 .2  A3/D). Data integration and reduction 
were performed with the programs DENZO and SCALEPACK 
(Otwinowski and Minor, 1997). Diffraction spots up to 2.0 A were 
observed (Figure 2.11) but completeness dropped beyond 2.2 A 
resolution (Tables 2.2, 2.3). The data collection statistics are presented 
in Table 2.4.
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2 .01  A
\  4 .0 2  A
Figure 2 .1 1
apo-LA diffraction pattern
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I / Sigma in resolution shells 
No. o f reflections with I/S igm a less than 
1 2 3 5 10 20 >20 total
oc 4 .7 4 53 1 1 0 1 6 6 2 1 8 3 1 5 5 9 0 1 6 2 7 4 3 8 8 6 0 1 5
4 .7 4 3 .7 6 4 8 9 7 1 6 6 2 2 8 3 5 9 7 2 9 2 2 0 2 3 5 8 4 5 7 8 6
3 .7 6 3 .2 9 7 2 1 5 6 2 7 5 4 0 1 6 3 9 1 3 8 1 5 2 1 0 5 6 6 5 7 7 6
3 .2 9 2 .9 9 1 4 2 3 0 2 50 1 7 4 9 1 2 4 9 3 1 7 7 5 7 1 6 0 5 7 1 6
2 .9 9 2 .7 7 2 7 9 5 6 7 9 9 3 1 4 8 7 2 6 4 2 5 5 6 3 5 6 7 7 0 5 6 7 7
2 .7 7 2 .6 1 4 0 7 8 4 1 1 4 0 7 2 1 2 2 3 5 6 7 5 6 7 2 5 6 7 2 0 5 6 7 2
2 .6 1 2 .4 8 4 6 2 9 7 0 1 7 1 6 2 5 1 4 4 1 4 5 5 6 7 8 5 6 7 8 0 5 6 7 8
2 .4 8 2 .3 7 5 8 2 1 1 8 4 2 0 0 5 2 9 5 9 4 7 5 4 5 6 5 5 5 6 5 5 0 5 6 5 5
2 .3 7 2 .2 8 7 0 2 1 4 3 4 2 3 8 2 3 3 8 0 5 0 6 9 5 6 4 5 5 6 4 5 0 5 6 4 5
2 .2 8 2 .2 7 8 6 1 6 2 3 2 6 7 1 3 8 0 1 5 3 4 3 5 6 5 3 5 6 5 3 0 5 6 5 3
All hkl 3533 7284 12282 17859 28082 39743 48735 8538 57273




I/S igm a in resolution shells 
% of reflections with I/S igm a less than 
1 2 3 5 10 20 >20 total
cc 4 .7 4 0 .9 1 .8 2 .7 3 .6 5 .1 9 .6 2 6 .5 7 1 .5 9 8
4 .7 4 3 .7 6 0 .8 1 .7 2 .8 3 .9 6 .2 1 2 .5 3 7 .8 6 1 .4 9 9 .2
3 .7 6 3 .2 9 1 .2 2 .7 4 .7 6 .9 11 2 3 .8 8 9 .7 9 .7 9 9 .5
3 .2 9 2 .9 9 2 .5 5 .3 8 .7 13 2 1 .8 5 5 .3 9 9 .5 0 9 9 .5
2 .9 9 2 .7 7 4 .9 9 .9 1 7 .4 2 6 4 6 .2 9 7 .3 9 9 .3 0 9 9 .3
2 .7 7 2 .6 1 7 .1 1 4 .8 2 4 .7 3 7 .3 6 2 .6 9 9 .6 9 9 .6 0 9 9 .6
2 .6 1 2 .4 8 8.1 17 3 0 .1 4 4 .2 7 2 .8 9 9 .7 9 9 .7 0 9 9 .7
2 .4 8 2 .3 7 1 0 .3 2 0 .9 3 5 .3 5 2 .1 8 3 .8 9 9 .6 9 9 .6 0 9 9 .6
2 .3 7 2 .2 8 1 2 .4 2 5 .3 4 2 5 9 .6 8 9 .4 9 9 .6 9 9 .6 0 9 9 .6
2 .2 8 2 .2 1 3 .8 2 8 .6 4 7 6 6 .9 9 4 .1 9 9 .5 9 9 .5 0 9 9 .5
All hkl 6.1 12.6 21.3 31 48.7 68.9 84.5 14.8 99.3
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Table 2.4 Data collection statistics for apo-LA and bLA
Spacegroup details
apo-LA BLA
C e ll  d im e n s io n s  
(a , b, c )  (A )
a = b = l  1 9 .5 7 ,  
c = l  5 2 .7 4
a = 7 2 .0 5 ,  b = l 0 4 .6 5 ,  
c = l  1 7 .4 1
a. P> Y ( ° ) 9 0 , 9 0 ,  9 0 9 0 ,  9 0 ,  9 0
S p a c e  g ro u p P 4& 2 P2l2l2
N o  o f  m o le c u le s  p er  a sy m m e tr ic  u n it 6 6
Data collection and processing statistics
S ta t io n  (S y n c h r o tr o n ) D a re sb u ry  P X 9 5 E M B L , B W 7 B
Im a g e  p la te M a r 3 0 M a r 3 0
W a v e le n g th  (A) 0 .9 0 .8 4 7
N o  o f  o b se r v a tio n s 5 6 1 2 5 4 3 7 1 7 3 4 *
N o  o f  u n iq u e  r e f le c t io n s 5 7 2 7 3 4 5 3 6 3 *
M a x . r e so lu t io n  (A ) 2 .2 2.2*
^ C o m p le te n e s s  (o u te r m o s t  s h e l l )  (% ) 9 9 .3  (9 9 .5 ) 9 9 .2  ( 9 9 .2 ) *
*Rsym ( I )  (o u te r m o st  s h e l l )  (% ) 8 .6  ( 6 3 .3 ) 8 .1  (5 1 .7 ) *
< / / a ( / ) >  (o u te r m o s t  s h e l l ) 8 .8  ( 2 .5 ) 1 1 .5  ( 2 .1 )*
O u te r m o st  sh e ll  (A) 2 .2 8  - 2 .2 0 2 .3 2  - 2 .2 0 *
0 Completeness in the range oo-resmax, where resmax is the maximum resolution to which data were 
collected. Tor bLA includes reflections after merging with the in-house data collected on a Siemens 
detector mounted on a Siemens X-ray generator (X= 1.5418A, 0.25° per frame.
bLA: Data from one bLA crystal were collected to 2.2 A on 
station BW7B at EMBL-Hamburg Synchrotron Radiation Source, using 
a MAR300 image plate (Table 2.4). The oscillation range per image was 
1.0° (A=0.847 A) and the exposure time was 40-50 sec/image. Both 
DENZO  and SCALEPACK programs were used for data processing 
(Otwinowski and Minor, 1997). To improve the completeness at low
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resolution shells, a medium resolution data set which was collected 
previously, using crystals exposed to graphite monochromated CuKa X- 
rays (X=l .5418 A) produced by a Siemens rotating anode generator 
operating at 50kV and 80mA at room temperature was merged using 
SCALA and subsequently converted to structure factor amplitudes with 
the program TRUNCATE (Table 2.5) as implemented by the CCP4 suite 
o f programs (CCP4, 1994). The systematic absences were found to 
agree with orthorhombic P2l2l2 space group with either 6 or 8 
molecules in the asymmetric unit with a solvent content o f -50  % 
(Matthews coefficient of -2 .6  A3/D). The statistics of the data collection 
and reduction are presented in Table 2.4.
Table 2.5 Completeness, multiplicity, Rmeas vs. resolution for bLA
C o m p le te n e s s  an d  m u lt ip lic ity , in c lu d in g  r e f le c t io n s  m e a su r e d  o n ly  o n c e  
N o te :  c o m p le te n e s s  f ig u r e s  are a p p r o x im a te , a s  th e y  are c a lc u la te d  b y  v o lu m e ,  
( s o  th e re  are g r id -sa m p lin g  errors).
% p o ss . is  c o m p le te n e s s  in  th e  sh e ll .
N Dmin Nmeas Nref Ncent %poss Mlplcty (Rsym)
1 6 .7 3 6 5 8 6 1 7 5 5 4 7 0 9 9 .8 3 .8 0 .0 4 6
2 4 .7 6 1 2 2 2 3 3 0 0 9 4 8 1 9 9 .7 4 .1 0 .0 4 6
3 3 .8 9 1 5 7 0 2 3 8 5 2 4 9 0 1 0 0 .3 4 .1 0 .0 5 2
4 3 .3 7 1 8 2 0 4 4 4 8 6 4 8 2 9 9 .7 4 .1 0 .0 8 5
5 3 .0 1 2 0 2 0 5 5 0 7 9 4 8 3 1 0 0 .2 4 .0 0 .1 5 7
6 2 .7 5 1 9 9 8 8 5 5 5 0 4 8 6 9 9 .4 3 .6 0 .2 4 9
7 2 .5 5 1 5 9 4 4 5 9 7 4 4 6 0 9 9 .0 2 .7 0 .2 3 6
8 2 .3 8 1 5 8 6 9 6 4 2 3 4 4 4 9 9 .5 2 .5 0 .3 4 6
9 2 .2 4 1 4 4 9 2 6 6 7 4 3 9 8 9 7 .6 2 .2 0 .4 7 9
10 2 .1 3 8 3 7 3 5 0 7 1 2 1 5 7 0 .8 1 .7 0 .5 3 7
Overall 147586 47873 4409 95.1 3.1 0.081
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2.2.1.4. Structure determination
Apo-LA: The structure of recombinant bLA (mLA, monoclinic 
form) determined at 2.3 A (Pike et a l 1996) was used for molecular 
replacement with the program AMoRe (Navaza, 1994). Due to the 
difficulty in assigning the correct spacegroup amongst possible 
spacegroups in the tetragonal lattice (P42{2, P4,2j2, ^422,2, /^43212), the 
molecular replacement technique was applied for all four of them. First 
the self-rotation function was calculated with POLARRFN (CCP4, 
1994). The stereographic projection of section k= 180° (in polar 
convention) indicated that the molecules are related by three local 2-fold 
symmetry axes to each other (Figure 2.12).
90.0
- 90.0
apo-la self-rotation  R=29A, 5 -  7 A 
Section kappa = 180
Figure 2 .1 2
Rotation function from molecular replacement
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DATA IN TEG R ATIO N AND REDUCTION  
using DENZO AND SCALEPACK  
(O tm now ski and Minor, 1997)
PRELIMINARY CHARACTERISATION  
.aitice *=> Systematic:absences 4*Snacesiroun
MOLECULAR REPLACEMENT  
using AMoRe  
(Nava/.a. 1994)
SEARCH MODEL FOR INITIAL PHASES 
M’oimc lime, form of Recombinant bovine LA at 2,2 
TPrke et a U 1996)
SE L F-R O T A T IO N  FUNCTIO N
Molecules are related by 
three 2-fpld axes to each other
O rient model in unit cell ' 
•Selection of:Patterson self-vectors : 
Radius o f 2 1 A, data betVveeh 204) aiid  3.0 A
C R O SS RO TATION FUNCTION
► Position molecule in unit cell •TRANSLATION FUNCTION
Optimise coordination of 
modef iii unit cell
RIGID BODY REFINEMENT
APPLY THE APPROPRIATE  
ROTATION AND TRANSLATION
C R Y S T A L L O G R A P H I C
R E F I N E M E N TC O R R E C TS OL UT I ON
LOOK FOR NEW MOLECULES  
IN THE ASYM M ETRIC UNIT
NEW SEARCH M O D E L :  
SOLUTION + SEARCH MODEL
Figure 2 . 1 3
Flow diagram describing I he procedure followed for the structure determination 
o f  the apo- and holo- forms o f LA using the molecular replacement technique.
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All data between 20.0 and 3.0 A were used to calculate the cross 
rotation and translation functions. Rigid body refinement against the 
data in the above range was used to optimise the position of the initial 
model. The appropriate rotation and translation parameters were applied 
to the starting model and the position of one molecule was determined. 
Combination of molecular replacement, rigid body refinement using X- 
PLOR (Briinger, 1992b) and visual inspection of the (2F0-FC) electron 
density maps were helpful in identifying positions for five apo-LA 
molecules in the asymmetric unit in spacegroup P 41212. An outline of 
the procedure adopted for the structure determination is summarised in 
Figure 2.13.
Further attempts to determine the sixth molecule (the search 
model consisted of five molecules) using molecular replacement were 
not successful. However, visual inspection o f the (FQ-FC) electron 
density map calculated using the refined model with five molecules, 
identified the position of the sixth molecule as a large piece of 
contiguous density sufficient to accommodate one more molecule. 
Careful examination of the packing features for five molecules and the 
symmetry information derived from the self-rotation function enabled 
accurate positioning of the sixth molecule in the unaccounted electron 
density region. These results confirmed the presence of only six 
molecules in the asymmetric unit {Figure 2.14). The list of the best 
translation function solutions and their progression in terms of 
correlation coefficient and R factor are summarised in Tables 2.6-2.10. 
The final solutions after the rigid body refinement with the highest 
correlation coefficient and the best R factor are shown in Table 2.11.
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Figure 2 .1 4
Packing o f apo-LA (6 molecules/a.u)
MOLECULAR REPLACEMENT RESULTS FOR apo-LA
Tables 2.6-2.10: The columns a, (3, and y correspond to the orientation Euler angles; Tx, Ty and 
Tz represent the positional parameters (fractions of the unit cell), cc the correlation coefficient, Rf 
the R-factor and no- to the sorting number of the peak when the translation function was 
calculated for the first time. The solutions are shown in shaded areas and the peak number is in 
boldface.
Table 2.11: See Tables 2.6-2.10. The highest peak numbers that correspond to five out o f six 
molecules in the asymmetric unit after rigid body refinement are shown in bold face.
Figure 2 .1 4 a
Packing o f apo-LA (6 molecules/a.u)
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Table 2.6 Molecule I (apo-LA)
a P Y Tx Ty Tz CC no
SOLUTIONTFI 28.11 97.92 252.18 0.8243 0.805 0.015 23.7 56.7 1
SOLUTIONTFI 61.89 82.08 72.18 0.3037 0.3256 0.4846 23.5 56.6 2
SOLUTIONTFI 72.99 67.73 249.33 0.6266 0.3861 0.2491 22.4 56.6 32
SOLUTIONTFI 76.06 31.98 192.53 0.8851 0.8538 0 . 0 2 1 2 2 2 . 8 56.2 33
SOLUTIONTFI 13.94 148.02 12.53 0.5932 0.4859 0.2759 22.9 56.2 34
SOLUTIONTFI 19.01 143.28 4.87 0.2307 0.7207 0.1949 22.5 56.6 55
SOLUTIONTFI 71 36.72 184.87 0.7472 0.7294 0.0104 22.3 56.5 56
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7 57
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 13.5 157.74 3.64 0.7224 0.3442 0.2938 23.1 56 58
SOLUTIONTFI 1.81 136.65 108.9 0.3516 0.6333 0.2719 2 2 . 6 56.3 59
SOLUTIONTFI 88.19 43.35 288.9 0.881 0.2206 0.232 22.5 56.5 60
SOLUTIONTFI 69.43 62.85 64.6 0.0706 0.082 0.4976 22.5 56.9 61
SOLUTIONTFI 20.57 117.15 244.6 0.7955 0.2125 0.3098 23.1 56.2 62
SOLUTIONTFI 38.5 92.74 252.04 0.8445 0.7832 0.4549 22.3 56.7 63
SOLUTIONTFI 56 123.37 113.83 0.9098 0.9024 0.4976 22.5 57 73
SOLUTIONTFI 34 56.63 293.83 0.4029 0.4221 0.0148 22.5 56.5 74
SOLUTIONTFI 5.86 119.95 194 0.6512 0.638 0.031 2 2 . 6 56.3 75
SOLUTIONTFI 84.14 60.05 14 0.219 0.2483 0.0453 2 2 . 8 56.5 76
SOLUTIONTFI 29.92 64.89 55.33 0.9266 0.8007 0.0134 23.5 55.9 77
SOLUTIONTFI 60.08 115.11 235.34 0.3026 0.4254 0.4871 23.2 55.9 78
Table 2.7 Molecule II (apo-LA)
a  p y Tx Ty Tz cc R{ no
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1 1
******************************************************
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 61.89 82.08 72.18 0.634 0.8399 0.4062 32 53.1 2
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Table 2.8 Molecule III  (apo-LA)
a P Y Tx Ty Tz CC no
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 69.43 62.85 64.6 0.6702 0.7794 0.5124 30.3 54 63
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 34 56.63 293.83 0.8035 0.138 0.6646 30.5 53.6 72
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 5.86 119.95 194 0.1876 0.6528 0.9514 35.2 51.9 75
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 84.14 60.05 14 0.6528 0.1876 0.0486 35.2 51.9 78
Table 2.9 Molecule IV (apo-LA)
a P Y Tx T* y Tz cc R< no
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 5.86 119.95 194 0.1876 0.6528 0.9514 35.2 51.9
SOLUTIONTF4 44 146 1.5 0.8085 0.304 0.6054 33.2 53 21
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 5.86 119.95 194 0.1876 0.6528 0.9514 35.2 51.9
SOLUTIONTF4 72.99 67.73 249.33 0.4314 0.2074 0.0326 32.7 53.1 29
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * : * * * * * * * * * * * * * * * * * * * * * * * * *
S O L U T IO N T F I 76.5 22.26 183.64 0 .1285 0 .7264 0.1105 25.4 54.7
S O L U T IO N T F 2 28.11 97.92 252.18 0 .8399 0.634 0.5938 32 53.1
S O L U T IO N T F 3 5.86 119.95 194 0 .1876 0 .6528 0.9514 35.2 51 .9
S O L U T IO N T F 4 76.06 31.98 192.53 0 .4768 0 .3495 0.9451 38.9 50 .7 33
* * * * * * * * * * * * * * * * * * * * * * * * * * * * *  *  *  *  * * * * * * * * * * * * * c *  *  * * * * ** *
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 5.86 119.95 194 0.1876 0.6528 0.9514 35.2 51.9
SOLUT10NTF4 13.94 148.02 12.53 0.3495 0.4768 0.0549 38.9 50.7
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Table 2.10 Molecule V (apo-LA)
a P Y Tx Tx y CC no
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 5.86 119.95 194 0.1876 0.6528 0.9514 35.2 51.9
SOLUTIONTF4 76.06 31.98 192.53 0.4768 0.3495 0.9451 38.9 50.7
SOLUTIONTF5 69.43 62.85 64.6 0.8166 0.195 0.8556 36.4 51.8 53
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 5.86 119.95 194 0.1876 0.6528 0.9514 35.2 51.9
SOLUTIONTF4 76.06 31.98 192.53 0.4768 0.3495 0.9451 38.9 50.7
SOLUTIONTF5 20.57 117.15 244.6 0.195 0.8166 0.1444 36.4 51.8 58





* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 
28.11 97.92 252.18 0.8399 0.634 0.5938 32 
5.86 119.95 194 0.1876 0.6528 0.9514 35.2 
76.06 31.98 192.53 0.4768 0.3495 0.9451 38.9





SOLUTIONTF5 38.5 92.74 252.04 0.4243 0.9944 0.4737 39.7 50.5 63
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 76.5 22.26 183.64 0.1285 0.7264 0.1105 25.4 54.7
SOLUTIONTF2 28.11 97.92 252.18 0.8399 0.634 0.5938 32 53.1
SOLUTIONTF3 5.86 119.95 194 0.1876 0.6528 0.9514 35.2 51.9
SOLUTIONTF4 76.06 31.98 192.53 0.4768 0.3495 0.9451 38.9 50.7
SOLUTIONTF5 51.5 87.26 72.04 0.9944 0.4243 0.5263 39.7 50.5 68
Table 2.11 Final solutions for molecules I-V after FITING  (apo-LA)
a P Y Tx Ty Tz cc no
SOLUTIONF 78.75 20.1 180.88 0.128 0.7261 0.1105 54.5 45.2 57
SOLUTIONF 27.51 97.82 253.22 0.8388 0.6345 0.5938 54.5 45.2 1
SOLUTIONF 5.5 122.83 189.5 0.1878 0.6536 0.9514 54.5 45.2 75
SOLUTIONF 69.77 34.16 201.95 0.4754 0.349 0.9451 54.5 45.2 33
SOLUTIONF 39.34 83.49 253.22 0.4258 0.995 0.4737 54.5 45.2 63
bLA: The structure of bLA was also determined by molecular 
replacement with the program AMoRe (Navaza, 1994) using the 
structure of recombinant bovine LA (Pike et al., 1996) using a similar 
protocol as shown in Figure 2.13. As in the case of apo-LA, packing
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considerations and visual inspection of electron density maps revealed 
the positions for all six molecules in the asymmetric unit {Figure 2.15). 
The solutions that exhibited greatest improvement in terms of 
correlation coefficient and R factor are summarised in Tables 2.12-2.17 
while in Table 2.18 the results after rigid body refinement are shown.
MOLECULAR REPLACEMENT RESULTS FOR bLA
T a b le s  2 .1 2 -2 .1 7 :  The columns a, p, and y  correspond to the orientation Euler 
angles; Tx, Ty and Tz represent the positional parameters (fractions o f the unit 
cell), cc the correlation coefficient, Rfthe R-factor and no- to the sorting number 
o f the peak when the translation function was calculated for the first time. The 
solutions are shown in shaded areas and the peak number is in bold face.
T a b le  2 .1 8 :  See Tables 2.12-2.17. The highest peak numbers that correspond to 
the six molecules in the asymmetric unit after rigid body refinement are shown in 
bold face.
T ab le  2.12 M olecu le  I (b L A )
a P y Tx Ty F cc R f no
SOLUTIONTFI 30.82 88.44 265.36 0.4458 0.0068 0.0931 27.1 56 I
SOLUTIONTFI 149.18 91.56 85.36 0.0543 0.0064 0.4101 27 * 56.2 ' 2
SOLUTIONTFI 114 153.66 131.5 0.3644 0.0137 0.1528 23.8 57.1 3
SOLUTIONTFI 69.35 126.02 15.06 0.4774 0.4644 0.2966 24.6 57.4 14
SOLUTIONTFI 70.33 75.07 327.35 0.1167 0.1218 0.0349 24.3 56.7 15
SOLUTIONTFI 109.67 104.93 147.35 0.4745 0.0155 0.0324 24.4 57 16
* * * * * * * * * * * ****** * * * ** * * * * * * * * * * * * * * * * * * * * * *  *  *  * * * ** *
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55 17
*********** ****** * * * ** * * * ******* ***** ****** *  * * * * * * *  *
SOLUTIONTFI 93.22 87.59 261.76 0.0623 0.1085 0.4194 29.7 54.9 18
SOLUTIONTFI 93.52 26.27 66.5 0.4617 0.0027 0.3299 24 57.4 19
SOLUTIONTFI 86.48 153.73 246.5 0.3018 0.4252 0.4209 24.2 56.7 20
SOLUTIONTFI 93.22 87.59 261.76 0.0623 0.1085 0.4194 29.7 54.9 21
SOLUTIONTFI 93.52 26.27 66.5 0.4617 0.0027 0.3299 24 57.4 22
SOLUTIONTFI 86.48 153.73 246.5 0.3018 0.4252 0.4209 24.2 56.7 23
SOLUTIONTFI 10.81 91.33 80.03 0.4876 0.412 0.295 26.9 56 24
SOLUTIONTFI 169.19 88.67 260.03 0.0123 0.412 0.2037 26.9 56 25
SOLUTIONTFI 25.06 86.88 84.38 0.0116 0.493 0.2443 24 57.1 26
SOLUTIONTFI 154.94 93.12 264.38 0.4705 0.4774 0.1036 24.3 57.4 27
T able 2.13 M olecule II (bLA)
a P y Tx T Tz CC no
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8 1
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 2 9 7 55
SOLUTIONTF2 149.18 91.56 85.36 0.8209 0.0074 0.4087 36.1 52.8 2
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 114 153.66 131.5 0.1504 0.4082 0.9582 28.8 55.6 4
T able 2.14 M olecule III (bLA)
a P y Tx Ty Tx cc no
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 30.82 88.44 265.36 0.68 0.5087 0.0932 40.4 55 1
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 149.18 91.56 85.36 0.82 0.0087 0.9068 40.4 55 2
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 114 153.66 131.5 0.0534 0.4755 0.9506 33.8 54 3
Table 2.15 M olecule IV (bLA)
a P y Tx T r Tx CC no* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 30.82 88.44 265.36 0.68 0.5087 0.0932 40.4 55
SOLUTIONTF4 10.81 91.33 80.03 0.7834 0.7753 0.7525 46 51 21
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 30.82 88.44 265.36 0 . 6 8 0.5087 0.0932 40.4 55
SOLUTIONTF4 169.19 88.67 260.03 0.7166 0.2753 0.2475 46 51 25
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 30.82 88.44 265.36 0.68 0.5087 0.0932 40.4 55
SOLUTIONTF4 25.06 86.88 84.38 0.8456 0.7815 0.2431 44.1 51.8 29
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Table 2 .1 6  Molecule V (bLA)
a P Y T* X Ty T, CC R{ no
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 30.82 88.44 265.36 0 . 6 8 0.5087 0.0932 40.4 55
SOLUTIONTF4 10.81 91.33 80.03 0.7834 0.7753 0.7525 46 51
SOLUTIONTF5 169.19 88.67 260.03 0.7177 0.275 0.2472 43.4 50.8 18
* * * * * * * * * * * * * * * * * ♦ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 30.82 88.44 265.36 0.68 0.5087 0.0932 40.4 55
SOLUTIONTF4 10.81 91.33 80.03 0.7834 0.7753 0.7525 46 51
SOLUTIONTF5 25.06 86.88 84.38 0.8437 0.7822 0.243 50 48.8 23
* * * * * * * * * * * * * * * * : * * * * * * * * * * * * * * * * : * * * * * * * * * * * * : * * * :* * * * * *
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 30.82 88.44 265.36 0 . 6 8 0.5087 0.0932 40.4 55
SOLUTIONTF4 10.81 91.33 80.03 0.7834 0.7753 0.7525 46 51
SOLUTIONTF5 154.94 93.12 264.38 0.6563 0.2822 0.757 50 48.8 28
Table 2.17 Molecule VI (bLA)
a P Y Tx Ty Tz cc Rf no
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 30.82 88.44 265.36 0 . 6 8 0.5087 0.0932 40.4 55
SOLUTIONTF4 10.81 91.33 80.03 0.7834 0.7753 0.7525 46 51
SOLUTIONTF5 25.06 8 6 . 8 8 84.38 0.8437 0.7822 0.243 50 48.8
SOLUTIONTF6 167.73 90.16 260.11 0.6704 0.2778 0.7517 55.9 48.1 2
************ ******t * * * ** * * * ******* ***** ****** * * * ** * * **
SOLUTIONTFI 86.78 92.41 81.76 0.4378 0.1093 0.0815 29.7 55
SOLUTIONTF2 30.82 88.44 265.36 0.6791 0.5074 0.5913 36.1 52.8
SOLUTIONTF3 30.82 88.44 265.36 0.68 0.5087 0.0932 40.4 55
SOLUTIONTF4 10.81 91.33 80.03 0.7834 0.7753 0.7525 46 51
SOLUTIONTF5 25.06 86.88 84.38 0.8437 0.7822 0.243 50 48.8
SOLUTIONTF6 102.74 90.74 268.24 0.0333 0.6129 0.4288 62.9 44.5 3
************ ******: * * * ** * * * ******* ***** ****** * * * ** * * **
SO L U T IO N T F I 8 6 .7 8 92.41 8 1 .7 6 0 .4 3 7 8 0 .1 0 9 3 0 .0 8 1 5 2 9 .7 55
SO L U T IO N T F 2 3 0 .8 2 8 8 .4 4 2 6 5 .3 6 0 .6791 0 .5 0 7 4 0 .5 9 1 3 36.1 5 2 .8
SO L U T IO N T F 3 3 0 .8 2 8 8 .4 4 2 6 5 .3 6 0 .6 8 0 .5 0 8 7 0 .0 9 3 2 4 0 .4 55
SO L U T IO N T F 4 10.81 9 1 .3 3 8 0 .03 0 .7 8 3 4 0 .7 7 5 3 0 .7 5 2 5 4 6 51
SO L U T IO N T F 5 2 5 .0 6 8 6 .8 8 8 4 .3 8 0 .8 4 3 7 0 .7 8 2 2 0 .2 4 3 50 4 8 .8
SO L U T IO N T F 6 7 7 .2 6 8 9 .2 6 8 8 .2 4 0 .4 6 6 7 0 .1 1 2 9 0 .5 7 1 2 6 2 .9 44 .5
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Table 2.18 Final solutions for molecules I-VI after FITING  (bLA)
a p y Tx Ty T% cc R{ no
S O L U T I O N F 8 5 .0 7  9 3 .7 5 8 1 .9 4 0 .4 3 8 6 0 .1 0 9 3 0 .0 8 1 5 7 0 .3 3 8 .4 17
S O L U T I O N F 3 1 .2 6  8 8 .1 4 2 6 5 .0 7 0 .6 7 8 6 0 .5 0 5 9 0 .5 9 1 3 7 0 .3 3 8 .4 1
S O L U T I O N F 3 4 .7  8 9 .2 9 2 6 8 ,5 2 0 .6 8 2 0 .5 1 1 3 0 .0 9 3 2 7 0 .3 3 8 .4 1
S O L U T I O N F 1 2 .5 5  9 3 .3 2 7 8 .4 3 0 .7 8 2 5 0 .7 7 5 0 .7 5 2 5 7 0 .3 3 8 .4 21
S O L U T I O N F 2 2 .1 6  8 7 .7 2 8 2 .6 5 0 .8 4 2 3 0 .7 8 2 7 0 .2 4 3 7 0 .3 3 8 .4 23
S O L U T I O N F 1 0 1 .2 1  8 7 .8 8 2 7 0 .0 5 0 .0 3 2 0 .6 0 8 5 0 .4 2 8 8 7 0 .3 3 8 .4 3
Figure 2 .1 5
Packing o f  bLA (6 molecules/a.u)
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Figure 2 .1 5 a
Packing o f bLA (6 molecules/a.u)
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2.2.1.5* Refinement
The resultant models of apo-LA and bLA structures (six molecules) 
were first subjected to rigid body refinement. Cycles of refinement were 
performed using the slowcool protocol at moderate temperatures with 
the program X-PLOR (Briinger, 1992b) using non-crystallographic 
restraints for apo-LA and with CNS (Briinger et al., 1998) for bLA. The 
progress of refinement was monitored through both free and 
conventional R-factors (Briinger, 1992a). Alternative cycles of manual 
rebuilding with the graphics program ‘O’ (Jones et al., 1991), 
intertwined with refinement cycles using the standard protocol improved 
the quality of the model.
Table 2.19 Refinement statistics for apo-LA and bLA
apo-LA BLA
R e s o lu t io n  ra n g e  (A) 4 0 .0  - 2 .2 3 0 .0  -  2 .2
R e f le c t io n s 5 6 4 2 2 4 5 3 4 8
N o  o f  p r o te in  a to m s 5 8 4 4 5 8 5 6
N o  o f  s o lv e n t  m o le c u le s 1 6 7 8 9
C a 2+ io n s - 6
X  (% ) 2 4 .8 2 5 .3
X n v  (% ) 19.1 2 1 .6
R m s  d e v ia t io n s  in  "bond le n g th s  (A) 0 .0 1 1 0 .0 0 6
"bond a n g le s  ( ° ) 1 .5 8 2 1 .2 7
T em p era tu re  fa c to r s  (A2): o v e r a ll 3 6 .1 4 9 .7
a v e r a g e  m a in -c h a in 34 .1 4 8 .9
a v e r a g e  s id e -c h a in 3 7 .8 5 0 .7
C a 2+ io n s - 4 2 .3
^Rfree^hklcTl I Fobs-kl Fcalcl I/EhklczTl Fobsl xlOO, where hklczT represents the test set (5% of the 
diffraction data). n/?conv=Shkl| I Fobs-kl Fcalcl I/Ehkll Fobsl xlOO. ’Deviations from ideal values (Engh 
and Huber, 1991).
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In the case o f bLA structure, simulated annealing omit maps, 
calculated using CNS, indicated density (remained as a persistent feature 
of the structure at high sigma level) at the calcium site sufficient to 
accommodate a calcium ion in all six molecules. Six calcium ions were 
incorporated in to the model (one per molecule) at final stages of the 
refinement. In each case, water molecules were inserted in the model 
according to the (2F0-FC) and (F0-Fc) electron density maps. During the 
final cycles of refinement the non-crystallographic restraints were 
released and individual molecules were examined on the graphics with 
the aid of electron density maps. Analysis o f the Ramachandran plot 
[calculated with the program PROCHECK (CCP4, 1994)] for both 
structures showed that all residues lie in the allowed regions. The details 
of refinement statistics and model accuracy are listed in Table 2.19. 
Structural superpositions were performed with the program ‘O’ (Jones et 
al., 1991), SHP (Stuart et al., 1979) and M APS(Lu, 1998).
2*2*2. RESULTS 
2*2*2*1. Overall structures
Even though the crystals showed diffraction to 2.0 A, due to poor 
quality of data at high-resolution shells, the structures of both apo-LA 
and bLA were refined to 2.2 A resolution. The two structures are closely 
similar to that previously described for recombinant mLA (Pike et al., 
1996) {Figure 2.16) and other known LA species variants (Table 2.20). 
Some differences were observed in the flexible, solvent exposed loop 
regions between residues 43-47, 62-65 and the C-terminal tail (which is 
highly disordered) between LA molecules. The functionally important












apo-LA — 0.68 0.80 0.93 1.01 0.75 0.80 0.99 0.97 0.94
bLA 0 .3 9 — 0.51 0.89 0.82 0.61 0.60 0.87 0.87 0.89
mLA (bovine) 0 .4 1 0 .2 8 — 0.94 0.84 0.77 0.70 0.92 0.90 0.93
Baboon 0 .6 5 0 .6 5 0 .6 5 — 1.06 1.06 1.04 0.41 0.36 0.47
Guinea Pig 0 .5 7 0 .4 4 0 .4 4 0 .6 6 — 1.11 1.08 1.01 1.03 1.04
Goat 0 .6 0 0 .4 5 0 .5 4 0 .8 0 0 .7 0 — 0.52 1.05 1.01 1.02
Buffalo 0 .5 3 0 .9 5 0 .4 8 0 .7 6 0 .6 3 0 .2 7 — 1.01 1.01 1.02




0 .6 2 0 .9 4 0 .5 8 0 .2 1 0 .6 1 0 .71 0 .6 9 0 .2 6 — 0.35
Human with 
two Ca2+ ions
0 .6 3 1 .3 7 0 .6 0 0 .2 3 0 .5 9 0 .7 4 0 .7 1 0 .2 3 0 .1 6 —
The rms deviations are given after superposition using the least square fitting option in 'O' applied to Ca atoms of residues 1-120 (values in boldface) and to the 
core of the molecule (values in normal typeface). LA-core: residues 5-11, 23-40, 50-61 and 71-104.mLA: recombinant bovine LA at 2.3 A [(Pike et al., 1996); 
PDB code: 1HFZ]. Baboon LA at 1.7 A [(Acharya et al., 1989); PDB code: 1ALC]. Guinea Pig LA at 1.9 A [(Pike et al., 1996); PDB code: 1HFX]. Goat LA 
at 2.3 A [(Pike et al., 1996); PDB code: 1HFY]. Buffalo LA at 2.3 A (Calderone et al., 1996). Human LA at 1.7 A (Acharya et al., 1991). Human LA in 
complex with Zn2+ at 1.7 A [(Ren et al., 1993); PDB code: 1HML]. Human LA with two Ca2+ ions at 1.8 A [(Chandra et al., 1998); PDB code: 1A4V].
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Figure 2 .1 6
Superposition o f apo-LA, bLA and mLA
flexible loop region (involving residues 105-111) located adjacent to the 
lower end of the cleft adopts ‘helical’ conformation in both apo-LA and
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bLA structures (similar ‘helical’ conformation was observed in the 
previously reported mLA structure crystallised at pH 8.0, (Pike et al., 
1996). It is known that at high pH (6.5-8.0) this loop adopts the ‘helical’ 
conformation and at low pH (4.6), the ‘looped-out’ conformation. The 
helical conformation is predominant at pH above 6.0 in different LA 
structures reported so far (Harata and Muraki, 1992; Pike et al., 1996).
The monomers in the two structures have nearly identical 
structures (Table 2.21).
Table 2.21 Comparison of different LA molecules
apo-LA
moll Mol2 mol3 mol4 Mol5 mol6
moll — 0.39 0.40 0.39 0.28 0.32
mol2 0 .2 1 — 0.47 0.45 0.33 0.38
mo 13 0 .1 8 0 .2 2 — 0.49 0.46 0.37
mol4 0 .2 6 0 .3 0 0 .3 0 — 0.36 0.42
mol5 0 .1 8 0 .1 8 0 .1 7 0 .2 4 — 0.32
mol6 0 .2 3 0 .2 7 0 .1 9 0 .2 8 0 .2 0 —
BLA
moll Mol2 mol3 mol4 Mol5 mol6
moll — 0.41 0.57 0.53 0.58 0.62
mol2 0 .1 9 — 0.44 0.40 0.45 0.42
mol3 0 .2 3 0 .1 8 — 0.53 0.67 0.58
mol4 0 .2 4 0 .2 0 0 .2 3 — 0.51 0.58
mol5 0 .3 0 0 .2 5 0 .2 8 0 .2 1 — 0.48
mo!6 0 .2 1 0 .1 9 0 .1 7 0 .2 2 0 .2 8 —
The rms deviations are given after superposition using the least square fitting option in 'O' (Jones et al., 
1991) applied to Ca  atoms for residues 1-120 (values in boldface) and to the core of the molecule (values 
in normal typeface). LA-core: residues 5-11, 23-40, 50-61 and 71-104.
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Each monomer in apo-LA and bLA has -6,512 A2 and -6,820 A2 
accessible surface area respectively. Upon formation of dimers, a loss o f 
463.14 A2 (-3.6%) in apo-LA and 535.68 A2 (-3.9%) in bLA of the 
accessible surface area is observed, consistent with the results from 
other protein-protein interfaces.
The interactions between the monomers are mainly mediated 
through charged residues (Table 2.22). The packing arrangements in the 
two structures are shown in Figures 2.14 and 2.15.
A number of water molecules (167 in the apo-LA and 89 in the 
bLA structures respectively, Table 2.19) were identified with average 
temperature factors < 45A2. Seven water molecules are conserved in 
bLA and other known LA structures, and only two of these are 
conserved in apo-LA.
2*2*2*2. Calcium binding site
The Ca2+ binding site in bLA has maintained identical 
conformation (distorted pentagonal bipyramid co-ordination), known to 
be present in all LA structures {Figure 2.17, Table 2.23). As in the mLA 
structure, the average temperature factor for the Ca2+ ion is slightly 
higher. However, the presence of Ca2+ ion and the two water molecules 
that form the co-ordination sphere were clearly visible (except in mol5, 
where only one water molecule was identified) in the electron density 
map.
Examination of the apo-LA structure revealed that the absence of 
Ca2+ ion did not cause any structural change in this region (r.m.s. devia-
Table 2.22. Crystal packing contacts between monomers of bLA and apo-LA structures
bLA apo-LA
protein-protein water mediated protein-protein water mediated
Moll S70/L81-F, Q43/L05 -E, Q43/Y103-F, Q43/A106-E/012- W,
S70/Q39-F, Q43/E49-E, N44/N44-C, H6S/Y103-F/O12-W,
K98/Q43-F, D46/K58-5, E49/Q43-C, H6  8/Q65 -5 /0 13 5-W,





























K98/N71 -D/0268- W, 
A 106/Q43 -F /075-WN102/H68-D, Y103/Q43-A L105/Q43-A K108/D64-F
Mol4 N45/A121-F,
Q39/K98-F








A 106/Q43 -F /0287- W
MoI5 K114/E25-F,
L115/G20-F
L 115/E25-F/07 1-W, 
D116/E25-F/0119-JP,
D 116/H107-F/N102-F/0130-IV
Note : The crystal packing contacts listed above were calculated using CCP4 (CCP4, 1994) and include only H-bond interactions between the monomers with 
a cutoff distance 3.4 A. The letters in italics represent the molecule identity while numbers in superscript represent the number of contacts.
-Ioo
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Figure 2 .1 7
Comparison o f apo-LA and bLA structures at the calcium binding site. The figure was produced 
using BOBSCRIPT (Esnouf 1997).
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tion for C a atoms between residues 78-90 for apo-LA and bLA is 0.26 
A) to compensate for the large net negative charge in this region except 
slight change in orientation of Asp-87 side-chain and some perturbation 
of Lys 79 side chain beyond C(3 atom (the N £ atoms of apo- and holo- 
forms are separated by 1.7 A). Comparison of the thermal parameter 
distribution for apo- and holo-LA confirms also the above observations 
as it has been indicated in Figures 2.18-2.20.












OD1 Wat (1) Wat (2)
Moll 3 7 .6 8 3 5 .5 8 3 8 .1 6 3 8 .2 3 3 2 .3 4 3 5 .7 1 3 1 .8 2
Mol2 3 8 .4 5 5 2 .5 9 5 0 .3 9 4 0 .5 8 3 3 .8 0 4 6 .8 8 4 2 .5 7
Mol3 4 3 .2 4 4 9 .7 4 5 4 .5 0 4 4 .3 5 4 3 .0 4 4 0 .1 2 4 0 .6 1
Mol4 4 0 .9 6 4 3 .1 7 4 6 .4 1 3 4 .5 7 3 6 .6 3 3 2 .6 8 3 9 .3 2
Mol5 4 8 .3 1 6 2 .2 5 5 4 .4 5 5 3 .0 5 5 1 .1 0 4 0 .9 7 —
Mol6 3 9 .1 1 4 1 .3 7 3 8 .2 5 3 9 .8 4 3 0 .8 7 3 3 .8 6 3 5 .1 7











Moll 2 9 .7 6 5 5 .5 0 3 5 .7 8 5 6 .5 3 2 8 .3 8
Mol2 3 0 .9 9 6 4 .8 3 3 5 .4 4 4 2 .5 4 3 4 .2 6
Mol3 3 6 .3 0 6 2 .9 8 3 9 .6 2 4 2 .8 3 3 4 .2 0
mol4 3 7 .5 2 5 7 .5 1 3 8 .0 7 4 9 .2 0 3 7 .7 4
mol5 3 5 .0 4 6 4 .8 9 3 6 .5 7 5 1 .0 8 3 3 .7 4
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The two conserved water molecules (part of the Ca2+ site), which 
were observed in all LA structures were absent in the apo-LA structure.
This was confirmed independently by increasing the resolution 
limit to 2.0 A. One round of refinement was performed at this resolution 
(even though the quality of data between resolution shells 2.2 -2 .0  A 
were weak) and the electron density map did not indicate the presence of 
these two conserved water molecules.
Similarly independent checks (refinement followed by analysis of 
thermal parameters and careful examination of electron density maps) 
were performed to rule out the presence of any residual Ca2+ ion 
binding/sodium ion/replacement of Ca2+ ion by a water molecule.
In none of the above cases, the results were convincing to support 
the existence of any ligand at the calcium-binding site.
Comparison of the calcium-binding loop of bLA with the 
corresponding one in apo-LA in terms of accessibility shows that this 
region in apo-LA has slightly higher solvent accessibility. In the high- 
resolution structure of baboon LA (1.7 A resolution), an internal channel 
starting at lie 27 and Asp 88 (from the calcium binding site), partly 
occupied by internal water molecules has been described (Acharya et 
al.f 1989). The corresponding channel is present in both bLA and apo- 
LA structures. However, less number of water molecules are trapped in 
this channel (which may be partly due to the lower resolution of these 
two structures, at 2.2 A resolution) and three of these water molecules 
are conserved in all three structures (baboon LA, bLA and apo-LA).
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2 2 2 3 . Cleft region
It has been speculated that LA utilises the residues in the cleft 
region to stabilise monosaccharide binding in lactose synthase (Grobler 
et al., 1994b; Malinovskii et al., 1996). A similar cleft (the active site 
region) has been described for the homologous protein, LZ and consists 
o f six binding subsites (A-F) to which the hexasaccharide binds. In the 
case o f LA, subsites A and B are blocked by Tyr-103 side-chain 
(Acharya et al., 1989).
However, available data based on mutagenesis studies and 
crystallographic analyses of LA structures suggest that the region 
corresponding to subsite F of LZ and an adjacent surface participate 
either directly or indirectly in monosaccharide binding by the complex 
(Grobler et al., 1994b; Pike et al., 1996).
In the bLA structure, there is a hydrogen bond between the 
phenolic OH group of Tyr 103 and the carbonyl oxygen of Gln-54 (2.9 
A); this is part o f the interaction interface between the two lobes Tyr 
103 being in the helical lobe and Gin 54 in the beta-lobe. The most
Figure 2.21 (overleaf).
The molecular surfaces o f  apo-LA and bLA are shown in (A) and (B) 
respectively. Minor perturbation o f  Tyr-103 in apo-LA resulted in slight 
opening o f  the cleft region. The carbohydrate o f  hexa-N-acetylchitohexaose 
[from the human LZ structure, Song et al., 1994)] was modelled [followed by 
molecular dynamics using the program CNS (Briinger et al., 1998) in apo-LA 
(A). The predicted position o f  the hexasaccharide based on modelling studies in 
apo-LA structure has been retained in bLA (B) for comparative purpose. The 
figure was prepared using the program GRASP (Nicholls et al., 1991).
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significant structural change observed in apo-LA is found in this region; 
Tyr 103 is shifted towards the interior of the cleft and a water-mediated 
interaction with Gin 54 replaces the direct hydrogen bond. This 
perturbation of Tyr 103 is found in all 6 molecules of apo-LA and 
results in a more open cleft that is reflected in the altered position o f the 
beta-lobe {Figure 2.21).
Superposition of the two lobes of LA molecule for both apo-LA 
and bLA suggests a slight outward movement of the two lobes (a- 
domain and (3-domain) with respect to each other. More specifically the 
angle between the 310 helix h2 (residues 77-80) and helix C (residues 86- 
98) is 68.50° for apo-LA and 69.55° for bLA. Moreover superposition 
of the backbone of apo-LA and bLA reveals that apo-LA deviates more 
in the p-sheet region than in other parts o f the molecule. The 
superimposed structures as well as a more detailed view of the two 
aromatic clusters are shown in Figure 2.22.
In order to investigate further the reorientation of Tyr-103 side 
chain, an attempt to fit an oligosaccharide in the cleft was made using 
modelling approaches. The carbohydrate of hexa-N-acetyl-chitohexaose 
was selected from the human LZ structure determined by Song et al. 
(1994) and a simple molecular dynamics exercise was performed using 
the program CNS (Brimger et al., 1998). The results indicated that in 
both apo-LA and bLA, subsites D and F had maintained their 
conformation, while the more open cleft of apo-LA, unlike the closed 
cleft in bLA could potentially accommodate carbohydrate residues in 
sites A-E. This may be partly due to the flexibility of the loop region 
between residues 44-46 and the fact that Tyr-103 and Gln-46 seem to
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adopt a different conformation in apo-LA {Figure 2.21). The functional 







Figure 2 .2 2
Superposition o f apo-LA and bLA structures giving a more detailed view o f the 
two aromatic clusters
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2*2*3* DISCUSSION
Different conformational states of LA have varying affinities for 
Ca2+. The native state binds Ca2+ with submicromolar affinity; although 
the molten globule state has a relatively weak millimolar affinity for 
calcium (Kuwajima, 1989), Ca2+ does also stabilise this compact but 
disordered state (Forge et al., 1999; Vanderheeren and Hanssens, 1994). 
Calcium accelerates the rate of refolding in denatured bLA (disulphide 
bonds intact) by more than two orders of magnitude (Forge et al., 1999; 
Kuwajima, 1989) reflecting its binding to high energy intermediates in 
the folding process which have pre-formed Ca2+ binding sites. The 
requirement for Ca2+ for the formation of native protein with correct 
disulphide bond arrangements in the reduced denatured protein (Ewbank 
and Creighton, 1991; Rao and Brew, 1989) suggests that it also acts by 
selective binding to similar rate-limiting intermediates in the oxidative 
folding process. The ‘molten globule’ state and the ‘transition state’ for 
folding are arrays o f conformations as opposed to discreet species and 
Ca2+ binding appears to be a common property of a range o f partially 
folded states o f LA in which affinity for the ion increases as their Ca2+ 
binding sites become more native.
It has been established that the binding of calcium is not required 
for activity in LA (Berliner et al., 1983; Kronman et al., 1981; 
Kuwajima et al., 1986) in keeping with the structural studies described 
here that show that overall fold of LA is unchanged and the Ca2+ binding 
site has similar structures in the holo- and apo-forms o f bLA. A cation 
from the crystallisation medium does not replace the calcium in the apo- 
form (for example sodium ion). This confirms that stabilisation of the
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native state of the apo-protein by higher concentrations of monovalent 
cations is related to ionic strength effects as opposed to specific binding. 
The calcium-chelating water molecules are also absent. Although 
changes in the immediate vicinity of the site appear to be trivial, a larger 
structural change is found at the inter-lobe interface (which connects the 
calcium binding site and the cleft involving Tyr-103 through a channel 
with trapped water molecules) located on the opposite face of the apo- 
LA structure.
The architecture of the LA Ca2+-binding site is superficially 
similar to the E-F hand of calmodulin (CaM) and related Ca2+ binding 
proteins. Although the affinity of LA for Ca2+ is similar to that of CaM 
(Kronman, 1989; Kronman et al., 1981), in other ways the interaction of 
Ca2+ with LA is unique (the dissociation constant of Ca2+ to apo-LA is of 
the order of 10'7M). The association of Ca2+ to CaM and other 
intracellular regulatory proteins, as well as organic chelators, involves a 
positive entropy change. This change is thought to reflect the fact that 
the increase in entropy resulting from the loss of hydration from the 
Ca2+ and coordinating groups in the binding site, exceeds the decrease in 
entropy resulting from enhanced order in the Ca2+ complex (Schaer et 
al., 1985). In LA, Ca2+ binding is accompanied by a large negative 
entropy change, indicating that the Ca2+ ion has a major role in the 
protein. The binding of Ca2+ to CaM is essential for its ability to activate 
enzymes whereas both apo and holo-LAs are active in lactose synthase 
(Berliner et al., 1983; Kronman et al., 1981). Moreover recent studies by 
Anderson et al. (1997) have shown that the disruption of the Ca2+ 
binding site in bLA did not prevent the protein from stimulating lactose
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synthase activity even though the binding ability of the Ca2+ ion was 
lost. The precise role o f Ca2+ has remained unclear. Although it is not 
uncommon to find Ca2+ or another metal ligand acting in stabilising a 
secreted protein (e.g. trypsinogen) and the Ca2+ in LA does increase 
stability, this seems unlikely to be biologically significant since the site 
of action of LA is in an intracellular compartment (the lumen of the 
golgi) and involves the short time span in which it is in contact with GT 
in the golgi.
However, we can rule out a ‘functional role’ for the Ca2+ ion in 
LA by drawing analogy with LZ molecule. It is known that LA arose 
through gene duplication for a Ca2+ binding LZ (Brew and Grobler, 
1992; Grobler et al., 1994a). Interestingly, the crystal structure analyses 
of the apo- and holo mutant human LZs with an introduction o f a Ca2+ 
binding site did not seem to have had any effect on the overall structure 
or change in molecular rigidity o f the proteins (Inaka et al., 1991). Only 
subtle, local perturbations were noticed to accommodate the Ca2+ ion in 
the LZ structures. Based on calorimetric studies, these small changes 
were attributed to an increase in entropy due to the release of water 
molecules bound to the Ca2+ in solution (Kuroki et al., 1992). Similarly 
comparison o f the Ca2+ loop in equine LZ (Tsuge et al., 1992) and the 
corresponding loop in hen-egg-white LZ (a prototype non-Ca2+ binding 
LZ (Steinrauf, 1998), did not show any significant difference in 
conformation (r.m.s. deviation o f 0.59 A for Ca atoms between residues 
81-93). These results are complementary to those observed in apo-LA 
and bLA structures as presented here.
Calcium appears to affect folding by binding to the ‘transition
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state’ or array of transition states, facilitating the locking in of tertiary 
interactions between the two lobes of the molecule. Iyer and Qasba 
(1999) have performed a molecular dynamics simulation of LA and 
calcium binding c-type LZ and the results o f their investigation suggest 
the possibility of a general mechanism by which the protein dynamics 
and function are modulated by metal binding. It may be possible that the 
function of metal ion binding site may be not only to maintain the 
geometry of the cleft, but also to increase the flexibility of the protein at 
regions both away from the binding site and those involved in 
monosaccharide binding during the formation of LS complex. Hence, it 
is plausible that the conformational alteration observed in the cleft 
region of apo-LA and bLA structures could be attributed to the Ca2+.
It has been observed that at temperatures above 20°C, on 
removal of Ca2+ from native LA, it adopts a molten globule structure, a 
compact conformer with a large proportion o f native secondary structure 
but little fixed tertiary structure. This state also predominates at low or 
high pH and at higher temperatures (Kuwajima, 1989). There is much 
interest in the molten globule state o f LA (Alexandrescu et al., 1992; 
Alexandrescu et al., 1993; Baum et al., 1989; Ewbank and Creighton, 
1991) since it is closely similar to an early intermediate in the folding 
pathway. However, we may not be able to determine the molten globule 
state structure of LA using X-ray crystallography. On the other hand, the 
comparison of the structures of apo-LA and bLA presented here clearly 
points to a ‘structural role’ for the Ca2+ ion that seems to be important 
for the stability of the protein with Ca2+ binding region being the most 
rigid part of LA molecule.
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2.2.4. FURTHER CRYSTALLOGRAPHIC STUDIES WITH 
apo-LA
The crystal structure of apo-LA could be set as a template for 
further binding studies of metal ions in LA molecules. Several studies 
over the years have shown that possible binding site/sites for ions such 
as Tb3+, Mn2+, Co2+ etc. exist in LA molecule and since most of these 
ions can bind also to GT it is very important to establish the structural 
details of various metal ion interactions with LA molecule.
With this aim, co-crystallisation experiments of apo-LA with 
excess of Ca2+, Co2+ and Tb3+ were performed and low quality data have 
been collected for the complex o f apo-LA with calcium ion. The crystals 
co-crystallised either with Co2+ or Tb3+ showed very poor diffraction and 
turned out to be disordered after exposure to X-rays. Recent studies 
concerning the effect of pH on apo-LA showed that apo-LA crystallises 
in the tetragonal lattice in pH 8.0 (buffer: Tris/HCl) also in the presence 
of 2.2 M ammonium sulphate.
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2.3. a-LACTALBUMIN VARIANTS
2.3.1. PREVIOUS WORK ON a-LACTALBUMIN VARIANTS
2.3.1.1. Preparation of mLA variants
The gene for bovine LA has been cloned and expressed at high 
levels in Escherichia coli and recombinant bovine LA (mLA) was 
obtained by limited proteolysis of the fusion protein, consisting of the 
mature bovine LA sequence connected to the NH2-terminal 50 residues 
of human cathepsin D by a linker sequence containing protease cleavage 
sites (Wang et al., 1989). This fusion protein was expressed in an 
insoluble form and accumulated to about 50% of the total bacterial 
protein within 3h after induction of T7 RNA polymerase synthesis and 
was converted to an active form, the maximum specific activity of which 
was only 25% of that of native LA. However, after cleavage with trypsin 
a product indistinguishable in structure and activity from native LA was 
obtained. The non-specific cleavage of the fusion protein could be 
destructive in the study of LA variants, hence a methionine residue was 
introduced prior to the coding sequence using M l3 site-directed 
mutagenesis. The coding region of LA was also rendered resistant to 
CNBr cleavage by local substitution of methionine 90 with a valine, a 
residue that appears to be conserved in several LA primary structures. 
This new construct (pC-LA), provided a recombinant form of bovine LA 
(M90V-LA) by specific cleavage of the expressed fusion protein with 
CNBr, that was essentially identical to the wild type protein in terms of 
kinetic parameters and CD spectra while the final yields were improved 
to lOmg folded protein per litre of bacterial culture.
Although the fusion expression system was used successfully the
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quantities of the produced proteins were not sufficient for crystallisation 
studies, thus the construction of a new non-fusion expression system was 
performed (Grobler et al., 1994). Bovine LA was expressed in 
Escherichia coli strain BL21(DE3) by using a vector (pMLA) generated 
by cloning the coding sequence for LA into pET3a vector at a site 
adjacent to the codon for the initiator methionine. The coding region for 
mature LA (in which the codon for methionine 90 was modified by M l3 
site directed mutagenesis to valine as described above) was amplified by 
PCR using the primers designated NF-N and NF-C. These primers were 
designed to introduce a NdeI site at the 5 ’ end and a BamHl site at the 3 ’ 
end, together with an initiator methionine codon immediately preceding 
the bovine LA sequence. The product of the amplification was purified 
by agarose gel electrophoresis, digested with Ndel and BamHl, and 
cloned into a preparation of the expression vector (pET3a) that had been 
previously digested with the same restriction enzymes. The ligated 
product was transformed into competent DH5a subcloning efficiency 
cells (Gibco BRL, Gaithersburg, MD) and the tranformants were 
screened for correctly inserted DNA using Ndel/BamHl and BamHl/Sail 
double digestions. Twelve of the transformant colonies screened the 
correct insert. The new expression vector (p-MLA) was transformed 
intro competent BL21(DE3) expression cells, a lysogenic E. coli strain 
carrying the bacteriophage T7 polymerase gene, and ampicillin resistant 
transformants were selected. p-MLA was sequenced using an automatic 
DNA sequencing system to confirm that the LA coding sequence was 
correctly inserted and that no undesired mutations had been introduced 
during the PCR amplification (Pike, 1995; Wang et al., 1989).
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2.3.1.2. Generation and purification of mLA variants.
The single site substitutions were introduced into p-MLA 
(template in all amplifications) using the PCR Megaprimer method 
(Sarkar and Sommer, 1990). Megaprimer method involves two separate 
PCRs and makes use of appropriate oligonucleotide primers depending 
on the site of the mutation: T7 promoter or T7 terminator primer. The 
final PCR product (it has undergone two successive amplifications) was 
isolated, purified, digested and cloned into cut pET3a as in the case of 
mLA (section 2.3.1.1.). In particular changes at positions 117 and 118 
had to be constructed using a modified mutagenesis protocol.
Replacement of aromatic clusters I and II with non-aromatic 
residues reduced the final yields and such an effect was attributed either 
to destabilisation of the native conformation or to alterations in the in 
vitro folding kinetics of the mutant (Pike, 1995). However, sufficient 
quantities of pure variant proteins (reported in this thesis) were produced 
by Dr. A.C.W. Pike for crystallographic study.
2.3.1.3. Kinetic studies on mLA variants
A plausible model has been suggested in order to explain the 
mechanism under which LA comes into contact with GT to form the LS 
complex and three schemes based on this model have been proposed. A 
random but highly synergistic binding of LA with glucose to GT is a 
common point of view for all three mechanisms, where LA associates 
with GT prior to the release of products and dissociates from LS 
complex before the completion of each catalytic cycle. The proposed 
schemes variations appear in defining the moment that LA gets involved
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in the complex formation as well as in the level of randomness of the 
reactions. According to (Morrison and Ebner, 1971 ) GT substrates are 
Mn2+, UDP-galactose and finally LA while (Khatra et al., 1974) and 
(Powell and Brew, 1976) consider a partially ordered mechanism as 
more appropriate to interpret LA’s action in which UDP-galactose binds
^ I
to GT-Mn complex prior to the random equilibrium binding o f LA and 
glucose. Finally the third scheme supports a completely random addition 
of substrates (UDP-galactose, LA and acceptors) to G TM n2+ complex 
(Bell etal., 1976).
2.3.1.4. Results from other studies on mLA variants
The LA variants have been designed with the aim to investigate 
regions of LA molecule to be directly involved in the formation o f LS 
complex such as aromatic clusters I and II, as well as the flexible loop 
(see chapter-2 introduction for more details). Most of the substitutions 
involving residues from aromatic cluster II and more specifically Tyr 
103 and Trp 104 affect the folding kinetics of the protein, in agreement 
with the NMR results that this region is of great importance for the 
stability of molten globule state of LA (Alexandrescu et al., 1993; Pike, 
1995; Smith et al., 1994). However, residues like proline seem to replace 
tyrosine at position 103 without affecting either the yields or the folding 
of the protein. Mutations at both aromatic cluster II and flexible loop 
appear to lead in functionally deficient variants. Point mutations at 
positions 31 and 32 exhibit reduced affinity to GT and increased glucose 
binding in the LS complex. In the case of tyrosine substitution for 
phenylalanine at position 31 only a lower ability in glucose binding is 
observed and minimal effects on GT binding supporting the idea that Phe
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31 is participating in the monosaccharide binding. On the contrary 
residues 117 and 118 affect the strength of LA binding to GT.
The above observations confirm that only a small surface area in 
the tail of LA molecule (residues 105-118) is implicated in the 
interaction with GT a result that is strengthened also by the weak affinity 
of LA for GT (kd 10'5M) (Pike, 1995).
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2.3.2. MATERIALS AND METHODS
2.3.2.1. Crystallisation and diffraction data collection.
Crystals of LA variants had been produced using the vapour 
diffusion method with hanging drops. Equal volumes (2.0 pi) of protein 
(~2 0 mg/ml) and reservoir solution were mixed on siliconised coverslips 
and left to equilibrate against the reservoir solution.
Diffraction data were collected using the Synchrotron Radiation 
Source (SRS) at Daresbury, UK or at EMBL Hamburg outstation either 
at room temperature or under cryogenic conditions. Data were recorded 
on a 18cm or 30cm image plate (MAR Research, Hamburg, Germany) 
and integrated and reduced with the programs DENZO  and SCALEPACK 
(Otwinowski and Minor, 1997). In the case o f His 32 to Tyr data 
integration and reduction was performed with the program MARXDS and 
MARSCALE (Kabsch, 1988).
A lai 09-Pro, Tyr 103-Pro, Trpl 18-His variants: Crystals appear at 
37°C in the hexagonal form (Table 2.23, Figure 2.23a) using ammonium 
sulphate as the precipitant at pH 6.5. Although no surface anomaly was 
detected under the microscope, all three variants exhibit ‘merohedral 
twinning’-an inherent problem of most LA crystals grown in the 
hexagonal form- which can be identified by careful examination o f the 
diffraction pattern or by the use of algorithms that have recently been 
developed.
Phe31-Tyr: Crystallisation trials using conditions analogous to 
those optimised for the above three variants were initially performed by
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increasing the concentration of ammonium sulphate concentration from 
2.1 -  2.4 M. The crystals seem to belong to the hexagonal form, judging 
from their shape and when they were exposed to X-rays their diffraction 
pattern was disordered. Matrices of various concentrations of 
precipitating agent and pH were used and a new crystal form in 
tetragonal spacegroup, 7^41212 (somewhat similar to apo-LA described 
earlier) was obtained with six molecules per asymmetric unit (Table 
2.23, Figure 2.23b).
His32-Tyr: Crystals o f His 32 to Tyr variant appeared fairly quickly as 
very thin, almost two-dimensional plates forming a cluster of crystals 
and it was rather difficult to isolate a single crystal at a size suitable for 
collecting data. Optimisation o f the crystallisation conditions was 
attempted by means o f detergents but did not improve the quality of the 
crystals. An incomplete data set was collected to 2 .8  A under cryogenic 
conditions using glycerol as cryoprotectant and preliminary 
characterisation of the crystal indicated that it belonged to orthorhombic 
lattice (Table 2.23).





Crystals of LA in different forms: (a) Hexagonal, (b) Tetragonal
Table 2.23 Crystallisation, Data collection and processing statistics of LA variants
A109P Y103P W118H F31Y
Crystallisation conditions
Ammonium Sulph. 1.8M 
CaCl2 lOmM 
PIPES O.IMpH 6.5
Ammonium Sulph. 1.8M 
CaCl2 lOmM 
PIPES O.IMpH 6.5
Ammonium Sulph. 1.8M 
CaCl2 lOmM 
PIPES O.IMpH 6.5












a=b=l 19.96 c= l52.56
a ,  P , Y ( ° ) 90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 90
Space group P3 P3 P3 P4,2,2
No of mol. per asymmetric unit 2 2 2 6







Image plate Mar 18 Mar30 Mar30 Mar30
Wavelength (A) 0.87 1.0 1.0 1.488
Distance (mm) 195 270 270 241
Oscillation range (degrees) 1.0 1.0 1.0 1.0
No of images (degrees) 104 (104) 58 (58) 62 (62) 42 (42)
No of observations 257443 164024 159565 104602
No of unique reflections 36113 41053 42824 18019
Max. resolution (A) 2.03 2.0 2.0 3.2
^Completeness (outermost shell) (%) 87.4 (68.3) 90.6 (89.7) 95.1 (95.2) 94.5 (96.4)
^Rsym ( I ) (outermost shell) (%) 10.4(48.8) 4.2(21.5) 4.2 (29.7) 16.6(48.1)
< I / ct( I ) >  (outermost shell) 8.0 (2.6) 14.2 (3.7) 8.9 (3.9) 4.9 (2.9)








Cell dimensions (a, b, c) (A)
PEG 4K 25%, CaCl2 10mM 








<*, P>Y(°) 90, 90, 90 90, 90, 120
Space group










Image plate Mar 18 Mar 18
Wavelength (A) 0.9057 1.542
Distance (mm) 215 160
Oscillation range (degrees) 1.0 1.0
No of images (degrees) 31 (31) 38 (38)
No of observations 2278 10891
No of unique reflections 980
Max. resolution (A) 2.8 3.0
^Completeness (outermost shell) (%) 32.1 (32.1)
^Rsym ( I ) (outermost shell) (%) 8.7(16.3) MARXDS statistics
< I / ct( I ) >  (outermostshell) 17.7 (7.7)
Outermost shell (A) 3.0-2.8





Chapter 2. a-Lactalbumin variants 104
Lysll4-Asn\ Single crystals were obtained from crystallisation 
conditions suggested by sparse matrix crystallisation screening kit, 
Crystal Screen I from Hampton Research (Jancarik and Kim, 1991) that 
were diffracting to 3.0 A resolution. Preliminary characterisation 
indicated that Lysl 14-Asn variant belongs to the hexagonal spacegroup 
with 8 molecules per asymmetric unit (Table 2.23, Mathews coefficient, 
Vm= 3.9 A3/D). Attempts to vary the crystallisation conditions by 
changing the precipitant from ammonium sulphate to lithium sulphate 
were made with an aim to obtain another form with reduced number of 
molecules but they were not successful.
His32-Ala: Preliminary indications showed that this LA variant 
might crystallise in the presence of PEG 4K 20%, CaC^ lOmM in 
Tris/HCl buffer pH 7.5. In addition a single crystal was grown using 
condition 5 of Hampton Research Crystal screen I (the ingredients of 
which were 30% MPD, 0.1M Sodium Hepes pH 7.5 and 0.2 M sodium 
citrate) at 16°C. This crystal was exposed to X-rays at SRS but further 
optimisation of the condition seem to be necessary.
Crystallisation trials have also been performed for Hisl07-Ala as 
well as Phe31-Ala, Leul 10-Arg, Cys6 -Ser and 166-Val variants, starting 
with the Crystal Screen kit or with matrices of various concentrations of 
PEG and ammonium sulphate against different pH ranges. Some 
indications of crystals have been observed which can be used to screen 
further conditions.
Due to lack of time structural determination of these variants could 
not be performed.
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2.4. INVESTIGATION OF BINDING OF Mn2+ to human 
a-LACTALBUMIN
In the context of the previous studies on metal ion binding in LA, 
before the structure determination of apo-LA, crystals of commercially 
available human LA (Sigma, chemical company) co-crystallised with 
5mM MnCl2 in the orthorhombic form and a high resolution data set was 
collected (Tables 2.24, 2.25), yet difference Fourier analysis did not
^  I
show direct binding of Mn to human LA protein.
Table 2.24. Crystallisation conditions
•  N a t iv e  H u m a n  a -L a c ta lb u m in  +  M n 2+ (c o c r y s ta llis a t io n )
R e se r v o ir : A m m o n iu m  S u lp h a te 2 .0  M T e m p .:  3 7 ° C
so lu t io n
C a C l2 2 0  m M
P IP E S 0 .2  M p H  7 .5
M n C l2 10 m M
G ly c e r o l 1%
D ro p : H L A 3 0  m g /m l
A m m o n iu m  S u lp h a te 1 .6  M
C a C l2 5 m M
P IP E S 0.1  M p H  7 .0
M n C l2 5 m M
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Table 2.25 Data Processing Statistics for HLA + Mn2+ complex
C e ll d im e n s io n s  (a , b , c )  (A ) a = 3 3 .6 4  b = 6 9 .8  c = 4 7 .1 2
a ,  P , Y ( ° ) 9 0  9 0  9 0
S p a c e  g ro u p P 2 t2 i2
N o  o f  m o l. p e r  a sy m m e tr ic  u n it 1 .0
S ta tio n I n -h o u s e  d ata
Im a g e  p la te M a r 3 0
W a v e le n g th  (A) 1 .5 4 2
D is ta n c e  (m m ) 1 0 9 .0
O s c il la t io n  r a n g e  (d e g r e e s ) 1 .0 °
N o  o f  im a g e s  (d e g r e e s ) 6 2  ( 6 2 ° )
N o  o f  o b s e r v a tio n s 6 5 1 6 7
N o  o f  u n iq u e  r e f le c t io n s 1 1 0 6 3
M a x . r e s o lu t io n  ( A ) 1 .7
® C o m p le te n e s s  (o u te r m o s t  s h e ll )  (% ) 8 6 .7  ( 8 5 .9 )
^Rsym ( I )  (o u te r m o s t  s h e ll)  (% ) 7 .9  ( 6 0 .2 )
< I / a ( I ) >  (o u te r m o s t  sh e ll) 5 . 3 7 ( 1 . 8 1 )
O u te rm o st s h e l l  (A) 1 . 7 6 - 1 . 7 0




NATIVE RECOMBINANT RBP (rRBP)
&
A DOUBLE VARIANT OF rRBP
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3. HUMAN SERUM RETINOL BINDING PROTEIN
3.1. INTRODUCTION
3.1.1. Human Serum Retinol Binding Protein as a member of the 
family of lipocalins.
The lipocalins are a structurally and functionally diverse family of 
proteins and they are only found in eukaryotic organisms. Members of 
the lipocalin protein family are typically low molecular weight secreted 
proteins, characterised by a range of different molecular-recognition 
properties such as ability to bind small, principally hydrophobic 
molecules, binding to specific cell-surface receptors and formation of 
macromolecular complexes. Sequence identity within the lipocalin 
family is very often below 25%. However, there are conserved sequence 
motifs characteristic of the family, and the family members also share a 
basic feature present in all lipocalins: the structural framework o f an 8 
stranded ‘up and down’ p-barrel {Figure 3.1) (Huber et al., 1987) 
(Flower, 1996) (Brownlow et al., 1997).
Figure 3.1 (overleaf)
Sequence comparison for RBP. The alignment shows a selection o f Retinol binding 
proteins (RBP), fatty acid binding proteins (FABP) and retinoic acid RBP (RABP). 
The shaded areas correspond to conservative residues. The sequence retrieval was 
performed using the program WU-Blust (version 2.0) and the alignment using the 
program Clustalx.
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The lipocalins have been classified as extracellular transport 
proteins and a good representative of such a function is the retinol 
binding protein (RBP). RBP is the sole specific carrier protein for 
retinol (vitamin A, C20H30O) and its single known physiological function 
is to protect from oxidation and deliver bound retinol from the storage 
sites in the liver to the peripheral target tissues. Within tissues, retinol is 
activated to retinoic acid (local mediator of cellular proliferation and 
differentiation), which in turn binds to nuclear receptors to regulate 
transcription o f more than 300 diverse target genes.
Dietary retinoids are the only retinoids present in the body. These 
are packaged by the intestine as retinyl ester, along with other dietary 
lipids, in chylomicrons. The majority of dietary retinoid is cleared by 
and stored within the liver. To meet tissue retinoid needs, the liver 
secretes into the circulation retinol bound to a single polypeptide chain 
of molecular weight 21kDa synthesised in the hepatocytes, RBP 
(Quadro et al., 1999; Soprano and Blaner, 1994). Only retinol triggers 
secretion of RBP, which in turn forms a complex with transthyretin 
(TTR, formerly called thyroxin-binding prealbumin) when circulating in 
the plasma. Although in vitro it has been shown that the complex is 
formed by one tetramer of TTR (55kDa) and two RBP molecules, the 
RBP concentration in plasma is very limiting and the complex isolated 
from the serum consists o f one molecule of each component. The 
formation of such a complex seems to be essential in order (i) to prevent 
extensive loss of the low molecular weight RBP during its filtration and 
degradation through the kidney glomeruli into the intercellular space 
outside the vascular system and (ii) to facilitate the newly synthesised
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retinol-RBP secretion (Naylor and Newcomer, 1999; Ronne et al., 1983; 
Soprano and Blaner, 1994). It has been shown that cellular RBP 
expression in hepatic stellate cells (the major site of metabolism and 
storage: more than 80% of the liver retinoids), relevant for both uptake 
and esterification of retinol, responds to the extracellular retinol status, 
and is correlated to the retinol binding capacity o f the cytosol (Vicente 
et al., 1998). The transfer of retinol from serum RBP to cellular RBP is 
shown to be mediated by a receptor (Sundaram et al., 1998). Such a 
receptor-mediated delivery of retinol to specific sites on the plasma 
membrane that influence overall retinol metabolism is not in agreement 
with studies on human keratinocytes. According to these studies the rate 
and extent of retinol esterification by keratinocytes and the types of 
retinyl esters synthesised are the same whether the retinol is delivered to 
the cells free or bound to RBP (Hodam and Creek, 1998). Coordinate 
function of co-localised cellular RBP, retinol and retinal dehydrogenase 
with the RBP-receptor in tissues dependent upon vitamin A for normal 
development, is responsible for the metabolic pathway from vitamin A 
to retinoic acid (Bavik et al., 1997).
Attempts to understand the role of RBP in retinoid physiology 
have been made by means of gene targeting. Experiments performed on 
RBP knockout mice suggest that the physiological role of RBP is to 
ensure that retinol is available for maintaining normal cellular functions 
in times of inadequate vitamin A intake (Quadro et al., 1999).
RBP has also been validated as a sensitive and accurate marker in 
assays concerning the production of monoclonal antibodies in dairy 
cows (Lindberg et al., 1999), the effect of ‘renal-dose’ dopamine on
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renal tubular function following cardiac surgery (Bhutta et al., 1999) 
and renal tubular dysfunction (Dillon et al., 1998), the detection of 
serum retinol in children with shigellosis (Mitra et al., 1998), the 
deficiency of vitamin A during inflammation by measuring the molar 
ratio of RBP to TTR (Rosales et al., 1999), the diabetic nephropathy 
diagnosis (Hong and Chia, 1998).
Apparent dissociation constants for human RBP vary from 1.5 to 
1.9 x 1 O' 7 M depending on the method of preparation of the apo-form. 
RBP appears to accommodate not only retinol but also retinol analogs 
such as retinoid acid with a dissociation constant comparable to that of 
retinol (2. lxlO ' 7 M vs 1.9x1 O' 7 M) (Cogan et al., 1976). The relative 
affinities of vitamin A derivatives for RBP can be placed in the order 
retinoid acid, retinol, retinal, retinyl ester, retinoyl ester. From binding 
studies of terpenoids to RBP it can be concluded that the more 
hydrophobic the ligand the higher the affinity it exhibits explaining the 
enhanced binding when p-ionone ring is present along with the 
hydrophobic isoprene chain with the five conjugated double bonds. The 
hydrophobic moiety alone though, may be insufficient to allow binding, 
since esters of retinol do not bind at all to RBP while the hydroxyl group 
of retinol might do the difference to the affinity it exhibits (Hase et al., 
1976).
About 5% of the total amount of RBP in the plasma does not 
participate in complex formation with TTR, 80-90% is apo- and the rest 
is holo RBP. The total pool o f RBP in the body is probably in the order 
of 410mg, slightly more than half of which (2 2 0 mg) is present in the 
plasma compartment (Fex et al., 1979).
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3.1.2. Description of RBP molecule.
According to the complete human RBP amino acid sequence 
determined by Rask et al. (1979), the primary structure of RBP consists 
of 182 amino acids. Crystallisation in the rhombohedral spacegroup and 
preliminary X-ray data collection of human plasma RBP was first 
reported by (Ottonello et al., 1983) followed by (Newcomer et al., 1984) 
who crystallised human and rabbit plasma RBP in the orthorhombic 
spacegroup. Previous x-ray crystallographic work has shown that RBP 
is composed of a single globular domain (~40A diameter) that 
comprises an N terminal coil, 8 antiparallel (3-strands (p-barrel), a short 
helix and a C terminal strand {Figure 3.2). The loops connecting the 
strands are all rather short. The p-strands correspond to regions of 
relatively low mobility whereas loop residues between the strands 
display larger positional fluctuations. The secondary structure of RBP is 
stabilised by three disulphide bridges formed between residues 4-160, 
70-174 and 120-129 (Cowan et al., 1990) {Figure 3.2).
The overall structure encompasses both transthyretin and retinol 
binding sites. The TTR binding site is a hydrophobic area on the protein 
surface formed by some of the loops that surround the opening of the P- 
barrel (residues 35, 63, 64, 67). The structures o f the complex of human 
RBP with its carrier protein transthyretin were reported recently by 
Naylor and Newcomer (1999) and chicken RBP in complex with TTR 
by Monaco et al. (1995) it is evident from these structures that RBP 
binds at a 2-fold axis o f symmetry in the TTR tetramer thereby creating 
a 2-fold symmetry at the interaction site. Four amino acids from the 
TTR molecule (Arg 21, Val 20, Leu 82 and Ile-84) are contributed by
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the two monomers, while amino acids from RBP that appear at the 





Figure 3 .2 .
Structure o f  Retinol Binding Protein. The figure was 
generated using the program BOBSCRIPT (Esnouf 1997)
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TTR symmetry related side chains. An interaction of the carboxy 
terminus of RBP with TTR has also been revealed and it has been 
suggested that such an interaction might be of physiological 
significance.
Residues involved in the formation o f the retinol binding site are 
mainly those that contribute to the formation of the P-barrel which 
completely surrounds the retinol molecule with the P-ionone ring in the 
centre and the isoprene chromophore stretching along the barrel axis 
almost to the solvent surface (residues 32-37, 47-53, 64-68, 92-98). The 
retinol is buried in the barrel with no covalent attachment to the protein. 
Although the p-barrel has two entrances, there is access to the core only 
through one due to blockage of the second entrance by a cluster of 
phenylalanine rings (Cowan et al., 1990). The P-barrel also forms a 
great number of hydrogen bonds (they are responsible for the formation 
of two orthogonal p-sheets) and its rigidity can be attributed either to 
hydrophobic or to interchain interactions (Zanotti et al., 1993).
The structure of human plasma RBP, in both the holo and apo 
forms, has been determined at 2.5 A resolution (Zanotti et al., 1993). 
The flexibility o f some regions of the molecule leads to different 
conformations and as a result the holo and apo forms of the protein 
crystallise in orthorhombic and trigonal space groups respectively 
(Newcomer et al., 1984; Zanotti et al., 1993).
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3.1.3. Human serum RBP as a model lipocalin.
Human serum RBP is a well characterised protein from both 
functional and structural points of view, thus it was selected as a model 
lipocalin (Greene, 1998). The presence of four tryptophan residues 
located in different regions of the structure can serve as probes of 
folding and unfolding processes. Being a carrier protein, RBP molecule 
appears to be a good model protein for protein engineering studies and 
for the design of molecules that will enable RBP to transport not only 
drugs but also other molecules.
Investigations into the relationship between sequence 
conservation, stability and folding with RBP were performed in our 
collaborator’s laboratory (Prof. Keith Brew, University of Miami School 
of Medicine, Miami) with the specific aims: (i) to elucidate the nature of 
the conserved sequence information in the lipocalin superfamily and 
evaluate its structural significance; (ii) to develop a high yield 
expression system, purification and in vitro refolding procedures for 
RBP; (iii) to generate and express mutants with tryptophan replacements 
used to experimentally investigate the roles of conserved residues versus 
non conserved tryptophans, in native and molten globule state stability 
in human serum RBP and (iv) to characterise the folding and unfolding 
behaviour of human serum RBP (Greene, 1998).
In the context o f above studies the cDNA encoding RBP was 
cloned into the prokaryotic expression vector pET3a. This vector and 
the bacterial host BL21(DE3) were selected for the expression system 
and provided high yields of recombinant protein in the form of inclusion 
bodies.
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Site directed mutagenesis by PCR using the ‘mega-primer 
method’ was applied to construct RBP variants. The sequence
Double variant YV67L
Figure 3 .3 .
Worm representation o f  rRBP variants showing the sequence substitutions. The 
figure was generated using the program BOBSCRIPT (Esnouf 1997).
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substitutions in rRBP targeted to tryptophan residues located at the 
entrance of the p-barrel close to the retinol hydroxyl group. Selection of 
substitutions was determined by a homology-based approach using an 
alignment of RBPs from different species and closest relatives or in 
consideration of similar side chain chemistry as to minimise structural 
disruption and effects on the folding pathway. Experimental 
investigations were conducted into the role o f the different tryptophans 
in structure, as well as native and molten globule state stability. Apart 
from the homology consideration tryptophans were subjected to 
mutagenesis for stability and folding studies based on criteria such as : 
(i) they are ideal intrinsic fluorophors; (ii) their excitation and emission 
can be selectively monitored at A,ex=295 and XQm =350nm; (iii) they 
contribute significantly to CD spectrum; (iv) the range of locations 
make them ideal probes of different structural regions; (v) differences in 
conservation enable comparison between conserved and non-conserved 
regions.
The sequence changes that have been introduced to the 
recombinant parent protein (rRBP) by mutagenesis are (a) a double 
substitution at positions 67 and 91 from tryptophan to leucine and 
histidine respectively, (b) a single point substitution at position 24 from 
tryptophan to tyrosine and (c) a single point substitution at position 105 
from tryptophan to phenylalanine as presented in Figure 3.3. According 
to the near- and far-UV circular dichroism (CD) measurements, the 
substitutions were found not to disrupt the overall native secondary or 
tertiary rRBP structure. Substitutions to the most conserved tryptophans 
had different effects on the CD spectrum in comparison to the other
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tryptophans. Thermal and chemical denaturation studies indicated that 
mutations had varying effects on the stability o f the native state and 
there was no correlation between sequence conservation and molten 
globule stability suggesting that the molten globule state o f RBP was 
not stabilised by native interactions (Greene, 1998).
rRBP : The high resolution structure of rRBP (1.7 A resolution) 
was determined using crystals of rRBP grown in the trigonal 
spacegroup. Although the apo-form of RBP had been previously 
determined (Zanotti et al., 1993) at 2.5 A resolution, the high resolution 
structure presented here was aimed at describing the fine details o f the 
p-barrel architecture and the structure of the water molecules in the 
interior of the barrel in the absence of retinol molecule and set a 
template for structural analysis of RBP variants.
W67L/W91H rRBP double varian t: Kinetic studies indicated that 
rRBP folds through a biphasic process (Greene, 1998). The properties of 
an intermediate suggest that some or all tryptophan residues are present 
in a less polar environment in the intermediate than in the native 
structure. In order to investigate further how the non-conserved 
tryptophans could affect the second rate of folding, sequence 
substitutions were performed considering the functional role of 
particular residues in RBP. The basis of the double sequence 
substitution of Trp 67 and Trp 91 was the primary structure of frog RBP 
where Leu and His are found at positions 67 and 91 respectively.
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Tryptophans 67 and 91 of RBP are also positioned at the surface 
of the molecule in loop regions that connect the (3-strands forming the 0- 
barrel. The crystal structure o f the TTR-RBP complex showed that these 
two tryptophans are located at the interface between the two proteins 
(Monaco et al., 1995; Naylor and Newcomer, 1999). Hence, in an effort 
to identify structural perturbations that could directly affect the TTR- 
RBP complex, the structure of the double variant W67L/W91H was 
determined at high resolution (2.0 A).
Tryprophan 24 to tyrosine rRBP variant : There appears to be a 
large difference between the contributions of Trp24 and other 
tryptophans in stability by thermal and solvent denaturation. The change 
in stability to thermal unfolding exhibits significant difference (four 
fold) in substitutions to conserved compared to non-conserved 
tryptophans (Greene, 1998). The equilibrium unfolding studies revealed 
that substitutions for the conserved Trp24 destabilises the native 
structure by about 2 kcal/mol to chemical denaturation. Molecular 
model building analysis with the hRBP 3-D structure, indicates that the 
Trp24-Tyr substitution did not disrupt the conserved tertiary H-bond. 
The decrease in stability may be attributed to the combined effect of a 
more polar side-chain with a lower volume, decrease in non-polar van 
der Waals packing interactions, and the reduced electrostatic interaction 
with Argl39. Preliminary crystallisation trials for this variant have been 
performed (see Table 3.11 for more details). It is hoped that the 3-D 
structure of this rRBP variant might reveal the functional role of Trp 24 
in the RBP structure.
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Tryptophan 105 to phenylalanine rRBP variant: Trp 105 is 
conserved in all known RBPs and appears to facilitate the folding 
process of the molecule by increasing the folding rates. Trp 105 also 
flanks a basic residue, Lys85 (Cowan et al., 1990). The folding kinetics 
of guanidine HCl-denatured rRBP appears to be biphasic (Greene, 
1998). The first phase is studied via the formation of Trp 24 used as a 
probe while the second phase reflects changes in the environment of one 
or more of the non conserved tryptophans 67, 91 or 105 in the 
superfamily of the lipocalins (only in RBP family) which appear to be 
more buried during the initial folding phase and become more exposed 
during the subsequent structural rearrangement to the native state. 
Attempts to crystallise this single rRBP variant are in progress.
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3.2.STRUCTURAL STUDIES ON NATIVE RECOMBI­
NANT RETINOL BINDING PROTEIN (rRBP) AND 
VARIANTS.
3*2.1* MATERIALS AND METHODS
3.2.1.1. Preparation of proteins
rRBP: The cDNA encoding human serum RBP was amplified by 
PCR using two primers designed specifically for directional cloning into 
the pET-3a expression vector. The cloning vector comprised the 
restriction enzyme NdeI cloning site, the initiator methionine codon 
Met-1, the BamHl cloning site and stop codon. Twelve extra bases were 
included outside each restriction site to allow for efficient cutting with 
restriction enzymes and the cDNA of interest was ligated to the vector. 
The product of the amplification was purified by agarose gel 
electrophoresis, digested with Ndel and BamHl, and cloned into a 
preparation of the expression vector (pET3a) that had been previously 
digested with the same restriction enzymes. The cells after being 
transformed they were plated on LB/ampicillin plates and colonies were 
screened for the presence of the recombinant vector by restriction 
endonuclease mapping of miniprep purified plasmids. Amplification of 
recombinant plasmids (pRBP) for sequencing and for use as templates 
in PCR mutagenesis experiments were carried out using E. coli strain 
DH5a as a host (Greene, 1998).
RBP mutants'. Mutations were introduced using the ‘megaprimer’ 
method (Sarkar and Sommer, 1990). During amplification the synthetic 
T7 promoter primer or T7 terminator primer together with the 
appropriate mutagenic primer were used in order to generate the
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‘megaprimer’. Purification of the ‘megaprimer’ followed by gel 
electrophoresis that was used in the second amplification with the same 
template and the cognate T7 primer. The final amplification product was 
purified and cloned into pET3a as described for RBP. The recombinant 
vectors containing RBP mutants were sequenced by automated DNA 
sequencing using both T7 promoter and T7 terminator primers (Greene, 
1998).
3.2.1.2. Protein expression and purification of rRBP. In vitro folding 
and purification of folded rRBP or variants.
Cultures of E. coli strain BL21(DE3) transformed with the 
recombinant vector (pRBP) or variant were grown, and inclusion bodies 
containing recombinant RBP (rRBP) were obtained by cell lysis and 
isolated by centrifugation. After their solubilisation by extraction with 
urea, they were passed through a Macroprep column equilibrated with 
tris-HCl, and SDS gel electrophoresis indicated that rRBP was in a 
relatively pure form.
Fractions containing rRBP or variants were collected and the 
protein concentration was estimated from the absorbance at 280 nm and 
the final concentration was between 50 pg/ml and 100 pg/ml. Properly 
folded rRBP along with some peaks standing for misfolded protein was 
recovered after further concentration and purification by anion exchange 
chromatography.
Functional characterisation of the produced rRBP followed along 
with determination of near and far UV CD spectra of rRBP and mutants.
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Equilibrium thermal unfolding studies were also conducted and 
guanidine hydrochloride equilibrium unfolding was determined. Urea 
unfolding of molten globule state studies and stopped flow fluorescence 
unfolding studies were finally performed. Expression and purification of 
rRBP and variants of RBP were performed by our collaborator, Prof. 
Keith Brew, at Miami and the required quantities of proteins for 
crystallographic studies at Bath were provided by his group.
3«2.13.Crystallographic studies.
rRBP : Large single needle shaped crystals of native recombinant 
human RBP (rRBP) were grown successfully using the vapour diffusion 
method with hanging drops (Figure 3.4). 2.0 pi of protein (~ 12mg/ml) 
dissolved in lOmM sodium cacodylate and 3.9 M sodium chloride pH 
6.8 are placed on siliconised coverslips and left to equilibrate against the 
reservoir solution that consists of 20 mM sodium cacodylate and 4.5 M 
NaCl, pH 6.8. The crystallisation conditions are recorded in Table 3.1.
Diffraction data from one rRBP crystal were collected on station 
9.5 (X=0.9 A) at the Synchrotron Radiation Source, CLRC Laboratory, 
Daresbury, UK under cryogenic conditions using glycerol as 
cryoprotectant at 1.7 A resolution. Prior to data collection at 100°K, the 
crystals were transferred to buffer solution (same as the reservoir 
solution) containing 25% v/v glycerol for about 30 sec. Data were 
recorded on a 30 cm image plate (MAR Research, Hamburg, Germany) 
with the crystal oscillating through 2.0° steps. Data integration and 
reduction were performed with the programs DENZO  and SCALEPACK 
(Otwinowski and Minor, 1997). Data collection details are summarised
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in Table 3.1 and Tables 3.2, 3.3 and the diffraction pattern of rRBP data 
is shown in Figure 3.5.
Figure 3 .4
Crystal o f  recombinant Retinol Binding Protein
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Table 3.1 Crystallisation and Data collection statistics for rRBP
Crystallisation
R e s e r v o ir  s o lu t io n
2 0  m M  S o d iu m  C a c o d y la te  
4 .5  M  S o d iu m  C h lo r id e  p H  6 .8
D r o p 12 m g /m l p r o te in  c o n c e n tr a tio n  
1 0  m M  S o d iu m  C a c o d y la te  
3 .9  M N a C l  p H  6 .8
T e m p er a tu r e 1 6 °C
C e ll  d im e n s io n s  (a , b , c )  (A ) a = b = 1 0 1 .3 4  c = 7 1 .9 8
a ,  P , Y ( ° ) 9 0 , 9 0 ,  1 2 0
S p a c e  g ro u p R3
M o le c u le s  p er  a s y m m e tr ic  u n it 1
Data collection & processing
T e m p er a tu r e 1 0 0 °K
S ta t io n  (S y n c h r o tr o n ) D a r e sb u r y  P X 9 5
Im a g e  p la te M a r 3 0
W a v e le n g th  (A) 0 .9 0
D is ta n c e  (m m ) 2 5 0
O s c i l la t io n  ra n g e  (d e g r e e s ) 2 .0
N o  o f  im a g e s  (d e g r e e s ) 2 5  (5 0 )
N o  o f  o b se r v a tio n s 6 7 3 5 9
N o  o f  u n iq u e  r e f le c t io n s 2 8 1 8 9
M a x im u m  r e s o lu t io n  (A) 1 .7
^ C o m p le te n e s s  (o u te r m o s t  s h e ll )  (% ) 9 0 .5  ( 9 1 .0 )
*Rsym ( I )  (o u te r m o s t  s h e ll )  (% ) 4 .7  ( 4 0 .5 )
< / / a ( / ) >  (o u te r m o s t  sh e ll) 7 .6 8  ( 2 .5 9 )
O u te r m o st  s h e ll  (A) 1 . 7 2 - 1 . 7 0
^C om p leten ess in the range oo-resmax, w here resm ax is  the m axim um  resolu tion  to  
w h ich  data w ere co llec ted , ^ w C O ^ h k l ^ i l  / h k l,K average,h k ll  ^ 2 hkl^il 4 k l , i l  x l 0 °-
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Table 3.2 Distribution of reflections for rRBP data
Shell I/S igm a in resolution shells
Lower Upper No. o f reflections with I/S igm a less than
limit limit 0 1 2 3 5 10 20 >20 total
oc 4 .9 7 1 1 2 4 15 3 7 9 9 2 8 0 9 2 8
4 .9 7 3 .9 4 0 0 0 1 7 3 8 3 8 6 7 0 8 6 7
3 .9 4 3 .4 5 0 1 3 4 9 4 7 7 1 0 0 7 0 1 0 0 7
3 .4 5 3 .1 3 3 5 13 18 3 4 5 2 5 1 0 6 2 0 1 0 6 2
3 .1 3 2 .9 1 2 8 21 3 2 5 7 5 9 3 1 1 0 3 0 1 1 0 3
2 .9 1 2 .7 4 8 15 31 4 3 81 6 4 8 1 1 2 6 0 1 1 2 6
2 .7 4 2 .6 7 2 0 4 5 6 8 1 1 9 7 0 4 1 1 4 9 0 1 1 4 9
2 .6 2 .4 9 8 21 5 4 8 7 1 6 9 7 6 0 1 1 5 7 0 1 1 5 7
2 .4 9 2 .3 9 16 53 8 6 1 2 7 2 1 6 8 1 7 1 1 4 6 0 1 1 4 6
2 .3 9 2 .3 1 11 2 9 63 1 2 2 2 4 2 8 4 5 1 1 6 0 0 1 1 6 0
2 .3 1 2 .2 4 19 5 0 9 4 1 3 9 2 3 7 4 7 3 9 1 9 2 4 9 1 1 6 8
2 .2 4 2 .1 7 19 5 7 113 1 6 9 2 7 6 5 5 3 9 8 0 188 1 1 6 8
2 .1 7 2 .1 1 2 7 6 8 1 3 6 2 0 1 3 2 4 6 1 0 1 0 0 9 1 5 9 1 1 6 8
2 .1 1 2 .0 6 2 2 7 9 1 5 9 2 2 9 3 7 8 7 1 9 1 0 4 0 113 1 1 5 3
2 .0 6 2 .0 2 3 7 105 1 8 6 2 7 2 4 7 8 7 7 5 1101 9 5 1 1 9 6
2 .0 2 1 .9 7 3 6 1 2 7 2 2 2 3 2 5 5 0 9 8 4 3 1 1 0 8 4 9 1 1 5 7
1 .9 7 1 .93 4 3 1 3 4 2 3 6 3 3 5 5 4 2 8 8 4 1 1 3 3 31 1 1 6 4
1.93 1 .9 5 9 1 5 6 2 8 8 4 0 8 6 6 0 9 5 9 1 1 5 6 16 1 1 7 2
1.9 1 .8 6 75 2 0 5 3 7 9 5 4 0 7 6 4 1 0 1 8 1 1 4 8 10 1 1 5 8
1 .8 6 1 .83 7 7 2 4 7 4 2 9 59 1 8 1 3 1 0 5 4 1 1 5 6 6 1 1 6 2
1.83 1 .8 8 6 2 4 8 4 6 6 6 4 2 8 8 3 1 1 0 7 1 1 8 9 0 1 1 8 9
1.8 1 .7 7 101 3 0 6 4 9 9 6 8 3 8 8 8 1 0 8 3 1 1 2 6 0 1 1 2 6
1 .7 7 1 .7 5 143 3 5 4 5 7 0 7 6 1 9 5 9 1 1 4 5 1191 1 1 1 9 2
1 .7 5 1 .7 2 1 5 9 3 8 0 6 1 2 7 8 8 9 7 5 1 1 2 8 1 1 4 8 0 1 1 4 8
1 .7 2 1 .7 1 7 9 4 2 3 6 6 3 8 4 5 1041 1 1 5 5 1 1 6 3 0 1 1 6 3
A llhkl 1138 3092 5370 7434 10676 19637 27272 917 28189
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Table 3.3 Completeness of the rRBP data
Shell I /S igm a in resolution shells
Lower Upper % o f reflections with 1 / Sigma less than
limit limit 0 1 2 3 5 10 20 >20 total
oc 4 .9 7 0 .1 0 .1 0 .2 0 .3 1 .2 3 0 .5 7 4 .7 0 7 4 .7
4 .9 7 3 .9 4 0 0 0 0 .1 0 .6 3 0 .8 6 9 .6 0 6 9 .6
3 .9 4 3 .4 5 0 0 .1 0 .2 0 .3 0 .7 3 8 .2 8 0 .6 0 8 0 .6
3 .4 5 3 .1 3 0 .2 0 .4 1 1 .4 2 .7 4 2 8 4 .9 0 8 4 .9
3 .1 3 2 .9 1 0 .2 0 .6 1 .7 2 .6 4 .6 4 8 .2 8 9 .6 0 8 9 .6
2 .9 1 2 .7 4 0 .6 1 .2 2 .5 3 .4 6 .5 5 1 .6 8 9 .7 0 8 9 .7
2 .7 4 2 .6 0 .6 1 .6 3 .6 5 .5 9 .5 5 6 .5 9 2 .1 0 9 2 .1
2 .6 2 .4 9 0 .6 1 .7 4 .3 7 1 3 .5 6 0 .8 9 2 .6 0 9 2 .6
2 .4 9 2 .3 9 1.3 4 .3 7 1 0 .3 1 7 .5 6 6 .2 9 2 .8 0 9 2 .8
2 .3 9 2 .3 1 0 .9 2 .3 5 9 .8 1 9 .4 6 7 .7 9 2 .9 0 9 2 .9
2 .3 1 2 .2 4 1.5 4 7 .5 11 .1 19 3 7 .9 7 3 .6 1 9 .9 9 3 .5
2 .2 4 2 .1 7 1.5 4 .6 9 .1 1 3 .6 2 2 .3 4 4 .6 7 9 .1 1 5 .2 9 4 .3
2 .1 7 2 .1 1 2 .2 5 .4 1 0 .9 16 .1 2 6 4 8 .9 8 0 .8 1 2 .7 9 3 .6
2 .1 1 2 .0 6 1 .8 6 .5 13 .1 1 8 .9 3 1 .2 5 9 .3 8 5 .8 9 .3 9 5 .1
2 .0 6 2 .0 2 2 .9 8 .3 1 4 .6 2 1 .4 3 7 .6 6 0 .9 8 6 .6 7 .5 9 4
2 .0 2 1 .9 7 2 .9 1 0 .2 1 7 .9 2 6 .2 41 6 7 .9 8 9 .3 3 .9 9 3 .2
1 .9 7 1 .9 3 3 .5 1 0 .9 1 9 .2 2 7 .2 4 4 7 1 .8 9 2 2 .5 9 4 .6
1 .9 3 1 .9 4 .7 1 2 .5 2 3 3 2 .6 5 2 .7 7 6 .5 9 2 .3 1.3 9 3 .5
1 .9 1 .8 6 6 1 6 .5 3 0 .4 4 3 .4 6 1 .4 8 1 .8 9 2 .2 0 .8 9 3
1 .8 6 1 .83 6 .2 1 9 .8 3 4 .4 4 7 .4 6 5 .2 8 4 .6 9 2 .8 0 .5 9 3 .3
1 .8 3 1 .8 6 .8 1 9 .5 3 6 .7 5 0 .6 6 9 .6 8 7 .2 9 3 .7 0 9 3 .7
1 .8 1 .7 7 8 .4 2 5 .6 4 1 .7 5 7 .1 7 4 .2 9 0 .5 9 4 .1 0 9 4 .1
1 .7 7 1 .7 5 1 1 .2 2 7 .7 4 4 .6 5 9 .6 7 5 .1 8 9 .7 9 3 .3 0 .1 9 3 .3
1 .7 5 1 .7 2 13 3 1 .2 5 0 .2 6 4 .6 8 0 9 2 .5 9 4 .2 0 9 4 .2
1 .7 2 1 .7 14 3 3 .1 5 1 .9 6 6 .1 8 1 .5 9 0 .4 91 0 91
All hkl 3.7 9.9 17.2 23.9 34.3 63.1 87.6 2.9 90.5
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Figure 3 .5
rBBP diffraction pattern
rRBP double mutant W67L/W91H: rRBP variant Trp67-Leu and 
Trp91-His, was crystallised by the vapour diffusion method at 16°C 
(Figure 3.6). Single crystals were obtained by applying the seeding 
technique from crystals of the native recombinant protein and their size 
was optimised by addition of 0.05% (3-octyl-glucoside. The 
crystallisation conditions are listed in Table 3.4. The data collection was
132
performed on station X31 (A=1.09 A )  at EMBL Hamburg outstation, 
Hamburg, Germany using glycerol as cryoprotectant. Prior to data 
collection at 100°K the crystals were transferred to buffer solution 
(same as reservoir solution) containing 20% v/v glycerol for about 30 
sec. The crystals diffracted to 2.0 A  resolution and data were recorded 
on a 18 cm image plate (MAR Research, Hamburg, Germany) with the 
crystal oscillating through 1.2° steps. Data integration and data 
reduction were performed with the programs DENZO and SCALEPACK 
(Otwinowski and Minor, 1997). Data collection details are summarised 
in Tables 3.4-3.6.
Figure 3.6
Crystal o f  the double variant W67L/W91H o f  rRBP.
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Table 3.4 Crystallisation and Data collection statistics for W67LAV91H rRBP 
variant
Crystallisation
R e s e r v o ir  s o lu t io n
S o d iu m  C h lo r id e  4 .5 M ,  
T r is /H C l 5 0 m M  p H  9 .1  
+  0 .0 5 %  p -o c ty l- g lu c o s id e
D ro p 12  m g /m l p r o te in  c o n c e n tr a tio n  
S o d iu m  C h lo r id e  2 .2 5 M ,  
T r is /H C l 2 5 m M  p H  9 .1  
+  0 .0 2 5 %  p -o c ty l -g lu c o s id e  ( s e e d in g )
T em p era tu re 1 6 °C
C e ll  d im e n s io n s  (a , b , c )  (A ) a = b = 1 0 1 .7 6  c = 7 2 .7 2
a ,  P , Y ( ° ) 9 0 ,  9 0 ,  1 2 0
S p a c e  g ro u p R 3
M o le c u le s  p er  a sy m m e tr ic  u n it 1
Data collection & processing
T em p era tu re 1 0 0 °K
S ta t io n  (S y n c h r o tr o n ) E M B L -H a m b u r g  X 3 1
I m a g e  p la te M a r l 8
W a v e le n g th  (A) 1 .0 9
D is ta n c e  (m m ) 1 4 6 .1 7
O s c il la t io n  ra n g e  (d e g r e e s ) 1 .2
N o  o f  im a g e s  (d e g r e e s ) 9 2 ( 1 1 0 .4 )
N o  o f  o b se r v a tio n s 1 0 9 5 2 5
N o  o f  u n iq u e  r e f le c t io n s 1 8 8 9 0
M a x im u m  r e s o lu t io n  (A) 2 .0
* C o m p le te n e s s  (o u te r m o s t  s h e ll )  (% ) 9 8 .0  ( 9 2 .7 )
*Rsym ( I )  (o u te r m o s t  s h e ll)  (% ) 1 0 .2  ( 3 7 .0 )
< / / a ( / ) >  (o u te r m o s t  sh e ll) 7 .5 3  ( 3 .1 9 )
O u te r m o st  sh e ll  (A) 2 . 0 7 - 2 . 0 0
^C om p leten ess in the range oo-resmax, w here resm ax is  the m axim u m  resolu tion  to w h ich  
data w ere co llec ted . * % w C 0 = £ h k l£ il  7h k U '/ average,hkll  ^ S h k £ il  x l 00.
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Table 3.5 Distribution of reflections for W67L/W91H rRBP variant data
Shell I/S igm a in resolution shells
Lower Upper No. o f reflections with I  /Sigm a less than
limit limit 0 1 2 3 5 10 20 >20 total
oc 4 .3 1 9 2 3 4 0 6 8 10 3 4 1 5 1 6 9 6 111 1 8 0 7
4 .3 1 3 .4 2 13 2 8 6 0 8 5 1 4 0 4 8 1 1 7 1 3 1 7 0 1 8 8 3
3 .4 2 2 .9 9 2 7 6 2 1 3 6 2 0 1 3 2 1 7 9 1 1 8 9 7 18 1 9 1 5
2 .9 9 2 .7 1 3 2 1 1 6 2 1 2 3 2 4 5 3 1 1 1 4 7 1 9 0 7 9 1 9 1 6
2 .7 1 2 .5 2 4 7 1 3 4 2 9 8 4 7 3 7 6 3 1 4 3 5 1 9 2 4 0 1 9 2 4
2 .5 2 2 .3 7 75 2 2 2 4 2 3 601 9 5 1 1 5 8 2 1 8 9 8 1 1 8 9 9
2 .3 7 2 .2 5 1 0 4 2 6 7 4 7 5 6 9 9  1 0 6 0 1 7 1 3 1 9 3 1 0 1 931
2 .2 5 2 .1 5 9 4 2 8 1 5 3 0 77 1 1 2 0 5 1 7 7 3 1 9 4 4 0 1 9 4 4
2 .1 5 2 .0 7 1 1 6 3 5 0 6 4 7 9 0 0  1 2 8 0 1 7 8 4 1 8 7 3 0 1 8 7 3
2 .0 7 2 .0 1 5 7 43 1 7 5 0  1051 1 4 3 7 1 7 5 9 1 7 9 8 0 1 7 9 8
All hkl 674 1914 3571 5173 7791 12880 18581 309 18890
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T a b le  3 .6  C o m p le t e n e s s  o f  t h e  W 6 7 L A V 9 1 H  r R B P  v a r ia n t  d a t a
Shell I/S igm a in resolution shells
Lower Upper % o f reflections with I/S igm a less than
limit limit 0 1 2 3 5 10 20 >20 total
4 0 4 .3 1 0 .5 1 .2 2 .1 3 .5 5 .4 2 1 .6 8 8 .2 5 .8 9 4
4 .3 1 3 .4 2 0 .7 1 .4 3 .1 4 .4 7 .2 2 4 .8 8 8 .3 8 .8 9 7 .1
3 .4 2 2 .9 9 1 .4 3 .2 7 1 0 .4 1 6 .5 4 0 .8 9 7 .8 0 .9 9 8 .7
2 .9 9 2 .7 1 1 .7 6 11 1 6 .8 2 7 .5 5 9 .5 9 8 .9 0 .5 9 9 .3
2 .7 1 2 .5 2 2 .4 6 .9 1 5 .4 2 4 .5 3 9 .5 7 4 .3 9 9 .6 0 9 9 .6
2 .5 2 2 .3 7 3 .9 1 1 .6 2 2 .2 3 1 .5 4 9 .9 83 9 9 .6 0 .1 9 9 .6
2 .3 7 2 .2 5 5 .4 1 3 .8 2 4 .6 3 6 .1 5 4 .8 8 8 .6 9 9 .8 0 9 9 .8
2 .2 5 2 .1 5 4 .8 1 4 .4 2 7 .1 3 9 .5 6 1 .7 9 0 .7 9 9 .5 0 9 9 .5
2 .1 5 2 .0 7 6 .2 1 8 .6 3 4 .4 4 7 .8 6 8 9 4 .7 9 9 .5 0 9 9 .5
2 .0 7 2 8 .1 2 2 .2 3 8 .7 5 4 .2 7 4 .1 9 0 .7 9 2 .7 0 9 2 .7
All hkl 3.5 9.9 18.5 26.8 40.4 66.8 96.4 1.6 98
3.2.1A Structure determination
rRBP: The structure of the native recombinant protein was 
determined using the molecular replacement technique with the program 
AMoRe (Navaza, 1994). The initial phases for RBP were obtained by 
using the human serum retinol binding protein structure at 2.0 A [PDB 
code: lrbp, (Cowan et al., 1990)] as a search model. After superposition 
of human serum retinol binding protein (hRBP) with rat androgen- 
dependent epididymal retinoic acid binding protein (E-RABP)
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(Newcomer, 1995) residues (14-30), 70, 80, (84-86), (106-115), (135- 
139), (146-151), (159-160), 165, 172 and 174 are considered to be 
conserved in the RBP structure hence they were included in the search 
model. Residues that were part of flexible loops or other disordered 
regions were excluded from the model and these are residues (1-3), (50- 
67), (94-105), (140-143) and (175-182).
T a b le  3 .7  A fte r  TRAING s o lu t io n s  fo r  o n e  m o le c u le
a P 7 TJ  X Ty Tz cc no
SOLUTIONTF1 31 27.49 151.5 0.0833 0.0714 0 27.8 54 1
SOLUTIONTF1 70.81 82.16 28.98 0.1944 0.2698 0 29.1 53.1 2
SOLUTIONTF1 7.56 42.13 162 0.0278 0.0437 0 29.4 52.9 3
SOLUTIONTF1 60.53 96.24 104.68 0.1825 0.377 0 28.7 52.8 4
SOLUTIONTF1 18.7 138.32 59.77 0.9921 0.4722 0 27.9 53.1 5
SOLUTIONTF1 58.87 90.75 214.26 0.0397 0.0675 0 28.5 53.4 6
SOLUTIONTF1 70.59 42.78 60.3 0.0079 0.0516 0 28 53.5 7
SOLUTIONTF1 75.74 139.85 145.4 0.5675 0.3849 0 29.4 53.1 8
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
S O L U T I O N T F 1 3 3 .2 4 4 8 .0 5  1 4 1 .5 6 0 .3 7 7 0 .2 0 6 3 0 4 5 .5 4 6 .6 9
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONTFl 17.13 109 44.59 0.0238 0.131 0 27.5 53.4 10
SOLUTIONTF1 108.45 80.42 102.12 0.0754 0.5079 0 28.6 53.3 n
SOLUTIONTFl 95.68 96.87 210.33 0.3294 0.2659 0 27.2 54.1 12
SOLUTIONTFl 46.49 85.03 207.72 0.119 0.0714 0 29 53.4 13
SOLUTIONTFl 98.98 132.03 101.91 0.3016 0.5437 0 29.2 52.7 14
SOLUTIONTFl 87.8 141.54 234.77 0.2619 0.5238 0 27.8 53.4 15
SOLUTIONTFl 114.58 79.87 283.5 0.2976 0.5833 0 28.6 52.8 16
Table 3.8 After FITING  final solution for one molecule
a P Y Tx T Tz cc no
SOLUTIONF 30.04 27.52 152.9 0.0818 0.0694 0 35.6 53.1 1
SOLUTIONF 70.74 81.95 28.9 0.1955 0.2704 0 35.3 52.6 2
SOLUTIONF 8.06 42.83 161.77 0.028 0.0439 0 36.4 52.2 3
SOLUTIONF 60.13 96.21 104.39 0.1822 0.3757 0 35.2 52.1 4
SOLUTIONF 19.17 138.54 59.61 0.9938 0.4736 0 34.6 52.5 5
SOLUTIONF 58.88 90.22 214.67 0.0411 0.0686 0 36.5 52.8 6
SOLUTIONF 71.65 42.82 60.11 0.0079 0.0503 0 35.4 52.7 7
SOLUTIONF 76.81 140.18 146.35 0.5673 0.3845 0 36.4 52.4 8
* * * * * * * * * * * * * * * * * * * :¥ * * * * * * * * * * * * * * * * * * * * * *
S O L U T I O N F 3 1 .9 9 4 8 .4 4  1 4 0 .9 7  0 .3 7 5 8 0 .2 0 5 8 0  5 2 .8  4 4 .6 9
* * * * * * * * * * * * * * * * * * * i* * * * * * * * * * * * * * * * * * * * * * *
SOLUTIONF 16.86 108.74 44.65 0.0239 0.1313 0 34.6 52.9 10
SOLUTIONF 109.16 80.81 102.29 0.0745 0.5079 0 35.2 52.7 n
SOLUTIONF 95.26 97.72 210.64 0.3294 0.2654 0 34.3 53.2 12
SOLUTIONF 47.02 84.39 207.14 0.1184 0.0714 0 36.9 52.6 13
SOLUTIONF 98.07 131.9 101.39 0.3015 0.5439 0 35.9 52.2 14
SOLUTIONF 88.29 141.56 235.13 0.2618 0.5248 0 34.7 52.9 15
SOLUTIONF 113.9 80.06 283.01 0.2971 0.5819 0 35.7 52.4 16
Note : Tables 3.7-3.8. The columns a, (3, and y correspond to the orientation Euler angles; Tx, 
Ty and Tz represent the positional parameters (fractions o f  the unit cell), cc the correlation 
coefficient, R{ the /^-factor and no- to the sorting number o f the peak when the translation 
function was calculated. The solution is shown in shaded area and the peak number is in bold
face.
rRBP double mutant W67L/W91H: The structure of the double 
mutant at 2 .0  A  resolution was determined using the molecular 
replacement technique with the program X-PLOR (Briinger, 1992b). 
The initial phases for RBP were obtained by using the rRBP structure 
at 1.7 A  as a search model. The solution appeared clearly in the 
rotation function list containing the most probable Euler angles as it is 
shown in the following table.
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T a b le  3 .9  R o ta t io n  f u n c t io n  l is t  f o r  r R B P  v a r ia n t
in d e x , a P Y R F -f u n c t io n  ( c =  0 .2 5 )
*  *  *  * * * * * * * * * * * : * *  *  *  *: * * * * * * * * * * * * * * * * * * * *
1 0 1 8 0 0 4.7434
*** *  * * * * * * * * * * * * *  *  * * * * * * * * * * | c * * * * * * * * * * * * *
121 32.143 72.5 327.857 2.3633
182 252.125 2.5 252.125 2.1029
206 340.938 127.5 260.007 2.0374
216 77.483 50 71.483 2.0057
226 123.429 105 123.429 1.9891
236 308.754 142.5 223.42 1.9691
247 63.404 60 328.404 1.95
258 338.615 47.5 269.141 1.929
266 296.17 172.5 183.83 1.9178
267 310.183 130 243.206 1.9177
293 312.795 122.5 198.509 1.8924
316 27.596 2.5 27.596 1.872
319 125.106 177.5 114.894 1.8698
321 17.236 65 310.036 1.8656
326 250.559 57.5 172.298 1.8612
336 274.966 50 262.966 1.8524
344 208.286 115 100.286 1.8477
370 262.109 147.5 196.891 1.8258
377 289.652 5 229.652 1.8182
381 34.422 67.5 343.653 1.8146
388 204.706 42.5 155.294 1.8031
399 313.571 77.5 213.571 1.7902
Note: The columns a , (3, and y correspond to the orientation Euler angles.
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3.2.I.5. Refinement of rRBP and W67L/W91H rRBP variant.
The resultant models of rRBP and W67L/W91H rRBP variant structures 
(one molecule per a.u.) were first subjected to restrained refinement with 
maximum likelihood method using the program REFMAC (CCP4, 1994) 
followed by the automated refinement procedure (ARP) (Lamzin and 
Wilson, 1993) and to rigid body refinement using the program X-PLOR, 
respectively. The combination of REFMAC and ARP refinement 
protocol applied to rRBP model, significantly improved the quality of 
the electron density map and enabled the building of the residues that 
have been initially excluded from the molecular replacement solution, 
which comprised only conserved residues. Cycles of refinement were 
performed using the slowcool protocol at moderate temperatures 
initially with the program X-PLOR (Briinger, 1992b) and during the 
final stages of refinement, with CNS (Briinger et al., 1998) for both 
structures. The progress of refinement was monitored through both free 
and conventional i?-factors (Briinger, 1992a). Alternative cycles of 
manual rebuilding with the graphics program ‘O’ (Jones et al., 1991), 
intertwined with refinement cycles using the standard protocol improved 
further the quality of the model. In both cases simulated annealing omit 
maps calculated using either X-PLOR or CNS indicated large pieces of 
density in the core of the p-barrel and as well as on the surface of two 
proteins sufficient to accommodate sometimes more than one glycerol 
molecules (glycerol used as cryoprotectant during data collection). Six 
glycerol molecules were incorporated in to the rRBP model (five in the 
W67L/W91H variant structure) at the very final stages of the 
refinement. In each case, water molecules were inserted in the model
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according to the (2F0-FC) and (F0-Fc) electron density maps. The final 
refinement statistics and model quality are summarised in Table 3.10 
and portion of the (2Fo-Fc) electron density map at 1.7 A resolution is 
shown in Figure 3.7 for the rRBP structure.
Table 3.10 Refinement statistics for rRBP and W67L/W91H rRBP variant
Refinement rRBP W67L/W91H rRBP variant
Resolution range (A) 4 0 .0 -1 .7 4 0 .0 -2 .0
Reflections 27458 18877
No o f  protein atoms 1407 1398
No solvent molecules 205 218
glycerol molecules 6 5
X e e  (%) 27.0 22.9
H*conv <%) 24.8 20.5
Model quality
Rms deviations in:
*bonds (A) 0.006 0.006
* angles (°) 1.468 1.379
Temperature factors (A^) :
overall 26.5 22.6
average main-chain 24.2 20.1
average side-chain 24.8 21.6
*^free=£hklcTll^obs‘kl^calclb£hklcTl^obslx100, where hklcT represents the test set (5-10% of the 
diffraction data). n/?conv=^hkll I ^obs'kl ^calcl I /^hkll ^obsl xlOO. *Deviations from ideal values (Engh and 
Huber, 1991)
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Figure 3 . 7
Portion o f  the 2(Fo-Fc) electron density map from rRBP structure at 1.7 A 
resolution. The figure was generated using the program BOBSCRIPT (Esnouf 
1997)
3.2.1.6. Structure analysis
The refined crystal structure of rRBP was compared with 
representative members of the Retinol-binding protein family by 
superposition with program MAPS (Lu, 1998) (Tables 3.12and 3.13). 
The accessibility of the protein surface was calculated with program 
DSSP (Kabsch and Sanders, 1983) and the program PROCHECK 
(Laskowski et al., 1993) was used to assess the quality of the final 
structure. Analysis of the Ramachandran {(p - y/) plot showed that all
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residues lie in allowed regions except Tyr 111 in both rRBP and 
W67L/W91H rRBP variant structures for which the <p and y/values are 







Residues in most favoured regions [A.B.L] 139 88.5%
Residues in additional allowed regions [a,b,l,p] 17 10.8%
Residues in generously allowed regions [~a,~b,~l,-p] 0 0.0%
Residues in disallowed regions 1 0.6%
Number of non-glycine and non-proline residues 157 100.0%
Number of end-residues (excl. Gly and Pro) 213
Number of glycine residues (shown as triangles) 10
Number of proline residues 5
Total number of residues 385
B ased on  an analysis o f  118 structures o f  resolution o f  at least 2 0  A ngstrom s 
and R -factor no greater than 20% , a good quality  m odel w ould be expec ted  
to  have over 90%  in the m ost favoured reg ions.
rRBP_01.ps
Figure 3 . 8





P lo t s ta tis tic s
Residues in most favoured regions (A.B.L) 144 91 7 *
Residues in additional allowed regions (a.bJ.p) 12 7 .6*
Residues in generously allowed regions ( -a .-b .- l.-p ) 0 0 .0 *
Residues in disallowed regions 1 0 .6 *
Number of non-glycine and non-prolinc residues 157 100.0*
Number o f end-residues (excl. Gly and Pro) 225
Number of glycine residues (shown as triangles) 10
Number of prolinc residues 5
Total number o f residues 397
Based on an analysis of 118 structures of resolution of at lexst 2 0 Angstroms
and R factor no greater than 20**. a good quality model would be e*peeled 
to have over 909 in (he most favoured regions
W67L-W9IH_0l.ps
Figure 3.9
3.2.1.7.. Crystallisation trials on two more rRBP variants: Trp24- 
Tyr and Trpl05-Phe
Crystallisation trials on two more rRBP variants Trp-24-Tyr and 
Trpl05-Phe were performed using the vapour diffusion method. The 
conditions that were initially tested were based on those that the native 
recombinant protein and the double mutant that had been crystallised. A
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wide range of pH values from acidic to very alkaline was tested, and 
different salts like sodium chloride, lithium sulphate, cadmium acetate, 
were also used. Further attempts were also made by dissolving the 
protein in the reservoir solution with lower salt concentration but none 
of the above trials was successful. The seeding technique was also 
attempted with crystals from the double mutant o f rRBP (W67L/W91H).
Due to limitations imposed from the available quantities of the 
two variants the crystal screen I containing a great variety of 
crystallisation conditions from Hampton Research (Jancarik and Kim, 
1991) was not used. The conditions that were studied are summarised in 
Table 3.11. It can be observed that conditions that ended to turbid drops 
could be possible targets for optimisation by reducing either the protein 
concentration (~12mg/ml in the drop), or changing the salt 
concentration used.
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20mM Sodium Cacodylate, pH 5.4, 6.1, 6 . 8
Heavy precipitation became 
lighter with increasing pH.
4.5M Sodium Chloride 
50mM Hepes, pH 7.2
4.5M Sodium Chloride 
50mM Tris/HCl, pH: 8.1, 9.1
4.5M Sodium Chloride 
50mM Tris/HCl, pH 8 . 6  
0.05% P-octyl-glucoside
4.5M Sodium Chloride
50mM Tris/HCl, pH 8 . 6
0.05% P-octyl-glucoside





More alkaline pH 





4.5M Sodium Chloride 5 
20mM Sodium Cacodylate, pH: 5.4, 6.1, 6 . 8  \ Clear drops
4.5M Sodium Chloride £
50mM Hepes, pH 7.2 \
4.5M Sodium Chloride S
50mM Tris/HCl, pH: 8 .1, 9.1 \
4.5M Sodium Chloride 
54mM Tris/HCl, pH 9.4 Clear drops
4.5M Sodium Chloride 
50mM Tris/HCl, pH 9.9
4.5M Sodium Chloride 







50mM Tris/HCl, pH 8 . 6
0.05% P-octyl-glucoside
seeding from rRBP double variant crystals
|  Clear drops
1.5M Lithium Sulphate 
0.1M Hepes, pH 7.5 > Clear drops
1.7, 1.9, 2.1M Lithium Sulphate 
0.1 M Hepes, pH 7.5
s Drops become more turbid 
< with increasing concentration 
<; of Lithium Sulphate
6 mM Cadmium Sulphate 
16% 2,4 dimethyl-pentanediol 
0.2 M Tris acetate pH 6 . 8
|  Clear drops
6 mM Magnesium Acetate 
16% 2.4 dimethyl-pentanediol 
0.2 M Tris acetate pH 6 . 8
Clear drops
*
2.0M Lithium Sulphate 
0.1M Hepes pH 8 . 8 i  Turbid
2.5M Lithium Sulphate 
0.1M Hepes, pH 7.5 < Turbid
Chapter 3 .: Structural studies on rRBP and variants 146
3*2*2, RESULTS AND DISCUSSION 
3*2*2*1* Overall structure
Here we report the high-resolution structures o f rRBP and a 
double variant W67L/W91H at 1.7 and 2.0 A resolution, respectively. In 
the case of rRBP even from the first cycles of refinement, the high 
quality of the data was reflected in the electron density map especially 
around residues that form the P-barrel {Figure 3.7). However, the loop 
region 62-68 was highly disordered hence the incorporation of the 
initially excluded residues as alanines was possible only after applying 
the automated refinement procedure (Lamzin and Wilson, 1993). 
Further refinement considerably improved the phases and mutated 
residues were replaced according to the sequence apart from those from 
one flexible loop (residues 62-68) that were introduced to the model 
only towards the final stages of refinement. The density around residue 
67, located in a critical region in the structure was poor even after the 
last cycle of refinement. Although the complete amino acid sequence of 
RBP comprises 182 amino acids (Rask et al., 1979), sufficiently clear 
electron density was visible only up to residue 174 out o f 182 residues. 
As it has been indicated by previous crystallographic studies on RBP the 
C-terminal of the protein as well as the loop region mentioned above 
seem to have marked flexibility (Cowan et al., 1990; Zanotti et al., 
1993a).
Visual inspection of the rRBP electron density map revealed the 
presence of small but continuous piece of density in the core of the p- 
barrel and on the surface of the molecule that could not be accounted for 
by the addition of water molecules. Simulated annealing omit maps
(a) (b)
Figure 3.10
Worm representation o f  the rRBP (a) and double variant structures (b) showing the location o f  glycerol molecules 
bound to the protein.
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indicated the presence of six glycerol molecules bound to the protein 
(which was used as cryo-protectant during data collection), Figure 3.10 
(a). The final model consists of 205 water molecules. This is 
considerably higher in comparison with previously reported RBP 
structures due to better resolution (1.7 A).
The structure of the double variant (W67L/W91H), determined 
using the rRBP structure as starting model, had similar features as with 
the native recombinant protein. The most ordered region of the molecule 
was formed by residues surrounding the P-barrel while the flexible 62- 
68 loop, resulted with moderate electron density (better compared to the 
rRBP structure). Glycerol was used during data collection as 
cryoprotectant and five molecules were identified in the structure either 
bound in the core of the barrel or on the surface of the molecule, Figure 
3.10 (b). Three of these are located in identical positions for both 
structures of rRBP and variant, in the interior of the P-barrel the 
corresponding binding site of retinol molecule in the holo-form of RBP. 
The final model for this variant consists of 218 water molecules.
The overall structures o f the two proteins are very similar (r.m.s. 
deviation 0.32 A) apart from the flexible loop 62-68 and minor 
conformational changes of some surface residues. Two loop regions 
around residues 65 and 93 are involved in crystal packing contacts and 
the packing arrangement for rRBP is shown in Figure 3.11.





Packing arrangement o f  rRBP molecules in the crystallographic 
asymmetric unit.
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Figure 3.11a
Packing arrangement o f  rRBP molecules in the crystallographic 
asymmetric unit.
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rRBP and W67L/W91H structures were superimposed with other 
known homologous structures (members of the superfamily of 
lipocalins) and the results are shown in Table 3.12. As expected, there is 
good agreement with other known RBP structures determined 
previously by Zanotti et al., (1993a) and Cowan et al., (1990). The 
details o f the pdb codes for the structures compared are given in Table 
3.13. These comparisons show that all the known structures of this 
family have retained the ‘P-barrel’ and the conserved tryptophan 
residues. However, beyond this structural conservation there appears to 
be very little amino acid sequence conservation (see Figure 3.1).
Note for  Table 3.12. Structural superposition of known R B P  structures and its 
homologues: The rms deviations were calculated after superposition using the 
program MAPS (Lu, 1998)) applied to C a  atoms o f  residues 1-174 (values in bold 
face). The number o f  equivalences/identities is also described (values in normal type 
face). The total number o f residues included in the amino acid sequence o f  each 
structure is given (numbers in italics). (The pdb codes for the structures used for the 
superposition are explained in Table 3.13).
Table3.12 S t r u c t u r a l  s u p e r p o s i t i o n  o f  k no wn  RBP s t r u c t u r e s  and its h o mo l o g u e s
rrbp rdm lbbp lbeb lbrp lbrq lepa lepb lerb lfel lfem lfen lhbp lhbq lmup lobp lpbo lrbp laqb la3y Res
rrbp — 0.32 1.53 1.40 0.50 0.53 1.56 1.66 0.64 0.69 0.65 0.67 0.64 0.66 1.68 1.44 1.46 0.59 0.62 1.53 174
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Table 3.13 PDB codes for the structures compared
code Protein Res. (A) Authors
lbbp Bilin binding protein 2 . 0 (Huber et al., 1987)
lbeb P-lactoglobulin 1 . 8 (Brownlow et al., 1997)
lbrp Retinol transport. Human-RBP 
(Holo form)
2.5 (Zanotti et al., 1993c)
lbrq Retinol transport. Human RBP 
(apo form)
2.5 (Z 2 notti et al., 1993c)
lepa Retinoic-acid binding protein 2 . 1 (Newcomer, 1993)
lepb Retinoic-acid binding protein 
complexed with retinoic acid
2 . 2 (Newcomer, 1993)
lerb Retinol transport. RBP complexed 
with N-ethyl retinamide
1.9 (Zanotti eta l., 1993b)
l fe l Transport protein. Retinol binding 
protein complexed with 
Fenretinide
1 . 8 (Zanotti et al., 1994)
lfem Retinol binding protein complexed 
with retinoic acid.
1.9 (Zanotti et al., 1994)
lfen Transport protein. Retinol binding 
protein complexed with 
Axerophthene
1.9 (Zanotti et al., 1994)
lhbp Retinol transport. Bovine serum 
(holo-form)
1.9 (Zanotti et al., 1993a)
lhbq Retinol transport. Bovine serum 
(apo-form)
1.7 (Zanotti et al., 1993a)
lm up Pheromone-binding. Major urinary 
protein complex with 2 -(sec-butyl). 
Thiazoline Mouse (Mus Musculus)
2.4 (Bocskei et al., 1992)
lobp Odorant binding protein from 
bovine Nasal Mucosa
2 . 0 (Tegoni et al., 1996)
lpbo Complex of bovine odorant 
binding protein with a selenium 
containing odorant
2 . 2 (Blanchet et al., 1996)
lrbp Retinol transport. Retinol binding 
protein (holo form)
2 . 0 (Cowan et al., 1990)
laqb Retinol binding protein from Pig 
plasma
1.65 (Zanotti et al., 1998)
la3y Odorant binding protein from nasal 
mucosa of Pig.
2.25 (Spinelli et al., 1998)
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Most recently the structure of human RBP with its carrier protein 
Transthyretin (TTR) was determined by (Naylor and Newcomer, 1999) 
at 3.2 A resolution. Superposition of the RBP structure from the 
complex with TTR on to the rRBP structure and variant indicates that no 
major conformational change can be detected apart from the flexible 
loop region 62-67 (r.m.s. deviation 1.05 A). Due to limited low 
resolution structure of this complex only gross structural features could 
be compared with the high resolution structures of rRBP and the variant 
presented here. However, the complex structure confirms that Trp 67 of 
RBP is part of the interface with TTR. The most profound differences 
between the recombinant human serum RBP and RBP-TTR complex are 
those around residue 62 as well as the C-terminus, both regions appear 
to be involved in interactions with TTR in the complex. Superposition 
of RBP from the RBP-TTR complex (Naylor and Newcomer, 1999), 
RBP in the presence of retinol (Cowan et al., 1990) and rRBP (present 
structure) is shown in Figure 3.12.
P-barrel structure
The hydrophobic P-barrel structure is very similar to those from 
previously reported RBP structures (Figure 3.12). The structural 
similarity of apo-P-lactoglobulin and RBP (Sawyer et al., 1985) also 
suggests that retinol removal does not necessarily cause a collapse of the 
p-barrel and both the apo-form of RBP (Zanotti et al., 1993a) and the 
structures of rRBP and W67L/W91H variant confirm that point.
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Figure 3 .1 2 .
Superposition o f  the overall structure (only C a atoms included) o f  rRBP, 
W67L/W91H rRBP double variant, human serum RBP with retinol bound (Cowan et 
al., 1990) and human serum RBP when in complex with TTR (Naylor and Newcomer, 
1999), in yellow, green, red and cyan, respectively.
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This barrel is known to accommodate retinol molecule as it has 
already been shown by Cowan et al. (1990) {Figure 3.13). In the holo- 
form of RBP, retinol is bound at the interior of the barrel with the p- 
ionone ring pointing at the bottom of the barrel and the isoprene tail 
stretching out almost to the surface of the protein. The apo-form of RBP 
isolated from the human plasma was determined at 2.5 A resolution by 
Zanotti et al. (1993a) who observed that the internal cavity in the 
absence of retinol was not empty. Significant portions of (F0-Fc) electron 
density were identified but due to the insufficient resolution of the X-ray 
data it was suggested that the unexplained density could be attributed to 
solvent molecules.
The high-resolution structure o f rRBP at 1.7 A resolution 
presented here clarifies the tentative conclusions of Zanotti and co­
workers. Analysis of the P-barrel in the present rRBP structure revealed 
the presence of several water molecules and three glycerol molecules. 
These were also observed in the double variant structure {Figure 3.13). 
In both cases glycerol (25% v/v) was used as cryoprotectant during data 
collection under cryogenic conditions and a continuous piece of density 
was identified after a few cycles o f refinement that resulted in 
significant improvement of the initial phases.
Figure 3.13 (overleaf)
Schematic picture o f the /3-barrel in two orthogonal views: (left)-from an axis 
parallel to the /3-barrel axis pointing from the entrance to the bottom o f the barrel 
( 1 s) and (right)-from an axis perpendicular to the /3-barrel axis with a view in to the 
interior o f  the cavity from the entrance o f the barrel. The distribution o f glycerol and 
water molecules surrounding the barrel is also shown. (A) and (  B) : holo-form o f  
human serum RBP (Cowan et al., 1990); (C) and (D) : rRBP structure; (E) and (F) : 
rRBP double variant.
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The glycerol molecules were incorporated in the model only 
during the final stages of refinement and are well positioned in the 
density (Figure 3.14) stabilised by hydrogen bonds and van der Waals 
interactions in the interior of the barrel.
Figure 3 .1 4
Stereo diagram describing the (2Fo-Fc) electron density maps around 
glycerol molecules (GOL) in the core o f  the /3-barrel. The hydrogen bond 
interactions are shown in dashes.
The hydrophobic nature of the P-barrel is evident from the 
presence of a large number of aromatic rings located in the core of the 
barrel. An important residue Phe36, which is located at the entrance of 
the p-barrel appears to block the opening of the barrel in the apo-RBP 
structure (Zanotti et a l 1993a). However, this residue seems to adopt a 
significantly different conformation by opening the entrance of the 
barrel when retinol is bound (Cowan et al., 1990; Naylor and 
Newcomer, 1999). Thus, the side chain of Phe 36 seems act like a ‘toll- 
gate’ for retinol binding at the entrance of the barrel. Somewhat similar 
scenario (as in the case of apo-RBP structure) was observed in the 
structures of rRBP and the double variant {Figure 3.15).
Figure 3 .1 5
Stereo diagram of the superimposed structures of rRBP and retinol boundform o f RBP 
determined by Cowan et al. (1990) showing the conformational change o f the side chain of 
Phe 36 as well as the binding o f glycerol molecules in the place o f retinol in the interior o f 
the /3-barrel
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In these structures Phe36 do not seem to prohibit the binding of 
small molecules such as glycerol in the barrel. Interestingly, the position 
of two glycerol molecules in the barrel in the rRBP and the variant 
structures appear to mimic the interactions made by the retinol molecule 
as defined in the retinol bound form of the structure.
The binding of glycerol molecules as observed in the rRBP and 
the variant structures seem to provide some clues towards the design of 
new ligands, which could occupy the ‘hydrophobic barrel’ of the 
protein. It is hoped that this knowledge can be used in the design of 
compounds that can mimic the action of ligands such as retinol.
3*2*23. Environment of Tryptophan residues
The environment of the tryptophan residues is highlighted in 
Tables 3.14-3.16 for rRBP and Tables 3.17-3.19 for the double variant. 
Out o f four tryptophan residues, Trp 24, 91 and 105 are ordered and 
well defined in the electron density map in the case of rRBP while Trp 
24 and 105, which were not substituted in the double variant, fit nicely 
in the electron density map.
However, Trp67 is disordered in rRBP structure, due to the high 
flexibility of the loop region 62-68. This loop is involved in crystal 
packing interactions at the interface of the RBP-TTR complex as shown 
by Monaco et al. (1995) and Naylor and Newcomer (1999) who 
crystallised the complex comprising both proteins from human source. 
Both these complex structures indicate that the role o f Trp 67 and Trp 
91 is rather critical. More detailed examination concerning these 
particular residues was not possible for any of the above structures
Table 3.14. H y d r o g e n - b o n d i n t e r a c t i o n s  o f  T r y p t o p h a n  r e s i d u e s  in rR B P
T r p 2 4 T r p  91 T r p  105
atom H-bonds Distance Angle 
distance < 3.3 A (A) (°)
H-bonds Distance 




distance < 3.3 A (A)
Angle
(°)
N Ala43 0  2.84 154.9 Val74 0  2.95 157.4 Tyrll8 0  2.71 165.5
Nsl Phe20 O 2.76 145.2 Wat 3.17 Wat 2.87
O Ala43 N 2.87 162.3 Val74 N 2.73 
Val74 0  3.20
160.3
112.9
Tyrll8 N 2.82 142.0
Note : Trp 67 is disordered in the present structure of rRBP





Table3.15 E n v i r o n m e n t  o f  T r y p t o p h a n  re s id u es  in rRBP





Trp24 Phe20/15, Thr23/13, Tyr25/12, Ala43/1, 
Phe45/1, Thrl09/1, T yrlll/6 , Thrll3/1, 
Tyrll4/6, Alai 15/5, Phel37/1, Serl38/3, 
Argl39/16
0.0 19.5 well defined in the 
electron density map
Trp67 — — — disordered
Trp91 Met73/3, Val74/9, Thr76/2, Lys89/5, 
Tyr90/18, Gly92/14, Lys99/2
77.0 28.3 well defined in the 
electron density map
TrplOS Val6/5, Phe9/1, Vail 1/1, Ala84/2, Lys85/18, 
Hisl04/17, lie 106/11, V ail07/3, Gly 117/4, 
Tyrl 18/5, Wat/6
21.0 18.6 well defined in the 
electron density map
Note : van  der W aals in teractions w ere calcu lated  u sing  C C P4 (C C P4, 1994). van der W aals d istances are the m axim um  a llo w ed  
va lu es o f  C -C  : 4.1 A, C -N  : 3 .8  A, C-O: 3 .7  A, O-O: 3.3 A, 0 -N :  3 .4 A  and N -N :3 .4  A. A cc ess ib le  protein  surface per atom  for each  
Tryptophan residue w a s calcu lated  u sing  D S S P  (K absch  and Sanders, 1983).





Table3.16 D e t a i l s  o f  t he  e n v i r o n m e n t  f or  the  t h re e  T r y p t o p h a n  r e s i d u e s  in rRBP
T r p 2 4 Trp 91 Trp 105
atom
van der Waals interactions/ 




van der Waals interactions/ 




van der Waals interactions/ 




N Thr23/5, Tyr25/1 0.0 Tyr90/7, Gly92/1 0.0 His 104/6, Ilel06/1, Tyrl 18/1 0.0
Ca Thr23/3, Tyr25/1 0.0 Tyr90/3, Gly92/2, Lys99/1 0.0 Ala84/1, His 104/3, Ilel06/2, 
Tyrl 18/1
0.0
c p Thr23/1, Tyr25/1, Phel37/3 0.0 Tyr90/2, Gly92/1, Lys99/1 3.2 His 104/1, lie 106/1 0.0
CY Thr23/2 0.0 Tyr90/1, Gly92/1 2.9 Lys85/1, His 104/1 0.0
C82 Phel37/1, Argl39/1 0.0 Tyr90/1 2.8 Lys85/3 0.1
C e2 Phe20/3, Arg 139/4 0.0 Val74/2 4.5 Lys85/3, Wat/1 0.7
Ce3 Alai 15/1, Phe 137/2, Serl38/2, 
Arg 139/1
0.0 Lys89/3, Tyr90/2, 2.3 Vail 1/1, Lys85/1, Tyrl 18/1 0.0
C81 Phe20/3, Thr23/1, Phe45/1 0.0 Val74/1, Gly92/3 13.8 Lys85/2, Hisl04/2, Wat/1 0.0
N sl Phe20/7, Argl39/1 0.0 Val74/2 11.3 Lys85/3 3.6
C£2 Phe20/2,Tyrl 11/3, Alai 15/1, 
Arg 139/4
0.0 Val74/2 21.5 Val6/1, Lys85/3, Wat/1 17.0
CC3 Thrl 13/1, Tyrl 14/4, Alai 15/2, 
Arg 139/2
0.0 Thr76/1, Lys89/2 1.1 Val6/2, Phe9/1, Lys85/1, Wat/1 0.0
C ti2 T hrl09/1, Tyrl 11/3, Tyrl 14/2, 
Alai 15/1, Argl39/3
0.0 Val74/1, Thr76/1 11.4 Val6/2, Lys85/2, Wat/2 2.6
C Thr23/1, Tyr25/6, Phel37/1, 
Seri 38/1
0.0 Met73/1, Tyr90/1, Gly92/3 0.0 Ala84/1, His 104/4, lie 106/5, 
V all07 /l,T yr 118/2
0.0
o Tyr25/3, Ala43/1, 0.0 Met73/2,Val74/l, Tyr90/1 Gly92/3 0.0 He 106/2, V ail07/2, G lyll7 /4 0.0
Note : van der Waals interactions were calculated using CCP4 (CCP4,1994). van der Waals distances are the maximum allowed values of C-C : 4.1 A, C-N : 3.8 A, C-O: 3.7 A, O-O: 3.3 A, 0-N: 3.4A and N- 
N: 3.4 A. Accessible protein surface per atom of Tryptophan residue was calculated using X-PLOR (Brtlnger, 1992).
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Table 3.17 Hydrogen-bond interactions of Trp residues in W67L/W91H 
variant structure
atom











A n g le
(° )
N A l a 4 3 - 0 2 .8 1 5 9 .5 T y r 1 1 8 - 0 2 .8 1 6 3 .6
N e l P h e 2 0 -O 2 .9 1 4 5 .9 W a t - 0 2 .9
O A la 4 3 - N 2 .9 1 7 1 .1 T y r  1 1 8 -N 2 .9 1 4 6 .2
Table 3.18 Environment of Tryptophan residues in W67L/W91H variant
structure
Residue van der Waals 
interactions/ 







Trp24 P h e 2 0 /1 0  T h r 2 3 /1 3 ,  
T y r 2 5 /9  A la 4 3 /1 ,  
P h e 4 5 /1 ,  T y r l  1 1 /4 ,  
T h r l 1 3 /1 ,  T y r l  1 4 /4 ,  
A la i  1 5 /2 ,  P h e  1 3 7 /7 ,  
S e r i 3 8 /4 ,  A r g l3 9 / 1 9
0 .0 13 .1 w e l l  d e f in e d  in  
th e  e le c tr o n  
d e n s ity  m a p
Trp 105 V a l6 /2 ,  V a i l  1 /1 ,  
A la 8 4 /2 ,  L y s 8 5 /2 0 ,  
H i s l 0 4 / 1 3 ,  l i e  1 0 6 /1 2 ,  
V a i l 0 7 /1 ,  G ly  1 1 7 /2 ,  
T y r l 1 8 /3 ,  W a t/9
2 4 .0 1 2 .8 w e l l  d e f in e d  in  
th e  e le c tr o n  
d e n s ity  m a p
Note : van der Waals interactions were calculated using CCP4 (CCP4, 1994). van der Waals distances 
are the maximum allowed values of C-C : 4.1 A, C-N : 3.8 A, C-O: 3.7 A, O-O: 3.3 A, 0 -N: 3.4A and 
N-N:3.4 A. Accessible protein surface per atom for the Tryptophan residue was calculated using 
DSSP (Kabsch and Sanders, 1983).
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Table 3.19 Details of the environment of the Trp residues in W67L/W91H 
variant structure
T r p 2 4 T r p  105
atom
van der Waals 
interactions/ 




van der Waals 
interactions/ 




N T h r2 3 /5 0 .0 H is  1 0 4 /5 0 .0
Cot T h r 2 3 /3 , T y r 2 5 /2 0 .0 A la 8 4 /1 ,  H is  1 0 4 /3 ,  
I l e l 0 6 / 2 ,  T y r l 18 /1
0 .0
c p T h r 2 3 /1 , T y r 2 5 /1 ,  
P h e  13 7 /3
0 .0 H i s l 0 4 / 1 ,  I l e l0 6 /1 ,  
T y r l 18 /1
0 .0
C y T h r 2 3 /2 0 .0 L y s 8 5 /1 ,  H is  1 0 4 /1 0 .0
C52 P h e  1 3 7 /1 ,  
A r g l3 9 /1
0 .0 L y s 8 5 /3 0 .1
Cs2 P h e 2 0 /2 ,  A r g  1 3 9 /4 0 .0 L y s 8 5 /3 ,  W at/1 1 .2
Cs3 P h e  13 7 /2 ,
S e r i 3 8 /3 ,  A r g l3 9 /3
0 .0 V a i l  1 /1 , L y s 8 5 /1 ,  
T y r l  18 /1
0 .0
C81 P h e 2 0 /2 ,  T h r 2 3 /1 , 
P h e 4 5 /1
0 .0 L y s 8 5 /3 ,  H i s l0 4 /2 ,  
W at/1
0 .0
N e l P h e 2 0 /4 ,  A r g  1 3 9 /3 0 .0 L y s 8 5 /3 ,  W a t/2 3 .9
C£2 P h e 2 0 /2 ,  T y r l 1 1 /2 ,  
A rg  13 9 /4
0 .0 L y s 8 5 /3 ,  W a t/3 1 7 .6
C Q T h r l 1 3 /1 ,
T y r l 1 4 /2 ,
A la i  1 5 /1 , S er  
1 3 8 /1 , A r g l3 9 /2
0 .0 V a l6 /1 ,  L y s 8 5 /1 ,  
W at/1
0 .0
Cr\2 T y r l 1 1 /2 ,  
T y r l 1 4 /2 ,  
A la i  1 5 /1 ,  
A r g  13 9 /2
0 .0 V a l6 /1 ,  L y s 8 5 /2 ,  
W at/1
3 .6
C T h r 2 3 /1 , T y r 2 5 /5 ,  
P h e l3 7 /1
0 .0 A la 8 4 /1 ,  H is  1 0 4 /1 ,  
I l e l 0 6 / 6 ,  V a i l 0 7 /1
0 .0
O T y r 2 5 /1 , A la 4 3 /1 , 0 .0 l i e  1 0 6 /3 ,  G ly  1 1 7 /2 0 .0
Note : van der Waals interactions were calculated using CCP4 (CCP4, 1994). van der Waals distances 
are the maximum allowed values of C-C : 4.1 A, C-N : 3.8 A, C-O: 3.7 A, O-O: 3.3 A, 0 -N: 3.4A and 
N-N: 3.4 A. Accessible protein surface per atom of Tryptophan residue was calculated using X-PLOR 
(Brunger, 1992).
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considering that the resolution of these complex structures was ~3.1 A.
Thus, only gross structural differences could be identified in the 
W67L/W91H rRBP variant structure. The effect of sequence 
substitution at position 67 was not possible to investigate in detail due to 
poor electron density in this region, but the interactions of histidine at 
position 91 are listed in Tables 3.20-3.22. The five-membered ring of 
the tryptophan residue (native) is replaced by a water molecule in the 
mutant structure and the accessibility of histidine is slightly higher 
compared to that of tryptophan (Figure 3.16)
Table 3.20 Hydrogen-bond interactions of Histidine 91 in W67LAV91H variant 
structure
H is  91
Atom H-bonds distance < 3.3 A Distance (A) Angle (°)
N Val74-0 3.1 159.2
N51 Gly92-0 3.0 113.3
O Val74-0 3.3 111.1
Val74-N 2.8 149.1
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Table 3.21 Environment of Histidine 91 in W67LAV91H variant structure
Residue van der Waals Accessible protein 
interactions/ surface, (A2) 




His 91 M e t7 3 /4 ,  V a l7 4 /3 ,  ? g  
T y r 9 0 /1 1, G ly 9 2 /1 2 ,
L y s 9 9 /2 ,  W at/3
2 3 .5
w e l l  d e f in e d  
in  th e  e le c tr o n  
d e n s ity  m a p
Note : van der Waals interactions were calculated using CCP4 (CCP4, 1994). van der Waals distances 
are the maximum allowed values of C-C : 4.1 A, C-N : 3.8 A, C-O: 3.7 A, O-O: 3.3 A, O-N: 3.4A and 
N-N:3.4 A. Accessible protein surface per atom for the Histidine residue was calculated using DSSP 
(Kabsch and Sanders, 1983).
Table 3.22 Detailed Environment of Histidine 91 in W67L/W91H 
variant structure
atom
H is  91 
van der Waals interactions/ 
no o f contacts
Accessible protein 
surface (A2)
N V a l7 4 /1 ,  T y r 9 0 /6 , G ly 9 2 /1 0 .0
Cot T y r 9 0 /3 , G ly 9 2 /2 ,  L y s 9 9 /1 0 .0
cp T y r 9 0 /2 , G ly 9 2 /1 ,  L y s 9 9 /1 8 .3
Cy T y r 9 0 /1 ,  G ly 9 2 /1 4 .6
C52 T y r 9 0 /1 ,  W at/1 1 8 .9
N51 G ly 9 2 /3 ,  W at/1 1 .6
Csl V a l7 4 /1 ,  W at/1 2 8 .5
Ns2 — 1 3 .4
C M e t7 3 /1 ,  G ly 9 2 /4 0 .0
O M e t 7 3 /3 ,  V a l7 4 /1 0 .0
Note : van der Waals interactions were calculated using CCP4 (CCP4, 1994). van der Waals 
distances are the maximum allowed values of C-C : 4.1 A, C-N : 3.8 A, C-O: 3.7 A, 0 -0 : 3.3 
A, O-N: 3.4A and N-N: 3.4 A. Accessible protein surface per atom of Tryptophan residue was 
calculated using X-PLOR (Brunger, 1992).
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rRBP variant: 
Trp 67 to Leu & Trp 91 to His
Figure 3 .1 6
Portion o f (2Fo-Fc) electron density map at position 91. The figure was prepared 
using BOBSCRIPT (Esnouf 1997)
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Solvent accessibility calculations for the tryptophan residues in 
rRBP structure show that Trp24 is buried, Trp91 is partially exposed 
and Trp 105 is exposed to the solvent. Trp24 makes H-bond interactions 
with Phe20 and Ala43, Trp91 forms H-bonds with Val74 and Trp 105 is 
involved in H-bond interactions with Tyrl 18 (Table 3.14). Also, all 
three tryptophan residues make a large number of stacking (van der 
Waals) interactions as shown in Table 3.19. The interactions involving 
Trp 105 are presented in Figure 3.17.
Figure 3 .1 7
Portion o f the final 1.7 A (2Fo-Fc) electron density map for rRBP around 
Trp 105. The map is contoured at 1.0a  level. The stacking interaction between 
Trp 105 and Lys85 is shown. The figure was prepared using the program 
BOBSCRIPT (Esnouf 1997).
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No significant differences are observed in the double variant 
structure for tryptophans 24 and 105. Trp 24 is completely buried in the 
core of the barrel and Trp 105 has become slightly more accessible by 
the solvent. The H-bond interactions are essentially the same as in the 
rRBP structure and only minor differences can be observed.
It is worth noting that tyrosine 111, the only residue that lies in a 
disallowed region in the Ramachandran plot, in both rRBP and the 
variant structures appears to be in the vicinity of Trp24 and is involved 
in non-polar interactions. No functional significance has been assigned 
to Tyr 111 residue. Detailed interactions of Tyr 111 in rRBP and 
W67L/W91H double variant structure are listed in Tables 3.23-3.28.
Table 3.23 Hydrogen-bond interactions of Tyrosine 111 in rRBP
atom H-bonds distance < 3.3 A Distance (A) Angle (°)
N T h r l0 9  O y l 2 .9 1 2 2 .7
A s p l  10  0 5 1 3 .7 1 0 8 .5
O H A s p l 6  N 2 .8 1 5 2 .9
W a t O 2 .7 0 .0
0 A r g l3 9  N e 2 .7 1 5 3 .7
A r g 3 9  N r |2 2 .9 1 3 8 .3
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Table 3.24 Environment of Tyrosine 111 in rRBP
Residue
van der Waals 
interactions/ 






Tyr 111 L y s l 2 / 3 ,  P h e  1 5 /4 ,  
A s p l 6 / 5 ,  A r g l9 / 1 2 ,  
P h e 2 0 /2 ,  T r p 2 4 /6 ,  
T h r l0 9 /5 ,  A s p l  1 0 /1 7 ,  
A s p l  1 2 /1 1 ,T h r l 1 3 /2 ,  
A r g  1 3 9 /1 ,  W a t/2
1 2 .0 1 9 .9
w e l l  d e f in e d  
in  th e  e le c tr o n  
d e n s ity  m ap
Note : van der Waals interactions were calculated using CCP4 (CCP4, 1994). van der Waals distances 
are the maximum allowed values of C-C : 4.1 A, C-N : 3.8 A, C-O: 3.7 A, O-O: 3.3 A, O-N: 3.4A and 
N-N:3.4 A. Accessible protein surface per atom for the Tyrosine residue was calculated using DSSP 
(Kabsch and Sanders, 1983).
Table 3.25 Details of the environment of Tyrosine 111 in rRBP




N T h r l0 9 /1 ,  A s p l  1 0 /6 , A s p l  12/1 0 .0
Ccc T r p 2 4 /2 ,  T h r l0 9 /1 ,  A s p l  1 0 /4 , A s p l  1 2 /2 0 .0
c p A r g  1 9 /1 ,  A s p l  1 0 /2 , A s p l  12 /1 4 .4
Cy A r g l 9 / 3 ,  A s p l  10 /1 0 .0
C51 A r g  1 9 /2 ,  P h e 2 0 /2 ,  T h r l0 9 /1 0 .0
Cel P h e  1 5 /2 ,  A s p  1 6 /2 , A r g l9 / 1 ,  T h r l0 9 /1 0 .0
C52 A r g  1 9 /3 ,  A s p  1 1 0 /2 1 .9
Ce2 L y s l 2 / 1 ,  A r g l 9 / 1 ,  W at/1 7 .2
C ^ L y s l 2 / 1 ,  A s p  1 6 /2 , T h r l0 9 /1 ,  W at/1 0 .0
OH L y s l 2 / 1 ,  P h e l5 /2 ,  A s p l6 /1 1 .0
C T r p 2 4 /2 ,  A s p l  1 0 /2 , A s p l  1 2 /4 , T h r l 1 3 /1 0 .4
O A r g  1 9 /1 ,  T r p 2 4 /2 , A s p l  1 2 /3 , T h r l 1 3 /1 , A r g l3 9 /1 1 .6
Note : van der Waals interactions were calculated using CCP4 (CCP4, 1994). van der Waals 
distances are the maximum allowed values of C-C : 4.1 A, C-N : 3.8 A, C-O: 3.7 A, 0 -0: 3.3 A, 
O-N: 3.4A and N-N: 3.4 A. Accessible protein surface per atom of Tyrosine residue was 
calculated using X-PLOR (Briinger, 1992).
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Table 3.26 Hydrogen-bond interactions of Tyr 111 in W67LAV91H variant
structure
atom H-bonds distance < 3.3 A Distance (A) Angle (°)
N T h r l0 9  O y l 2 .9 1 2 4 .2
A s p l  10  0 5 1 3 .2 1 07 .1
O H A s p l 6  N 2 .8 1 4 7 .2
W a t O 2 .4
0 A r g l 3 9  N b 2 .7 1 5 1 .7
A r g 3 9  N r)2 2 .9 1 3 9 .6
Table 3.27 Environment of Tyrosine 111 in W67LAV91H variant structure
Residue van der Waals 
interactions/  







L y s l 2 / 1 ,  P h e  1 5 /4 ,
Tyr 111
A s p  1 6 /2 , A r g  1 9 /1 0 ,  
P h e 2 0 /3 ,  T r p 2 4 /4 ,  
T h r l0 9 /3 ,  A s p l  1 0 /1 6 ,  
A s p l  1 2 /1 0 , T h r l 1 3 /1 ,  
A r g l3 9 / 1 ,  W a t/2
1 2 .0 1 4 .9
w e l l  d e f in e d  in  
th e  e le c tr o n  
d e n s ity  m a p
Note : van der Waals interactions were calculated using CCP4 (CCP4, 1994). van der Waals distances 
are the maximum allowed values of C-C : 4.1 A, C-N : 3.8 A, C-O: 3.7 A, O-O: 3.3 A, O-N: 3.4A and 
N-N:3.4 A. Accessible protein surface per atom for the Tyrosine residue was calculated using DSSP 
(Kabsch and Sanders, 1983).
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Table 3.28 Details of the environment of Tyr 111 in W67LAV91H 
variant structure
atom van der Waals interactions /  no o f  contacts
Accessible protein 
surface (A2)
N T h r l0 9 /1 ,  A s p l  1 0 /6 , A s p l  12 /1 0 .0
C a T h r l0 9 /1 ,  A s p l  1 0 /4 , A s p l  1 2 /2 0 .0
c p A r g l 9 / 1 ,  A s p l  1 0 /2 , A s p l  12 /1 4 .0
C y A r g  1 9 /2 ,  A s p l  10 /1 0 .0
C51 A r g  1 9 /2 ,  P h e 2 0 /3 0 .0
C e l P h e  1 5 /2 ,  A s p  1 6 /4 , A r g l9 / 1 ,  T h r l0 9 /1 0 .0
C52 A r g  1 9 /4 ,  A s p l  10 /1 2 .2
Ce2 L y s l 2 / 1 ,  A r g l 9 / 1 ,  W at/1 7 .0
c ? A s p  1 6 /2 ,  W a t/1 0 .0
OH P h e  1 5 /2 ,  A s p  1 6 /1 1 .5
C T r p 2 4 /2 , A s p l  1 0 /2 , A s p l  1 2 /4 , T h r l 13 /1 0 .3
O T r p 2 4 /2 , A s p l  1 2 /2 , A r g  1 3 9 /1 1 .9
Note : van der Waals interactions were calculated using CCP4 (CCP4, 1994). van der Waals 
distances are the maximum allowed values of C-C : 4.1 A, C-N : 3.8 A, C-O: 3.7 A, O-O: 3.3 
A, O-N: 3.4A and N-N: 3.4 A. Accessible protein surface per atom of Tyrosine residue was 
calculated using X-PLOR (BrUnger, 1992).
The crystal structures o f rRBP and its double variant reveal the 
sequence substitutions at position 67 and 91 in rRBP molecule do not 
seem to disrupt the overall native structure o f the protein. These results 
are in agreement with those found by near- and far-UV circular 
dichroism (Greene, 1998).
The high mobility the loop around residue 67 exhibits, prevents
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the more detailed analysis of that critical region for the formation of the 
RBP-TTR complex. However, it seems that the loop 62-67 adopts a 











Loop region around position 67 for the structures o f  (a) rRBP-1. 7 A resolution, (b) 
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Further experimental work on RBP should include the 
optimisation of the crystallisation conditions of the two single variants 
Trp24-Tyr and Trpl05-Phe with the aim to assess the role that 
conserved residues within the RBP family of molecules (either within 
the lipocalin superfamily or the RBP family only) serve in the RBP 
molecule by giving structural evidence that could support a relationship 
between conservation and the molten globule stability.
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